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Abstract 
The unifying theme of this thesis is a series of research studies that collectively 
amount to a feasibility study for clinical trials of laryngeal reinnervation for the 
treatment of vocal fold paralysis. The question ‘Does laryngeal reinnervation or 
thyroplasty give better voice results for patients with unilateral vocal fold paralysis 
(UVFP)?’ remains outstanding; a question that ideally requires a randomised control 
trial. However, randomised control trials in surgery face inherent surgeons’ equipoise 
and recruitment issues that may lead to its failure. I performed a national survey of 
UK ENT consultants exploring their perception and obtaining crude numbers of 
eligible UVFP patients under their care for such trial, which revealed that the 
majority of ENT surgeons are receptive to the trial and the size of the potential 
patient pool is promising. I interviewed eligible UVFP patients to explore issues 
around the recruitment process, and this suggested that the proposed trial is feasible. 
Some phraseology used during recruitment that needed changing was identified, 
which may optimise the recruitment process for a trial.  
In voice surgery trials, outcome measures should be multidimensional and 
standardised. Acoustic analysis has been proposed but has limitations. OperaVOX is 
a potential new acoustic analysis software developed to resolve some of these 
factors. I demonstrated that OperaVOX is statistically comparable to the ‘gold 
standard’, Multidimensional Voice Programme, for most principal phonatory 
outcome measures. 
Another outcome measure- video-laryngostroboscopy, allows visual evaluation of 
characteristics and vibratory pattern of vocal folds. It is typically subjective that 
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requires inter- and intra-rater reliability study. Here, I demonstrated that certain 
parameters depicted substantial inter- and intra-rater reliability. However, I showed 
that rater training is required to improve the reliability of other parameters. 
I investigated MRI as a potential non-invasive method to evaluate vocal muscles’ 
denervation and reinnervation. I found that signal changes on the T2-weighted MRI 
larynx images correlated with electrophysiological results with good repeatability. 
Another MRI sequence, dynamic contrast enhanced- and diffusion weighted MRI, 
suggested reduced perfusion in paralysed muscles, whilst cine-MRI for vocal fold 
mobility assessment demonstrated considerable potential as a method to grade vocal 
fold mobility. 
Finally, I present a small prospective case series of non-selective and selective 
laryngeal reinnervation in UVFP and unilateral vagal paralysis following vagal 
tumour excision respectively concomitant with injection laryngoplasty. Voice 
improvement was demonstrated by voice handicap index-10 and other 
multidimensional outcome measures, and these were supported by laryngeal 
electromyography and T2-weighted MRI outcomes. To my knowledge, this is the 
first multidimensional prospective study of laryngeal reinnervation and also the first 
to suggest that 3T MRI may be a promising outcome measure for future 
reinnervation trials. 
In summary, I have shown that a randomised trial of laryngeal reinnervation versus 
thyroplasty is feasible in the UK, and have validated patient- and observer-rated 
outcome measures. I have also shown that MRI may offer an alternative to 
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electromyography in the assessment of laryngeal neuromuscular function in future 
trials and the clinic.
 6 
Acknowledgement 
First and foremost, I would like to extend my sincere gratitude to my supervisors 
Martin Birchall and Shonit Punwani. They had tirelessly given their continuous 
support, guidance, advice and help throughout my research. I learned a lot from them 
either directly or indirectly how to be a good researcher. Their helpful comments for 
my thesis writing are greatly appreciated. Without them I couldn’t have survived the 
PhD research course. 
 
I would also like to express great appreciation to John Rubin, Anne Schilder and 
Guri Sandhu for their invaluable support and feedback throughout my research and 
patients recruitment. Thanks to Peter Clarke, Alasdair Mace, Elfy Chevretton, Khalid 
Ghufoor, Taran Tatla and other ENT surgeons for collaborating in my study. 
 
I am thankful to the Centre for Medical Imaging of University College London team 
members: Shonit Punwani; David Atkinson; Alex Menys; Georgekutty Naduvilethil; 
Nicola Stevens; and Lorna Smith for assisting me in developing the MRI protocol 
and scanning the participants. The MRI study would not be possible without their 
help, support and extremely useful feedback. 
 
I thank Anil Alexander, Oscar Forth and Owain Hughes for introducing me the 
OperaVOX, a new voice analysis software package. I was given an opportunity to 
test the prototype of the software of which subsequently I purchased and used the 
final version of the software package for my PhD research. 
 
 7 
A heartfelt special thanks to Gary Wood, Philippa Ratcliffe and Marion Alston, for 
they had given unconditional commitment in evaluating video clips of the video-
laryngostroboscopy study and collaborating in the OperaVOX study. I really 
appreciate time and technical support on acoustic analysis provided by Gary. 
 
I am extremely thankful to Robert Royston, Bryan Youl and the Neurophysiology 
team members of Royal Free Hampstead Hospital. Robert had provided technical 
support for laryngeal electromyography tests and Bryan contributed his expertise in 
evaluating the electromyography tracing. 
 
I thank JW Fairley and ENT UK Members for their voluntary contribution in the 
survey of perception of the proposed randomised control trial of laryngeal 
reinnervation versus thyroplasty.  
 
I am very grateful to all staffs of Royal National Throat Nose Ear Hospital, 
University College Hospital and University College London. They are very kind, 
friendly and helpful throughout my research period. Anne Oliphant, Heather Fitzke, 
Angela Constantinou and Jumoi Abiona are some of the names that I could mention 
here. 
 
My gratitude also extended to all volunteers of University College London and 
University College London Hospital PhD and masters students and staffs, and 
patients for participating in my study and willingly attended all the clinic visits and 
tests.  
 
 8 
Thanks to the Otorhinolaryngology Department of Universiti Kebangsaan Malaysia 
Medical Centre especially to Abdullah Sani for infusing motivation and Muhammad 
Razif M. Yunus and my colleagues for their continuous moral support. 
 
I would like to thank the Ministry of Higher Education Malaysia, National 
University of Malaysia (University Kebangsaan Malaysia) and Universiti 
Kebangsaan Malaysia Medical Centre for providing financial sponsorship, and 
Radiological Research Trust for funding the MRI research.  
 
Last but not least, My deepest gratitude goes to my husband, Muhammad Nazri and 
children, Muhammad Zaim, Nurun Nuha and Sofiyyah Hani for their support, 
patience and understanding during my difficult times through out my study. 
 9 
Table	  of	  content	  
Declaration	  .........................................................................................................................	  2	  
Abstract	  ...............................................................................................................................	  3	  
Acknowledgement	  ...........................................................................................................	  6	  
List	  of	  figures	  ..................................................................................................................	  13	  
List	  of	  tables	  ....................................................................................................................	  18	  
Abbreviation	  ...................................................................................................................	  22	  
Chapter	  1	   Introduction	  ............................................................................................	  24	  
1.1	   Intrinsic	  laryngeal	  muscles	  and	  the	  innervation	  ..............................................	  24	  
1.2	   Pathophysiology	  of	  peripheral	  nerve	  injury	  and	  repair	  ................................	  29	  
1.3	   Spontaneous	  laryngeal	  reinnervation	  and	  synkinesis	  ...................................	  31	  
1.4	   Vocal	  fold	  paralysis	  .....................................................................................................	  35	  1.4.1	   Unilateral	  vocal	  fold	  paralysis	  .......................................................................................	  35	  1.4.2	   Bilateral	  vocal	  fold	  paralysis	  ..........................................................................................	  38	  
1.5	   Laryngeal	  Reinnervation	  ..........................................................................................	  40	  
1.6	   Non-­‐selective	  reinnervation	  -­‐	  review	  ...................................................................	  41	  1.6.1	   Methods	  ...................................................................................................................................	  46	  1.6.2	   Results	  ......................................................................................................................................	  47	  1.6.3	   Discussion	  ...............................................................................................................................	  53	  
1.7	   Selective	  reinnervation	  -­‐	  review	  ............................................................................	  55	  1.7.1	   Phrenic	  nerve	  ........................................................................................................................	  56	  1.7.2	   Variability	  of	  nerve	  supply	  to	  the	  PCA	  .......................................................................	  57	  1.7.3	   Selective	  reinnervation	  in	  vagal	  nerve	  tumour	  patients	  ....................................	  58	  1.7.4	   Conclusion	  ..............................................................................................................................	  63	  
1.8	   Randomised	  controlled	  trial	  in	  UVFP	  intervention–	  the	  need	  and	  
problems	  ...................................................................................................................................	  64	  
1.9	   Voice	  outcome	  measures	  ..........................................................................................	  68	  
1.10	   Acoustic	  analysis	  .......................................................................................................	  73	  
1.11	   Assessment	  of	  denervation	  and	  reinnervation	  of	  laryngeal	  muscles	  .....	  76	  1.11.1	   Laryngeal	  electromyography	  ......................................................................................	  76	  1.11.2	   Magnetic	  resonance	  imaging	  .......................................................................................	  79	  
1.12	   Assessment	  of	  visual	  findings	  of	  vocal	  folds	  ....................................................	  82	  1.12.1	   Visual	  findings	  of	  vocal	  folds’	  vibration	  patterns	  and	  characters	  ...............	  82	  
 10 
1.12.2	   Visual	  findings	  of	  vocal	  fold	  mobility	  .......................................................................	  83	  
1.13	   Thesis	  outline	  .............................................................................................................	  86	  1.13.1	   Laryngeal	  reinnervation	  in	  vocal	  fold	  paralysis	  ..................................................	  86	  1.13.2	   Outcome	  measures	  to	  monitor	  the	  treatment	  effect	  .........................................	  87	  1.13.3	   Non-­‐invasive	  outcome	  measures	  for	  laryngeal	  reinnervation	  .....................	  87	  1.13.4	   Case	  series	  of	  laryngeal	  reinnervation	  ....................................................................	  89	  
Chapter	  2	   A	  qualitative	  study	  of	  the	  views	  and	  beliefs	  of	  surgeons	  and	  
patients	  on	  a	  randomised	  control	  trial	  of	  laryngeal	  reinnervation	  versus	  
thyroplasty	  for	  unilateral	  vocal	  fold	  paralysis.	  ...................................................	  90	  
2.1	   Abstract	  ...........................................................................................................................	  91	  
2.2	   Background	  ...................................................................................................................	  93	  
2.3	   Methods	  ..........................................................................................................................	  97	  2.3.1	   For	  UK	  ENT	  surgeons	  (survey)	  ......................................................................................	  97	  2.3.2	   For	  UVFP	  patients	  (individual	  interview)	  ................................................................	  98	  
2.4	   Results	  ..........................................................................................................................	  102	  2.4.1	   For	  ENT	  surgeons	  (survey)	  ...........................................................................................	  102	  2.4.2	   For	  UVFP	  patients	  (individual	  interview)	  ..............................................................	  107	  
2.5	   Discussion	  ...................................................................................................................	  121	  2.5.1	   Overview	  ...............................................................................................................................	  121	  2.5.2	   For	  ENT	  surgeons	  (survey)	  ...........................................................................................	  121	  2.5.3	   For	  UVFP	  patients	  (individual	  interview)	  ..............................................................	  125	  2.5.4	   Conclusion	  ............................................................................................................................	  130	  
Chapter	  3	   Reliability	  of	  OperaVOX	  against	  Multidimensional	  Voice	  
Program	  (MDVP)	  .........................................................................................................	  131	  
3.1	   Abstract	  ........................................................................................................................	  132	  
3.2	   Background	  ................................................................................................................	  133	  
3.3	   Methods	  .......................................................................................................................	  135	  
3.4	   Results	  ..........................................................................................................................	  141	  
3.5	   Discussion	  ...................................................................................................................	  147	  
3.6	   Conclusion	  ...................................................................................................................	  154	  
Chapter	  4	   Reliability	  of	  video-­‐laryngostroboscopy	  evaluation	  in	  patients	  
with	  unilateral	  vocal	  fold	  paralysis	  .......................................................................	  155	  
4.1	   Abstract	  ........................................................................................................................	  156	  
4.2	   Introduction	  ...............................................................................................................	  157	  
 11 
4.3	   Methods	  .......................................................................................................................	  160	  
4.4	   Results	  ..........................................................................................................................	  163	  
4.5	   Discussion	  ...................................................................................................................	  165	  
4.6	   Conclusion	  ...................................................................................................................	  170	  
Chapter	  5	   Denervation	  changes	  on	  T2-­‐MRI	  of	  vocal	  fold	  paralysis:	  a	  
repeatability	  study	  .....................................................................................................	  171	  
5.1	   Abstract	  ........................................................................................................................	  172	  
5.2	   Introduction	  ...............................................................................................................	  174	  
5.3	   Methods	  .......................................................................................................................	  177	  
5.4	   Results	  ..........................................................................................................................	  183	  
5.5	   Discussion	  ...................................................................................................................	  188	  
5.6	   Conclusion	  ...................................................................................................................	  192	  
Chapter	  6	   Muscle	  perfusion	  in	  laryngeal	  muscles	  paralysis:	  Findings	  on	  
dynamic	  contrast	  enhanced	  MRI	  and	  diffusion	  weighted	  MRI	  ....................	  194	  
6.1	   Abstract	  ........................................................................................................................	  195	  
6.2	   Introduction	  ...............................................................................................................	  197	  
6.3	   Methods	  .......................................................................................................................	  199	  
6.4	   Results	  ..........................................................................................................................	  205	  
6.5	   Discussion	  ...................................................................................................................	  208	  
6.6	   Conclusion	  ...................................................................................................................	  212	  
Chapter	  7	   Functional	  assessment	  of	  vocal	  fold	  mobility	  using	  cine-­‐
Magnetic	  Resonance	  Imaging	  ..................................................................................	  213	  
7.1	   Abstract	  ........................................................................................................................	  214	  
7.2	   Introduction	  ...............................................................................................................	  216	  
7.3	   Methods	  .......................................................................................................................	  218	  
7.4	   Results	  ..........................................................................................................................	  230	  
7.5	   Discussion	  ...................................................................................................................	  235	  
7.6	   Conclusion	  ...................................................................................................................	  239	  
Chapter	  8	   Case	  series	  of	  non-­‐selective	  and	  selective	  laryngeal	  
reinnervation	  ...............................................................................................................	  240	  
8.1	   Non-­‐selective	  laryngeal	  reinnervation	  in	  unilateral	  vocal	  fold	  paralysis	  
patients	  ...................................................................................................................................	  241	  8.1.1	   Abstract	  .................................................................................................................................	  241	  8.1.2	   Background	  ..........................................................................................................................	  243	  
 12 
8.1.3	   Methods	  .................................................................................................................................	  245	  8.1.4	   Results	  ....................................................................................................................................	  250	  8.1.5	   Discussion	  .............................................................................................................................	  261	  8.1.6	   Conclusion	  ............................................................................................................................	  265	  
8.2	   Immediate	  selective	  laryngeal	  reinnervation	  in	  vagal	  paraganglioma	  
patients	  ...................................................................................................................................	  266	  8.2.1	   Abstract	  .................................................................................................................................	  267	  8.2.2	   Background	  ..........................................................................................................................	  269	  8.2.3	   Methods	  .................................................................................................................................	  271	  8.2.4	   Results	  ....................................................................................................................................	  274	  8.2.5	   Discussion	  .............................................................................................................................	  285	  8.2.6	   Conclusion	  ............................................................................................................................	  289	  
General	  conclusion	  .....................................................................................................	  290	  
General	  limitations	  and	  future	  research	  .............................................................	  294	  
References	  .....................................................................................................................	  296	  
Appendix	  1-­‐	  ENT	  UK	  survey	  questionnaire	  ........................................................	  319	  
Appendix	  2	  –	  Participant	  information	  sheet	  ......................................................	  322	  
Appendix	  3	  –	  Voice	  Handicap	  Index	  (VHI-­‐10)	  ...................................................	  331	  
Appendix	  4	  -­‐	  Eating	  Assessment	  Tool	  (Eat-­‐10)	  .................................................	  332	  
Appendix	  5-­‐	  Stroboscopy	  Research	  Instrument	  ...............................................	  333	  
Appendix	  6	  –	  Stage	  I	  and	  II	  MRI	  study	  ..................................................................	  334	  
13 
List of figures 
Figure 1-1: This picture shows a bird's eye view of intrinsic laryngeal muscles 
and the attachments................................................................................................... 25 
Figure 1-2: This diagram shows components of a nerve trunk .................................. 29	  
Figure 1-3: This diagram shows an implant inserted through the thyroid cartilage     
lamina window to medialise vocal fold in a thyroplasty operation ........................ 38 
Figure 1-4: These intra-operative photos show: a) an identification of the ansa 
cervicalis nerve; b) an identification of the recurrent laryngeal nerve; and d) an 
ansa cervalis to recurrent laryngeal nerve anastomosis. .................................... 43	  
Figure 1-5: Diagrammatic picture of one form of laryngeal reinnervation- ansa-RLN 
operation ........................................................................................................... 45	  
Figure 1-6: Laryngeal electromyography procedure. This photo shows a needle being 
inserted at the anterior part of the neck through the cricothyroid space to reach 
targeted laryngeal muscles. ................................................................................ 76	  
Figure 2-1: Number of UVFP patients failed voice therapy .................................... 102	  
Figure 2-2: Surgeons' treatment preference ............................................................. 103	  
Figure 2-3: Surgeons' preferred way of trial participation ....................................... 104	  
Figure 3-1: This figure shows OperaVOX that has been installed on an iPod touch 
that shows: A) software icon; B) start analysis page; C) VHI-10 page; D) voice 
recording page; and E) results page. ................................................................ 137	  
14 
Figure 3-2: This photo shows a participant holding the iPod taut during the voice 
recording .......................................................................................................... 138	  
Figure 3-3: Inter-software Bland Altman plot after excluding severe aperiodic voice. 
Dotted lines represent upper and lower 95% limit of agreement. .................... 143	  
Figure 3-4: Intra-software Bland Altman plot for MDVP after excluding severe 
aperiodic voice. Dotted lines represent upper and lower 95% limit of agreement.
 .......................................................................................................................... 145	  
Figure 3-5: Intra-software Bland Altman plot for OperaVOX after excluding severe 
aperiodic voice. Dotted lines represent upper and lower 95% limit of agreement.
 .......................................................................................................................... 145	  
Figure 5-1: This figure shows T2-MRI of larynx images in coronal view showing the 
main cross-sectional bulk of thyroarytenoid muscles of a: A) healthy volunteer; 
and B) unilateral vocal fold paralysis patient. The arrow shows left side 
paralysis in which the bulk is smaller than the normal side. ............................ 180	  
Figure 5-2: This figure shows T2-MRI of larynx images in axial view showing 
posterior cricoarytenoid muscles of a: A) healthy volunteer; and B) unilateral 
vocal fold paralysis patient. The arrow shows left side paralysis in which the 
bulk is smaller and the signal intensity is higher than the normal side. The 
region of interests are drawn in redlines. ......................................................... 181	  
Figure 5-3: This figure shows T2-MRI of larynx images in axial view showing 
thyroarytenoid muscles of a: A) healthy volunteer; and B) unilateral vocal fold 
paralysis patient. The arrow shows left side paralysis in which the signal 
intensity is higher than the normal side. The region of interests are drawn in 
redlines. ............................................................................................................ 181	  
Figure 5-4: This figure shows graphs of correlation between T2-MRI metrics and 
laryngeal electromyography recruitment. r: correlation value, p: p value ....... 187	  
15 
Figure 6-1: Post-contrast T1 weighted image from DCE MRI. The image 
demonstrates enhancement within the: A) Thyroarytenoid (TA) and B) Posterior 
cricoarytenoid (PCA) muscles. Regions of interest outlined in green lines within 
the TA and PCA are used to derive time versus signal intensity curve (below) 
from which quantitative metrics (SoE, ME, AUC-1) can be derived. ............. 201	  
Figure 6-2: Time intensity curve (TIC) .................................................................... 202	  
Figure 6-3: These are b0 images of diffusion weighted imaging of: A) TA; and B) 
PCA. The region of interests are drawn in green lines. ‘b0 images’ indicates 
images acquired at b-value 0 s/mm2 in which the diffusion sensitising gradient 
is absent so free water in tissues appears bright due to the intrinsic T2-
weighting. ......................................................................................................... 202	  
Figure 7-1: A) A T2-weighted coronal view of a participant showing three slices 
placement, two bold lines at the top and bottom and one line in the middle 
through the superior surface of the true vocal folds. B) A sagittal reference scan 
showing the angulation of the axial motion sequence positioned at right angles 
to the larynx. C) A frame from an axial motion sequence image of vocal folds 
during respiration. ............................................................................................ 221	  
Figure 7-2: This endoscopic view of the normal larynx depicts the vocal folds 
position during: A) respiration; and B) phonation. AC: Anterior commissure, 
PC: Posterior commissure. ............................................................................... 222	  
Figure 7-3: Schematic depicting an imaginary line bisecting the anterior and 
posterior commissure and dividing the: A) respiration; and B) phonation area 
into right and left. Note that the phonation area is very small. LRA: Left 
respiration area, RRA: Right respiration area. ................................................. 223	  
Figure 7-4: This endoscopic view of left vocal fold paralysis depicts the position of 
the paralysed vocal folds during respiration and phonation ............................ 224	  
16 
Figure 7-5: A, D: Selected image that represent glottal area during phonation and 
respiration respectively; B, E: A vertical line was drawn from anterior 
commissure bisecting the posterior commissure and the cervical vertebra 
dividing the triangular larynx to left and right glottal area; and C, F: Region of 
interests drawn to measure left and right phonation area and respiration area. 227	  
Figure 7-6: Selected sequential images of respiration at 10 time points of: A) a 
healthy volunteer; B) a patient with left vocal fold paralysis. The arrows shows 
right and left vocal fold .................................................................................... 228	  
Figure 7-7: These graphs show distribution of VFPa, VFRa and VFaP in left vocal 
fold paralysis patients and healthy volunteers. ................................................ 232	  
Figure 8-1: T2-weighted imaging of vocal folds images of patient-1, -2 and -3. 
Images on column (A) are taken at baseline and column (B) at 12-month. At 
baseline, the paralysed thyroarytenoid muscles (white arrow) had higher signal 
intensity than the opposite normal. The signal intensity normalised at 12-month 
except in patient-2 ............................................................................................ 253	  
Figure 8-2: These graphs show maximum phonation time, mean flow rate and 
maximum sound pressure level of 5 patients. .................................................. 255	  
Figure 8-3: These graphs show acoustic analysis results of 5 patients at different time 
points ................................................................................................................ 259	  
Figure 8-4: Videostroboscopy images of patient-1 during phonation (left column) 
and breathing (right column) at: (A) before; (B) 1-; (C) 6-; and (D) 12-months 
post selective reinnervation .............................................................................. 276	  
Figure 8-5: Videostroboscopy images of patient-2 during phonation (left column) 
and breathing (right column) at: (A)1-; (B) 6-; and (C) 12-months post-selective 
reinnervation. Her normal vocal folds before operation is not shown here. .... 279	  
17 
Figure 8-6: Graphs depict improvement of voice and swallowing in patient-1 and 
patient-2 as measured by the VHI-10 and EAT-10. ......................................... 280	  
Figure 8-7: Patient-1 (top row) and patient-2 (bottom row), T2-MRI showing signal 
intensity changes on the left TA muscle at baseline (A,D); 6- (B,E); and 12-
months (C,F) following the reinnervation. The arrow shows the left TA. ...... 283	  
Figure 8-8: Patient-1 T2-MRI PCA bulk on axial plane at: baseline (A); 6- (B); and 
12-months (C) post-selective reinnervation. The arrow shows the paralysed 
side. .................................................................................................................. 284	  
Figure 8-9: Patient-2 T2-MRI depicting PCA bulk on axial plane at baseline (A); 6- 
(B); and 12-months (C) post-selective reinnervation. The arrow shows the 
paralysed side ................................................................................................... 284	  
 18 
List of tables 
Table 1-1: Sunderland classification of peripheral nerve injury ................................ 30	  
Table 1-2: All studies of human laryngeal reinnervation from 2009 to 2013 ............ 50	  
Table 1-3: Summary of results of the three studies extracted in the systematic review
 ............................................................................................................................ 51	  
Table 2-1: Unilateral vocal fold paralysis patients identified in the clinics ............... 99	  
Table 2-2: Themes extraction of comments given by surgeons who are unwilling to 
participate ......................................................................................................... 105	  
Table 2-3: Voice problems related to unilateral vocal fold paralysis ...................... 108	  
Table 2-4: Problems encountered following the voice problems ............................ 111	  
Table 2-5: Unilateral vocal fold paralysis patients understanding of a) thyroplasty 
operation and b) laryngeal reinnervation operation ......................................... 113	  
Table 2-6: Unilateral vocal fold paralysis patients understanding on the concept of 
randomization ................................................................................................... 115	  
Table 2-7: Table V: What make them agree or disagree to participate ................... 117	  
Table 3-1: Demographic data. Where means are shown, brackets represent standard 
deviation. .......................................................................................................... 136	  
Table 3-2: Comparison between healthy volunteers and patients with voice disorder 
in females and males after excluding severe aperiodic voice. Where medians are 
shown, brackets represent interquartile range (IQR). ...................................... 142	  
Table 3-3: Normative data measured by OperaVOX and MDVP. Where means are 
shown, brackets represent standard deviation. ................................................. 146	  
 19 
Table 3-4: Normative data from previous studies .................................................... 150	  
Table 3-5: Previous studies inter-software or programme comparison ................... 152	  
Table 4-1: Summary of kappa values for inter-rater reliability ............................... 164	  
Table 4-2: Summary of kappa values for intra-rater reliability ............................... 164	  
Table 5-1: This table shows T2-MRI protocol for axial and coronal view .............. 178	  
Table 5-2: This table shows the summary of anatomical parameters between healthy 
volunteers and UVFP patients. Where medians are shown, brackets represent 
interquartile ranges. .......................................................................................... 183	  
Table 5-3: This table shows within subject repeatability, and inter- and intra-reader 
repeatability results. ......................................................................................... 184	  
Table 5-4: This table shows results of comparison between healthy volunteers and 
UVFP patients. ................................................................................................. 186	  
Table 6-1: MRI protocol of DCE-MRI and Diffusion weighted imaging (DWI) .... 200	  
Table 6-2: Formula for DCE-MRI metrics derived from the time intensity curve 
analysis ............................................................................................................. 203	  
Table 6-3: This table shows within volunteers’ median and interquartile ranges for 
DCE-MRI parameters and ADC of DWI of thyroarytenoid and posterior 
cricoarytenoid muscles. .................................................................................... 205	  
Table 6-4: This table shows within patients’ median and interquartile ranges for 
DCE-MRI parameters and ADC of DWI of thyroarytenoid and posterior 
cricoarytenoid muscles. .................................................................................... 206	  
Table 6-5: This table shows results of comparison between volunteers and patients 
normal thyroarytenoid  and posterior cricoarytenoid muscles. ........................ 207	  
 20 
Table 6-6: This table shows results of comparison between volunteers normal and 
patients paralysed thyroarytenoid posterior cricoarytenoid ............................. 207	  
Table 7-1: MRI protocol for vocal fold motion and coronal T2-weighted imaging 220	  
Table 7-2: This table shows summary of vocal fold motion metrics and the 
inferences ......................................................................................................... 225	  
Table 7-3: This table shows median and interquartile range of VFPa, VFRa and 
VFaP measurements of healthy volunteers and patients for measured for study-
1, study-2 and study-3. ..................................................................................... 231	  
Table 7-4: Results of intra-session, inter-scan repeatability, and inter-reader 
reproducibility. ................................................................................................. 233	  
Table 7-5: Comparison between studies that investigate vocal fold mobility. ........ 237	  
Table 8-1: This table shows the patients’ demographics, and VHI-10 scores, MPT 
and laryngeal electromyography motor unit recruitment ................................. 250	  
Table 8-2: VHI-10 scores at pre- and post-operative ............................................... 251	  
Table 8-3: Thyroarytenoid muscles signal intensity changes at pre- and post-
operation and LEMG motor unit recruitment evaluation comparing pre and 
post-operative tracings ..................................................................................... 252	  
Table 8-4: Inter-rater reliability for voice perceptual evaluation as calculated using
 .......................................................................................................................... 257	  
Table 8-5: Intra-rater reliability for voice perceptual evaluation as calculated using 
weighted kappa coefficient (kappa) and intraclass correlation (ICC) .............. 257	  
Table 8-6: Voice perceptual evaluation by the 3 raters ........................................... 258	  
Table 8-7: Video-laryngostroboscopy analysis evaluation by 3 raters .................... 260	  
 21 
Table 8-8: Summary of voice assessments, acoustic analysis and aerodynamic 
analysis of patient-1 and patient-2. .................................................................. 281	  
Table 8-9: Results of T2-MRI and laryngeal electromyography ............................. 282	  
Table 8-10: Pulmonary function status at before and after selective reinnervation . 282	  
 
 22 
Abbreviation 
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Chapter 1 Introduction 
1.1 Intrinsic laryngeal muscles and the innervation 
The larynx is important for speech, breathing and swallowing. It consists of a 
cartilaginous framework and muscular structures supporting a pair of vocal folds. 
The vocal folds adduct to the midline to make a firm contact during phonation and 
abduct away from the midline during breathing to allow movement of air during 
inspiration and expiration. Intrinsic laryngeal muscles that act as an adductor are the 
lateral cricoarytenoid (LCA), interarytenoid (IA), thyroarytenoid (TA) and 
cricothyroid (CT) muscle (Figure 1-1). For abduction, the vocal folds are mainly 
controlled by posterior cricoarytenoid muscle (PCA).  
The TA is a paired muscle forms the main mass of the true vocal folds. It arises from 
the lower half of the inner part of the angle of thyroid cartilage and inserts into the 
base and anterior surface of the arytenoid cartilage. It runs parallel with the vocal 
ligament and adherent to it. The TA is critical in phonation as vocal fold tension and 
mass are generated by its action. Changes in vocal fold tension affect the pitch of 
phonation while changes in vocal fold mass affect the glottic closure and indirectly 
changes the vocal intensity (Crumley, 1994a). 
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Figure 1-1: This picture shows a bird's eye view of intrinsic laryngeal muscles and the attachments.  
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The LCA is the most important vocal fold adductor and arises from the lateral border 
of the cricoid and inserts into the muscular process of the arytenoids. The contraction 
of LCA pulls the muscular process of the arytenoids in an anterior and medial 
direction. The vocal processes are pulled toward each other in an inward and 
downward movement thus bringing the vocal folds to the midline, closing the 
membranous glottis.  
The IA is an unpaired muscle that has two types of fibres, transverse portion and 
oblique portion. The transverse portion runs horizontally across the posterior part of 
the arytenoid cartilages. The oblique portion runs obliquely from the base of one 
arytenoid to the apex of the other arytenoid. When the IA muscle contracts, it glides 
the arytenoids medially towards each other hence closing the posterior glottis. Some 
of the muscle fibers attach to the posterolateral surface of the arytenoids. Hence its 
contraction will also glide the arytenoids laterally thus stabilising the vocal folds 
during adduction (Mossallam et al., 1987).  
The CT is a paired muscle that consists of two sets of muscle fibres, the pars recta 
and pars oblique. The pars recta originates from the lateral part of the cricoid 
cartilage and runs upward at an angle and inserts into the inferior border of the 
thyroid cartilage. The pars oblique also originates from the lateral border of the 
thyroid cartilage running obliquely upward and inserts into the anterior surface of the 
inferior horn of the thyroid cartilage. The CT muscle acts as a pitch changer by 
elongating and tensing the vocal fold. During contraction, the thyroid cartilage is 
tilted anteriorly and downward toward the cricoid cartilage hence increases the 
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distance between the anterior commissure of the thyroid and the arytenoid cartilages. 
The increase in distance stretches and elongates the vocal folds, decreasing their 
mass per unit of area and increasing the longitudinal tension.  
The PCA is a paired muscle that abducts the vocal folds during breathing. It arises 
from the posterior part of the cricoid lamina and inserts into the muscular process of 
the arytenoid. Its contraction during high-pitched phonation stabilises the arytenoids, 
opposing the anterior force by the TA muscles and the vocal ligaments. Acute 
denervation of the PCA muscle causes partial subluxation of the arytenoid anteriorly, 
inferiorly and medially.  
The intrinsic laryngeal muscles are innervated by two branches of the vagus nerve, 
the recurrent laryngeal nerve (RLN) and the superior laryngeal nerve (SLN). All the 
intrinsic laryngeal muscles- LCA, TA, IA and PCA, are innervated by the RLN 
except the CT muscle innervated by the SLN. Complete transection of the RLN 
completely denervates the ipsilateral muscles except for IA, which has crossed 
innervations. Complete transection of the vagus nerve affects both SLN and RLN 
hence symptoms following the injury may be worse in vagal nerve palsy compared 
to isolated recurrent laryngeal nerve palsy (Crumley and Izdebski, 1986; Woodson, 
2007). 
However, animal and human cadaveric studies on intrinsic laryngeal muscles 
innervation showed nerve supply of the larynx is complex. The classic description 
that all intrinsic laryngeal muscles are supplied by the RLN except the CT muscle 
which is exclusively innervated by the external branch of SLN (eSLN) is inaccurate 
(Maranillo et al., 2003; Martin-Oviedo et al., 2011). TA and PCA muscles were 
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shown to have dual innervation from the RLN and eSLN (Maranillo et al., 2003; 
Nasri et al., 1997) with the RLN predominating (Hydman and Mattsson, 2008). 
Hydman and Mattsson demonstrated electrophysiological evidence of the RLN and 
eSLN innervation of the PCA muscle in rats with an amplitude ratio of 4:1 (Hydman 
and Mattsson, 2008). Oviedo studied human laryngeal nerve connections in 13 
patients undergoing total laryngectomy found that in 7 patients, the CT muscles were 
not exclusively innervated by the eSLN but received some innervation from the RLN 
as well (Martin-Oviedo et al., 2011). And in 3 patients, the PCA muscles were 
showed to receive some innervation from the eSLN. The dual innervation was 
contributed by either inter-connection between the RLN and eSLN or direct 
innervation by the distal branch of the eSLN (Martin-Oviedo et al., 2011; Paskhover 
et al., 2014).  
 
The RLN comprises abductor and adductor motor neurons that are separated in the 
brainstem’s nucleus ambiguus. Abductor motor neurons receive input from the 
inspiratory centre are located in ventral division whereas adductor motor neurons 
receive input from the cortex through the midbrain are located on the dorsal division 
(Flint et al., 1991; Gacek, 2001). This separation was demonstrated by injecting 
retrograde axoplasmic tracers such as horseradish peroxidase (HRP) in individual 
laryngeal muscles. However, the motor axons of abductor and adductor neurons are 
mixed when they enter the peripheral nerve pathway in the vagus as well as the RLN 
in humans. 
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1.2 Pathophysiology of peripheral nerve injury and repair 
A nerve trunk consists of axons, axonal sheath, funiculus (bundles of fascicles) and 
epineurium (Figure 1-2). There are 3 layers of tissue arranged concentrically about 
the axon. Schwann cells form a single layer on the surface of the axon. It is then 
covered by 2 connective tissues, neurilemma (inner) and endoneurium (outer). Axons 
and the nerve sheath comprise a nerve fibre. A number of nerve fibres bundled in a 
sheath of connective tissue (perineurium) form a funiculus. A number of funiculi are 
held together by epineurium and form a nerve trunk. 
Figure 1-2: This diagram shows components of a nerve trunk 
(Biazar et al., 2010). 
30 
An essential component of nervous system is the nerve cell body with its associated 
dendrites and axons. Motor axons are closely associated with Schwann cells that are 
organised in a longitudinal sequence and meet at nodes of Ranvier where they are 
interdigitate with cellular processes. Electrical impulses pass from node to node as 
extracellular ions gain access to the axon. 
Peripheral nerve injury was classified by Seddon (Seddon, 1942) and then was 
further expanded by Sunderland (Sunderland, 1951) as summarised in Table 1-1. The 
peripheral nerve injury was classified in 5 types according to its severity in which 
Wallerian degeneration occurs in type 3 to 5 nerve injury. Wallerian degeneration is 
a condition that occurs when the axon is separated from the cell body. The stump that 
was disassociated from the cell body will undergo degeneration followed by myelin 
degeneration and macrophage infiltration, which removes degenerated axons and 
myelin. Following Wallerian degeneration, the degenerated axons of peripheral 
nerves are able to regenerate due to the ability of the Schwann cells to promote a 
permissible environment. In type 3 to 5 injury, muscle end organ function may not 
return to normal despite effective regeneration due to the phenomenon of synkinesis. 
Table 1-1: Sunderland classification of peripheral nerve injury 
Type of injury Wallerian 
degeneration 
Type I (neuropraxia) Conduction block  No 
Type 2 (axonotmesis) Axonal injury  No 
Type 3 Type 2 + endoneurium injury Yes 
Type 4 Type 3 + perineurium injury Yes 
Type 5 (neurotmesis) Type 4 + epineurium injury  Yes 
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1.3 Spontaneous laryngeal reinnervation and synkinesis 
Injury to the vagus nerve or its branch of the recurrent laryngeal nerve (RLN) causes 
vocal fold paralysis. Common aetiologies of vocal fold paralysis include iatrogenic, 
neoplastic and idiopathic. Other less common causes are traumatic, aortic aneurysm, 
radiation induced and cardiovascular pathology. However, the commonest cause is 
iatrogenic including thyroid surgery, carotid endarterectomy, anterior approaches to 
the cervical spine, and heart or great vessel surgery (Rosenthal et al., 2007). 
Thyroidectomy has the highest incidence and the trend may still be increasing 
despite improvement in surgical skill and use of intra-operative RLN monitor 
(Benninger et al., 1998; Chen et al., 2007; Rosenthal et al., 2007; Yumoto et al., 
2002). The injury could be temporary or permanent. Risk of permanent RLN palsy 
following thyroidectomy has been estimated at 1-2% (Jeannon et al., 2009) but this 
may be a considerable underestimate due to problems of follow up and reporting. 
Following peripheral nerve injuries, denervated skeletal muscles undergo 
morphological changes. In chronic denervation, reports on the laryngeal skeletal 
muscle morphology in animal studies were inconsistent. Some documented atrophy 
and fibrosis in denervated laryngeal muscles (Shindo et al., 1992; Zealear et al., 
1994) whereas others indicate that laryngeal muscles are resistant to atrophy for up 
to one year (Kano et al., 1991). Shindo et al. studied chronological 
electrophysiological, morphology and histochemical changes in a dog laryngeal 
nerve damage model and found that denervation atrophy and fibrosis occurred early 
at 2 to 3 months after nerve transection. After 3 months, a variable degree of partial 
reinnervation was observed. Large muscle fibres in clusters among small atrophic 
fibres were seen at 9 months indicating spontaneous reinnervation.  
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Studies suggest that denervated laryngeal muscles have a strong propensity of 
spontaneous reinnervation (Chen et al., 2011; Woodson, 2007). The reinnervation 
may be due to either (a) sprouting from surrounding intact nerve or (b) regeneration 
of the transected nerve. Woodson’s study (2007) supported the theory of 
regeneration of the transected nerve whereby axons were found scattered in 
surrounding fibrous tissue and/or organised myelinated axons were detected in the 
regenerated nerve across the gap. Likewise, Lewis et al. found no direct contact 
between normal and denervated PCA muscles microscopically and in control animals 
and no identifiable nerve between the right and left experimental muscles (Lewis et 
al., 1991). 
Spontaneous regeneration of an injured RLN in human is unpredictable and not 
universal. Chen et al. performed a cross sectional histologic study of injured RLN of 
unilateral vocal fold (UVFP) patients more than 6 months after injury who 
underwent laryngeal reinnervation surgery. Intraoperative exploration revealed that, 
of 29 cases, the RLN was transected in 24 cases whereas in five cases, the RLN 
stump exhibited continuity between the proximal and distal parts. Microscopic 
examination of all injured nerves revealed that the proximal and distal ends were 
connected by connective tissue. Histology demonstrated a varying degree of RLN 
axonal regeneration. The maximum number of axons found in the injured RLN was 
not more than 40% of axons in healthy control nerves taken from 15 laryngeal 
carcinoma patients undergoing total laryngectomy. The regenerated axons were 
randomly arranged in a manner that might suggest aberrant reinnervation (Chen et 
al., 2011).  
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Aberrant regeneration of abductor and adductor motor axons associated with a 
phenomenon of mass movement of vocal folds is called laryngeal synkinesis 
(Crumley, 2000; Dalgic et al., 2013; Flint et al., 1991; Woodson, 2007). This is 
hypothesised to be the main reason for absence of vocal fold mobility despite a 
robust spontaneous reinnervation of denervated vocal fold muscles. Woodson 
demonstrated that spontaneous reinnervation in TA was more robust than PCA and 
that this may indicate preferential reinnervation in the adductor than abductor 
muscles. Evolution of laryngeal synkinesis was depicted in rats undergoing 
reinnervation by end to end anastomosis immediately after a transection (Pitman et 
al., 2011). The rats were sacrificed at 4, 8, 12, 16 and 20 weeks and their histology 
was evaluated. Electromyography and vocal fold mobility were also evaluated. Vocal 
fold abduction was observed 4 weeks after the procedure and there was no vocal fold 
motion detected further in all but one animal. This phenomenon was shown to be due 
to synkinesis that was first detected at 8 weeks.  
In humans, Blitzer et al. documented 50% incidence of laryngeal synkinesis in vocal 
fold paralysis. A careful diagnosis of laryngeal synkinesis based on laryngeal 
electromyography (LEMG) tracing findings was proposed by Maronian et al. 
Adductor synkinesis may be diagnosed when there is recruitment of motor units of 
the TA during sniffing either equal to or more than the recruitment of motor unit 
during phonation. The recruitment has to be ‘equal or more’ because it is common to 
detect TA activity on the LEMG during sniffing to stabilise the arytenoids and stiffen 
the vocal folds to avoid air turbulence (Hillel, 2001). Abductor synkinesis may be 
categorized as the presence of any significant recruitment of motor units in the PCA 
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muscle during phonation (Maronian et al., 2004). Therefore, a lower incidence of 
laryngeal synkinesis – 10%, than previously published was documented.  
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1.4 Vocal fold paralysis 
1.4.1 Unilateral vocal fold paralysis 
In the acute phase of UVFP, the affected vocal fold is flaccid and incapable of 
closing the glottis during speech. The vocal folds cannot make a firm contact to 
produce a strong voice. The voice is frequently breathy and easily fatigued (Crumley, 
1994a; Misono and Merati, 2012; Woodson, 2007b). This problem may also lead to 
ineffective protective mechanisms by the larynx during swallowing causing 
aspiration that subsequently may lead to aspiration pneumonia. Following the acute 
phase that may last for several weeks, there will be slight improvement of voice as 
results of physiological compensation by the contralateral normal vocal fold 
(Crumley, 1994a). Subsequently, the voice may get spontaneous favourable or un-
favourable outcome (Crumley, 1994a; Hartl et al., 2005). This depends on the 
position of the immobile vocal fold that is varied by few factors such as the degree of 
spontaneous reinnervation, synkinesis and may be the dual innervation from eSLN. 
For favourable outcome, the vocal fold is in median or paramedian position, without 
much vocal fold atrophy and nicely compensated by the contralateral normal vocal 
fold. This results in complete glottal closure during speech producing good voice. 
For un-favourable outcome, the vocal fold is in lateral position with evidence 
atrophy causing incomplete glottal closure during speech, producing breathy, easily 
tired and hoarse voice (Crumley, 1994a; Hartl et al., 2005). 
Symptomatic patients with UVFP suffer reduced general health and quality of life 
due to social and emotional disturbance as a consequence of the voice disorder. In 
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one study, the mean of subscale scores of Assessment Medical Outcome Study 
Short-form 36 (SF-36) survey was significantly lower (p<0.001) from the normal 
population (Fang et al., 2008). The quality of life (QOL) measured with well-
validated voice related quality of life scales - voice handicap index (VHI) (Jacobson 
et al., 1997), voice outcome survey (VOS) (Gliklich et al., 1999), voice related 
quality of life (VRQOL) (Hogikyan and Sethuraman, 1999) was improved 
significantly after surgical interventions (Hogikyan et al., 2000; Spector et al., 2001). 
Therefore, rehabilitation of the paralysed larynx is important to patients.  
Rehabilitation of the paralysed larynx generally includes speech therapy during the 
first 6 months of the watch and wait period as 30 to 60% of patients with UVFP 
resolved spontaneously (Havas et al., 1999; Ramadan et al., 1998; Sulica, 2008) 
either due to spontaneous favourable voice outcome or recovery of vocal fold 
mobility. Where speech therapy alone is insufficient to improve the voice, surgical 
treatment is offered. The aim of surgical treatments for UVFP is to achieve optimum 
glottic closure during voice production. Various surgical treatment options have been 
proposed but, to date, there is insufficient evidence concerning the best surgical 
option to improve voice quality in patients with UVFP (Misono and Merati, 2012). 
The treatment options include injection laryngoplasty, Isshiki type I thyroplasty, 
arytenoid adduction and laryngeal reinnervation (Crumley and Izdebski, 1986; 
Isshiki et al., 1975, 1978; McCulloch and Hoffman, 1998).  
Injection laryngoplasty is a simple procedure whereby a material is injected into the 
space lateral to the paralysed true vocal fold. This material increases bulk to the 
atrophied vocal fold and medialises it to the midline so it makes a firm contact with 
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the contralateral normal vocal fold to produce a strong voice. It is the least invasive 
procedure that avoids neck incision and can be performed either under general 
anaesthesia via transoral or local anaesthesia via transcutaneous. However it is 
normally recommended for patients with small glottal gap (Kwon and Buckmire, 
2004; Lakhani et al., 1996) and the effect of the injection is commonly temporary for 
weeks or months as most of current materials resorbed with time. Therefore the 
patients may need repeated injections (Carroll and Rosen, 2011; Mallur and Rosen, 
2010). Injection materials for injection laryngoplasty include fat, bovine gelatin, 
collagen-based products, hyaluronic acid, carboxymethylcellulose and calcium 
hydroxyapatite (Carroll and Rosen, 2011; Kwon and Buckmire, 2004; Mallur and 
Rosen, 2010; McCulloch et al., 2002; Wen et al., 2013). The clinical effectiveness of 
these injection materials varies from 4 to 6 months (Mallur and Rosen, 2010). There 
is no high evidence in the literature as yet to suggest which is the most ideal material 
to be used that provides long term effect (Lakhani et al., 1996). 
Isshiki type I thyroplasty (Isshiki et al., 1975) is widely used to rehabilitate the 
permanently paralysed larynx (Leder and Sasaki, 1994; McLean-Muse et al., 2000). 
It is an operation in which an implant is inserted through a window in the thyroid 
cartilage lamina of the larynx. This implant medialises the paralysed vocal fold in the 
midline position allowing the normal opposite vocal fold to make firm contact and 
produce a stronger voice (Figure 1-3). However, theoretically voice improvement 
may not be long term due to progressive atrophy of the denervated laryngeal 
muscles. And there may be persistent mild hoarseness due vocal fold stiffness caused 
by the silastic block (Maronian et al., 2004; Uloza et al., 2005). Furthermore, this 
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procedure does not restore vocal fold tension, meaning that pitch variation remains 
suboptimal. Patients who had undergone thyroplasty also may require a second 
operation such as revision thyroplasty, injection laryngoplasty or arytenoid adduction 
to further improve the voice or to treat the deteriorated voice due to progression of 
denervation atrophy (Anderson et al., 2003). 
Figure 1-3: This diagram shows an implant inserted through the thyroid cartilage 
lamina window to medialise vocal fold in a thyroplasty operation (Franco Jr, 2012) 
1.4.2 Bilateral vocal fold paralysis 
For BVFP, both vocal folds are commonly unable to abduct during inspiration 
causing obstruction to the airway. It may present with critical impairment of 
respiration right through to simple voice changes (Benninger and Hseu, 2011; 
Cheung and McGinn, 2007; Dennis and Kashima, 1989). Treatments for BVFP are 
crucial and may be life saving. They are mainly surgery aiming to increase the glottal 
airway to alleviate the respiratory compromise. However, management of BVFP is a 
big challenge to laryngologists as one always needs to balance airway and voice. 
Multiple surgical procedures had been developed in an attempt to improve sufficient 
airway patency. The first option of treatment in severe cases was usually a 
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tracheostomy. However, it is not frequently accepted by the patients as a long-term 
solution as there will always be a tube on the anterior neck that needs care and 
frequent cleaning. Surgical options to enlarge the glottal airway are laser posterior 
cordotomy, arytenoidectomy and laterofixation of the vocal fold with a suture and 
selective reinnervation (Cheung and McGinn, 2007; Dennis and Kashima, 1989; 
Gorphe et al., 2013; Marina et al., 2011a; Olthoff et al., 2005). 
Laser posterior cordotomy and arytenoidectomy either partial or total involves 
opening the posterior part of the glottis. They have been preferred widely by ENT 
surgeons to enlarge the glottal airway (Cheung and McGinn, 2007; Gorphe et al., 
2013; Olthoff et al., 2005; Segas et al., 2001). These surgical treatments have been 
reported as safe and effective in improving the airway but with the expense of 
hoarse, weak and breathy voice. Olthoff measured the airway resistance pre- and 
post-laser posterior cordotomy documented significant reduction in airway resistance 
and dyspnea (p<0.001). However the voice quality as measured by acoustic analysis 
was significantly worse (p=0.001). Voice related quality of life was significantly 
worsened by this type of operation (Yılmaz T et al., 2013).  
Selective reinnervation is a procedure to improve the glottal airway by re-
establishing the vocal fold abduction while preserving the vocal fold tone and bulk 
for good voice quality (Cheung and McGinn, 2007; Marina et al., 2011). Therefore it 
may be the choice to gain both airway improvement and preservation of normal or 
near normal voice quality. This topic will be discussed later in 1.7. 
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1.5 Laryngeal Reinnervation 
A novel surgical approach for vocal fold paralysis is laryngeal reinnervation in which 
a foreign adjacent nerve is connected to a denervated muscle to re-establish working 
motor endplates and produce muscular contraction (Crumley, 1982). Reinnervation 
techniques described in the literature include nerve-to-nerve anastomosis (Crumley 
and Izdebski, 1986), nerve-muscle pedicle (Tucker, 1976) and nerve implant. Nerve 
‘anastomosis’ is actually not an accurate term for nerve repair as it is supposed to be 
used in describing connection of two luminal structures such as bowel, blood vessels, 
bile ducts and others. The more accurate term is nerve repair. However nerve 
anastomosis is a common misuse in the literature related to reinnervation surgery.  
The adjacent nerves that have been used for reinnervation are the ansa cervicalis, 
hypoglossal, superior laryngeal and phrenic. Nerve-to-nerve anastomosis involves 
connecting a donor nerve to the viable distal end of the RLN.  The nerve-muscle 
pedicle technique uses a donor nerve attached to a small block of ‘donor’ muscle 
surrounding its terminal portion. The nerve implant technique is the modification of 
Tucker’s technique whereby the nerve ending is implanted directly into the laryngeal 
muscle. Two main types of laryngeal reinnervation that have been reported are non-
selective and selective.  
Non-selective reinnervation is mainly for UVFP where providing tone and bulk to 
the laryngeal muscle is the primary concern whereas re-establishment of vocal 
mobility is secondary (Crumley, 1991; Lee et al., 2007; Lorenz et al., 2008; Wang et 
al., 2011). Selective reinnervation aims at re-establishing functional mobility to the 
vocal folds (Crumley, 1982; Fex, 1970; Marie et al., 1989; Rice, 1982). Successful 
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functional reinnervation to the PCA would allow BVFP patients to trigger vocal fold 
abduction during respiratory cycle (Marina et al., 2011; Remacle and Eckel, 2010), 
thereby overcoming the main handicap of this disorder.  
1.6 Non-selective reinnervation - review 
Non-selective laryngeal reinnervation presents some low morbidity operations with 
the potential to restore normal or near normal voice in UVFP patients without 
changing vocal fold pliability (Blumin and Merati, 2008; Crumley et al., 1988). The 
most common technique that had been used in the published literature is nerve-to-
nerve anastomosis (ansa cervalis-to-RLN) as described by Crumley (Figure 1-5).  
In this technique, the functioning ansa cervicalis nerve that overlies the internal 
jugular vein and the distal stump of injured RLN are identified and anastomosed 
without tension (Figure 1-4) (Crumley, 1991) . Wang et al. had proposed slight 
modification in which the main branch of the ansa cervicalis to be used instead of the 
branch to sternohyoid or omohyoid (Wang et al., 2011a). First, a horizontally oblique 
incision is made at the mid-thyroid cartilage level. The fascia between the strap 
muscles and the sternocleidomastoid muscles is opened to identify the ansa cervalis 
nerve superficial to the internal jugular vein. The main branch is identified and 
dissected to its termination in muscle. The RLN is then identified at the tracheo-
oesophageal groove. In post-thyroidectomy cases, the RLN can be identified by 
doing intra-laryngeal dissection whereby the nerve will be found a few millimetres 
distal to the cricothyroid joint overlying the posterior cricoarytenoid muscle (PCA). 
The ansa cervicalis (proximally) and RLN (distally) are transected retaining 
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sufficient length for a tension free anastomosis, which is then performed using an 
operating microscope and 9/0 sutures, reinforced by fibrin glue.  
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Figure 1-4: These intra-operative photos show: a) an identification of the ansa cervicalis nerve; b) an identification of the recurrent laryngeal nerve; and d) an 
ansa cervalis to recurrent laryngeal nerve anastomosis. 
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Quality of voice is determined by mass, elasticity, resistance and symmetry of the 
vocal folds, all of which are affected in UVFP. Denervation of the PCA and IA 
muscle causes anterior subluxation of the arytenoid and vocal process causing 
asymmetry of the vocal folds. Reinnervating the paralysed laryngeal muscles in 
UVFP employs the principle of gaining favourable synkinesis (Crumley, 2000) that 
will improve the resting tone and muscle bulk as well as restore the arytenoid to an 
upright position thus reducing the glottal incompetence (Crumley and Izdebski, 
1986; Maronian et al., 2003). Firm contact of the two folds allows synchronous 
oscillation of the mucosa, reducing aperiodicity and perturbation of voice. There are 
several advantages of reinnervation over other surgical techniques.  
This procedure avoids manipulation of the vocal fold therefore the mucosa remains 
supple and pliable. It precludes the need of implant adjustment to fine-tune the voice 
and this makes it suitable even in children. Furthermore, it preserves the possibility 
of other medialisation technique in future if it fails. Disadvantages of this technique 
are the requirement of a general anaesthetic, voice improvement is not immediate, 
requirement of an intact nerve donor and recipient and a suggestion of increased 
probability of delayed or failed reinnervation in older patients (Lee et al., 2007).  
Although the effect of reinnervation is delayed, the problems of aspiration and 
hoarseness may be assisted temporarily by bulking up the vocal fold with absorbable 
injectable substances. 
45 
Figure 1-5: Diagrammatic picture of one form of laryngeal reinnervation- ansa-RLN 
operation (Crumley et al., 1988) 
Rewiring(site(between(the(
uninjured(voice(box(nerve(and(
the(other(nerve(that(supplies(
other(muscle(of(the(neck(
The(injured(part(
of(voice(box(nerve(
left(behind(
Wind(pipe(
VOICE(BOX(FRAME(WORK(
46 
A recent systematic review of studies on reinnervation in UVFP patients was done to 
investigate the effectiveness in improving the voice (Aynehchi et al., 2010). The 
authors extracted 14 papers (Chou et al., 2003; Crumley, 1991; El-Kashlan et al., 
2001; Lee et al., 2007; Lorenz et al., 2008; Maronian et al., 2003; May and Beery, 
1986; Miyauchi et al., 2009; Olson et al., 1998; Paniello, 2000; Smith et al., 2008; Su 
et al., 2007; Tucker, 1989; Zheng et al., 1996) out of 686 papers retrieved from 
literature databases that met the inclusion and exclusion criteria. They were all of 
level IV evidence. Reinnervation techniques used in the studies were varied. Eight 
used ansa-RLN technique, most combined with injection laryngoplasty to assist the 
voice while waiting for the effect of reinnervation. Outcome measures used in the 
studies as well as the measurement time points were also heterogeneous. This review 
revealed that reinnervation is effective in improving voice to a varying degree. 
However due to the low quality of the current literature and heterogeneity in the 
outcome measures used that preclude comparison between studies, a formal 
prospective trial was recommended using standardised, internationally accepted 
outcomes. Here, I performed an additional review to update the 2010 findings. 
1.6.1 Methods 
Search engines were Pubmed, Cochrane and Scopus database from 2009 until 2013. 
Keywords used in carrying out this review were “vocal fold paralysis” OR “vocal 
cord paralysis” OR “recurrent laryngeal paralysis” AND “laryngeal reinnervation” 
OR “nerve anastomosis” OR “nerve-muscle pedicle” OR “nerve implant”.  
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Inclusion citeria: 
Papers on non-selective laryngeal reinnervation in UVFP patients reporting the 
clinical outcomes that include case series, prospective or retrospective cohort, case 
control and randomised controlled studies.  
Exclusion criteria: 
1. Experimental studies of laryngeal reinnervation in animals
2. Other language than English
3. Selective laryngeal innervation in BVFP patients
4. Laryngeal reinnervation in children
5. Studies that did not include clinical outcome measures.
1.6.2 Results 
From 44 papers retrieved, three papers fit the inclusion criteria were extracted. The 
papers reported a prospective study with and without control subjects, and an RCT 
(Paniello et al., 2011; Wang et al., 2011; Yumoto et al., 2010). Two studies (Marcum 
et al., 2010; Zur, 2012) were excluded due lack of clinical outcome measures. 
Another three studies (Hassan et al., 2011; Li et al., 2013; Wang et al., 2011) were 
excluded because the same population of patients was included from other published 
studies (Table 1-2). The three studies included for review are summarised in Table 
1-3. 
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Yumoto et al. included 22 UVFP patients in a retrospective study that used a 
modified nerve implant technique combined with arytenoid adduction. The patients 
were followed up short term (1 to 6 months) and long term (7 to 36 months) post-
operatively. Treatment outcome measures were maximum phonation time (MPT), 
maximum airflow rate and acoustic analysis (jitter, shimmer, harmonic to noise ratio 
and pitch range). The study revealed that there was a significant improvement in all 
outcome measures between pre-operative and post-operative review, at short term 
and long term time points. There was no data on neurological status of the vocal fold 
muscles included in the study. Two of 22 patients had difficulty in breathing 
necessitating tracheostomy to secure the airway. One patient who had surgical 
history of oesophagectomy, developed inspiratory dyspnoea possibly due to 
laryngeal closure reflex triggered by oesophageal regurgitation. Another patient had 
stridor due to laryngeal oedema. Both of them were decannulated in a few days post-
surgery. 
Paniello et al. included 24 patients in the data analysis of an RCT of reinnervation 
(combined with injection laryngoplasty) versus medialisation (thyroplasty with or 
without arytenoid adduction). The primary outcome measure was perceptual 
evaluation by untrained listeners (RUL). The number of patients was small due to 
premature termination of the study by the sponsor as a consequence of a low 
recruitment rate and some issues around obtaining informed consent and study 
administration. The study demonstrated a significant improvement between pre- and 
post-operative data of both groups (For RUL, medialisation group- p=0.008; 
reinnervation group- p=0.027). However, some data interpretation was not clear. 
They found that there was no significant difference of RUL, perceptual evaluation by 
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professionals (GRBAS score) and voice related quality of life (VRQOL) between the 
two groups. MPT improvement was better in the medialisation group that showed a 
significant difference at 6-months (p=0.008) and 12-months (p=0.023). A subgroup 
analysis, although methodologically inappropriate, purported to suggest that those 
aged less than 52 years had better results in reinnervation than thyroplasty: they 
achieved a perfect GRBAS score and normal range for VRQOL. LEMG results of 
the reinnervation group based on Koufman classification revealed that the 
neurological status was either improved or the same except in one patient. None of 
them had total denervation after the reinnervation procedure (Koufman and Walker, 
1998). Three patients of each group needed additional surgery, injection 
laryngoplasty or thyroplasty, to improve the voice further or alleviate aspiration. 
Wang et al. published a large retrospective study that included 237 UVFP patients 
undergoing ansa-RLN reinnervation and 237 normal control subjects. Post-operative 
outcomes were measured at 2 to 12 years. The outcome measures employed in the 
study were MPT, mean airflow rate, acoustic analysis, GRBAS score, 
videostroboscopy evaluation and motor unit recruitment on LEMG. The study 
demonstrated significant improvement in all parameters between pre- and post-
reinnervation and no significant difference between the post-reinnervation voice 
quality and normal control subjects. There was no paradoxical vocal fold mobility 
observed. For GRBAS score, the inter-rater reliability was >0.76 and intra-rater 
reliability >0.81. The LEMG results revealed significant improvement in voluntary 
motor unit recruitment between pre- and post-operative measurement (p<0.001). The 
failure rate of the ansa-RLN reinnervation was 2% in which 4 of 237 patients did not 
achieve satisfactory vocal function. The causes of failure were postulated to be 
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inadequate removal of scarred end of the injured recurrent laryngeal nerve distal 
stump, interruption of recipient and donor nerve connection following evacuation of 
post-operative haematoma and long denervation course of more than 3 years that 
may contribute to insufficient laryngeal reinnervation. The complication rate was 
5.5% (13 of 237 cases) and the most common were mild complications such as 
ecchymosis (11 cases). Other documented complications were haematoma, wound 
issues and stridor. Two patients had stridor due to haemorrhage that necessitate 
tracheostomy.  
Table 1-2: All studies of human laryngeal reinnervation from 2009 to 2013 
Author Year Study design Level of evidence 
Marcum et al. 2010 Case report 4 
Yumoto et al. 2010 Retrospective 4 
Hassan et al. 2011 Retrospective  4 
Wang et al. 2011 Retrospective with normal controls 3 
Paniello et al. 2011 RCT 2B 
Wang et al. 2011 Retrospective 4 
Zur et al. 2012 Retrospective 4 
Li et al. 2013 Retrospective 4 
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Table 1-3: Summary of results of the three studies extracted in the systematic review 
Yumoto et al. Wang et al. Paniello et al. 
MPT Pre, 5.2(2.1); post, 13.1(5.1), 
p<0.001 and continue to improve 
up to 36 months (p<0.01) 
Pre, 6.18(4.87, 7.63); Post, 
17.22(14.44, 21.78), p<0.001. No 
difference between the UVFP and 
normal subjects 
MPT in ML significantly longer 
than reinnervation at 6 months 
(p=0.009) and 12 months 
(p=0.023) 
MFR, ml/s Pre, 713(680); Post, 145(58), 
p<0.01 and remain unchanged up 
to 36 months p=0.69 
Not done Not done 
Pitch range, semitone Pre, 7.6(4.84); Post, 14.0(4.2), 
p<0.01 and remain unchanged up 
to 36 months p=0.69 
Not done Not done 
Jitter, % Pre, 7.67(4.84); Post, 2.08(1.25), 
p<0.001 and continue to improve 
up to 36 months p<0.05 
Pre, 1.52(1.13, 2.04); Post, 
0.33(0.21, 0.58), p<0.00. No 
difference between the UVFP and 
normal subjects (p value ranged 
from 0.11 to 0.667).  
Not done 
Shimmer, % Pre, 12.28(7.17); Post; 6.7(4.14), 
p<0.01 and remain unchanged up 
to 36 months p=0.5 
Pre, 9.33 (7.95, 11.82); Post, 4.22 
(2.59, 6.42) p<0.001. No difference 
between the UVFP and normal 
subjects 
Not done 
Noise measurement HNR, Pre, 5.42(3.27); Post, 
8.00(1.64) (p<0.01) and remain 
unchanged up to 36 months 
NHR, Pre, 0.147 (0.113, 0.212); 
Post, 0.018 (0.012, 0.029) 
p<0.001. No difference between 
Not done 
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p=0.96 the UVFP and normal subjects 
RUL Not done Not done No siginificant difference between 
the groups.  
GRBAS Not done Pre, each item, ranged from 1.0 to 
2.2; Post, 0, p<0.001  
No significant difference between 
the groups 
Patient self-evaluation Not done Not done VRQOL, no significant difference 
between the groups 
Videostroboscopy Not done Significant improvement of glottic 
closure, vocal fold position, vocal 
fold edge, and phase symmetry and 
regularity (p<0.001) 
Not clearly shown 
LEMG Not done Significant improvement in 
voluntary motor unit recruitment 
between pre- and post-operative 
measurement (p<0.001) 
Koufman classification was either 
improved or the same from before 
the operation except in one patient. 
None of them had total 
denervation. 
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1.6.3 Discussion 
Significant long-term voice improvement was documented in UVFP patients when 
the results were analysed between pre- and post-operative. Ansa-RLN technique as 
described by Crumley was still the most common technique used. Wang et al. had 
improved the technique by using the main branch of the ansa cervicalis that has more 
axons to regenerate to the injured RLN instead of ansa hypoglossi to sternohyoid, 
and they described details of the surgery for a successful reinnervation. Successful 
results were supported by evidence of reinnervation on LEMG data in the two 
studies that used ansa-RLN technique. Yumoto et al. employed modified Tucker’s 
technique and combined it with an arytenoid adduction. Their study had shown 
significant immediate and long-term voice improvement but lack of evidence of the 
neurological status to support the voice improvement (Yumoto et al., 2010).  
Of the 3 studies, Wang et al. had included the largest number of patients. In this 
study, the success rate of ansa-RLN technique was found to be high with only 2% of 
failure to achieve satisfactory vocal function. The rate of major complications 
involving airway compromise was low (2 of 237 patients). None of these patients 
developed paradoxical vocal fold mobility (Wang et al., 2011).  
Treatment outcome measures still vary between the studies and do not follow the 
suggested basic protocol (Dejonckere et al., 2001). The only parameter that was 
measured in all three studies was MPT. Nevertheless, GRBAS score and acoustic 
analysis (jitter, shimmer, NHR) were measured in two studies. Self-patient 
evaluation that reflects patients’ satisfaction of voice improvement and its 
psychosocial impact is important but was only measured in one study. Paniello et al. 
chose evaluation by untrained listeners as the primary outcome measure, which is to 
54 
my knowledge the first study to use it. It was also the only study that stated the 
primary outcome. 
There was only one RCT since the last review in 2009. The study showed that there 
was no significant difference in the voice quality evaluated by untrained and trained 
listeners’ as well as self-perceptual evaluation between reinnervation and 
medialisation group. However the study was underpowered since the sponsor 
terminated it prematurely due to inherent recruitment issues. Therefore, there 
remains the central question as to which treatment is better for UVFP – reinnervation 
or thyroplasty. Thus, a further RCT is required but must be properly planned and 
piloted. Issues around patients’ recruitment need to be explored before embarking the 
trial to help ensure feasibility. 
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1.7 Selective reinnervation - review 
The amended part of this review has been published by the Current Opinion of 
Otolaryngology & Head and Neck Surgery (Marina et al., 2011).
Research and literature on selective laryngeal reinnervation are limited down to the 
variability and complexity of nerve supply. Airway problems resulting from 
simultaneous bilateral RLN transection in animal studies are another factor impeding 
progress. Thus, most studies on humans relate to non-selective reinnervation in 
UVFP.  
There are numerous animal studies in the literature exploring the feasibility of 
selective reinnervation of the PCA to reacquire vocal fold abduction. Many of the 
studies showed good results, confirmed by endoscopic observation of vocal fold 
abduction either spontaneous or by electrical stimulation, the electromyographic 
characteristics and histological evidence.  
Results of studies on humans are sparse and based on case series. In the earlier 
reports, nerve muscle pedicle techniques using ansa hypoglossi-omohyoid muscle 
pedicle were applied to reinnervate the PCA muscles (Applebaum et al., 1979; 
Tucker, 1976). Vocal fold abduction was observed at four to eight weeks post 
operatively. However, there was no report on the same technique for bilateral 
reinnervation in human since then. The other technique used was the split-phrenic 
nerve–graft procedure that however failed to return any abduction to the vocal fold 
even though the results in animal studies were encouraging (Crumley, 1983).  
Marie has developed a bilateral selective reinnervation technique for bilateral vocal 
fold paralysis patients after a series of animal studies and had promising results. He 
reinnervated the PCA with right upper phrenic nerve root with the help of an 
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interposition free nerve graft and the adductors with thyrohyoid branch of the 
hypoglossal nerve (Figure 1). He started a clinical prospective trial in humans in 
2003 and to date more than 40 patients have received this technique (unpublished 
data). He reported a preliminary result of his early 12 patients (Remacle and Eckel, 
2010). Four of six evaluable patients had decreased dyspnoea. Three of six patients 
achieved active arytenoids adduction and all are decannulated, albeit one of them 
after an arytenoidectomy. 
Selective reinnervation to the adductor muscle in BVFP patients is important not for 
the return of adduction but to prevent atrophy and flaccidity of the vocal fold which 
may lead to voice deterioration. The flaccid vocal fold may also be sucked to the 
midline during inspiration and this would obstruct the airway. Furthermore it avoids 
the development of aberrant reinnervation of the adductor muscles from the nerve 
axons of the abductor muscle.  
1.7.1 Phrenic nerve 
Selective laryngeal reinnervation in BVFP patients is mainly to re-establish the vocal 
fold abduction during inspiration through reinnervation of the PCA muscle. The PCA 
muscle is the only laryngeal muscle that abducts the vocal fold. Therefore the 
adjacent nerve to be used for reinnervation must contain a homogenous composition 
of motor neurons that are active during the inspiratory phase of breathing. The most 
suitable nerve in this regards is the phrenic nerve (Baldissera et al., 1989). The PCA 
muscle is therefore selectively reinnervated with the phrenic nerve to allow the 
separation of re-growing homogenous axons in the phrenic nerve to the PCA 
muscles. The criticism of using the phrenic nerve is the possibility of diaphragmatic 
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paralysis after the nerve resection that may worsen the respiratory handicap 
especially if the laryngeal reinnnervation failed to improve the laryngeal obstruction. 
However, unilateral phrenic nerve resection has been shown to cause remarkably 
little effect on ventilatory capacity in patients with normal lungs (Fackler et al., 
1967). Experiments on animals suggested that highest root of the phrenic nerve or 
the accessory phrenic nerve which is supplied by C5 (in man) could be used for 
reinnervation as it functionally preserves valuable diaphragmatic innervation and 
unilateral phrenic nerve resection has limited effect on the diaphragm (Marie et al., 
1989, 1997) 
Distribution of the phrenic nerve roots in animals has been described. The 
distribution in humans was first investigated to delineate the topographical 
distribution of C3 to C5 innervating the diaphragm by stimulating the nerve roots in 
three patients undergoing selective laryngeal reinnervation. This was the first 
reported study in man. The diaphragmatic activity was detected by surface 
electromyographic recordings. It was revealed that in humans, the C4 instead of C5 
has a prominent proportion of phrenic nerve resembles the similarly large 
distribution of C5 in cats and rabbits. However, the study also indicated that C5 can 
provide a non-negligible proportion of the phrenic nerve that may have the 
possibility of a significant functional role of the accessory phrenic nerve in humans 
(Verin et al., 2011). 
1.7.2 Variability of nerve supply to the PCA 
The PCA muscle is critical to BVFP patients as it is the only abductor for respiration. 
The plausibility of reinnervating this muscle has been questioned since anatomical 
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studies confirm the variability of its nerve supply. The supply patterns to the human 
PCA muscle had been elegantly described by Maranillo et al. It was found that the 
main trunk of RLN divided into two terminal branches, the anterior and posterior 
division, just before entering the larynx with variable location from the cricothyroid 
joint (Maranillo et al., 2003). A PCA branch arose from the anterior branch, which 
subsequently gave off a number of branches forming a neural plexus under the deep 
surface of PCA muscle. Eller RL et al. confirm Maranillo’s findings and added that 
the PCA muscle also receives nerves from the interarytenoid branch in 70% of 
larynges (Eller et al., 2009). Identification of PCA branches is not straightforward as 
a posterior window in the thyroid cartilage was required in 57.1% in male specimens 
and 69.2% in female specimens in a cadaveric study (Kwak et al., 2010). 
The complexity of neural plexus, variability of nerve patterns and the involvement of 
nerve supply from the IA branch explain the occurrence of laryngeal synkinesis even 
following selective reinnervation of the PCA muscle. However this variability should 
not preclude selective reinnervation. The feasibility and efficiency had been proven 
in animal models (Kingham et al., 2005). A well designed surgical technique using 
this procedure has been described on human cadavers and also on patients with some 
encouraging preliminary results (Kwak et al., 2010; Remacle and Eckel, 2010).  
1.7.3 Selective reinnervation in vagal nerve tumour patients 
Cervical vagal nerve tumours could be classified into nerve sheath tumours and 
neuroendocrine tumours (Gilmer-Hill and Kline, 2000; Urquhart et al., 1994). The 
nerve sheath tumour is commonly known as vagal schwannoma and the 
neuroendocrine tumour as vagal paraganglioma. They are commonly benign in 
nature although there is 10% incidence of malignant tumour in vagal 
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paragangliomas. Most of patients with these tumours are asymptomatic as the 
progress is gradual and slow in nature. The commonest presentation is a neck mass. 
However lower cranial nerve palsies are possible as a result of tumour compression 
in which the commonest is vagal nerve paralysis (Urquhart et al., 1994).  
Definitive treatment for vagal paragangliomas is excision surgery. It is usually 
associated with post-operative unilateral vagal paralysis manifesting dysphonia, 
dysphagia and aspiration. Additional operative complications of glossopharyngeal 
and hypoglossal nerve paralysis may worsen the swallowing problems.  
Multiple paraganglioma is common especially in patients with positive family 
history (Urquhart et al., 1994). Netterville et al. reported 37% of vagal 
paragangliomas were bilateral (Fang et al., 2011; Netterville JL et al., 1998). 
Multicentricity of vagal paragangliomas is a significant factor to consider in 
selecting the therapeutic options (Lozano et al., 2008). Three of 19 patients with 
paraganglioma as reported by Urquhart et al. were subjected to irradiation therapy 
instead of surgery due to the potential of synchronous or metachronous 
multicentricity. This was designed to avoid the incapacitating morbidity of bilateral 
vocal fold paralysis (BVFP) with tracheostomy, an even greater burden for these 
patients whose swallowing may already be compromised (Netterville et al., 1993). 
Irradiation therapy has not been shown to cure paragangliomas and it has the 
drawback of possible temporal bone osteoradionecrosis and increased risk of 
malignant transformation (Netterville JL et al., 1998). Irradiation therapy also carries 
the risk of fibrosis to the vagus nerve that consequently results in vocal fold paralysis 
and makes later surgery more difficult.  
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Surgical rehabilitation to improve voice following unilateral vagal paralysis due to 
vagal paraganglioma excision that have been reported are thyroplasty, injection 
laryngoplasty and laryngeal reinnervation (Lamarre et al., 2010; Miller et al., 2000; 
Urquhart et al., 1994). Urquhart et al. documented voice improvement following 
Teflon injection laryngoplasty in all 11 of 16 patients with vocal fold paralysis 
following vagal paraganglioma excision surgery. Bielamowicz et al. reported early 
arytenoid adduction efficacy in 17 vagal paralysis patients after skull base surgery in 
which 76% of the patients had complete glottal closure with excellent voice quality 
as rated by speech therapists (Bielamowicz et al., 2000). Fang et al. mentioned great 
improvement in vocal fold performance following medialisation surgery but it was 
limited by the problem of nasal flow leakage that results in hypernasality (Fang et al., 
2011). However, assessement of the real results of surgery in these studies are 
limited by inadequate published data. 
For voice rehabilitation results following laryngeal reinnervation, Lee et al. included 
patients with vagal paraganglioma who underwent laryngeal reinnervation in their 
retrospective study. The study documented favourable outcome of ansa-RLN 
anastomosis in treating patients with UVFP characterized by improvement in patients’ 
voice perception, acoustic analysis and laryngeal appearance (Lee et al., 2007). 
Lorenz et al. reported long lasting improvement of the glottic closure and 
maintenance of the vocal fold edge following laryngeal reinnervation at the same 
sitting as the actual vagal nerve tumour resection (Lorenz et al., 2008). However in 
these studies, voice outcome data analysis of paraganglioma patients was precluded 
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due to unavailability of the preoperative data, although the paper states that voice 
was normal before the tumour resection. Lamarre et al. reported a case of vagal 
paraganglioma resection with primary reinnervation of the larynx in the same sitting 
(Lamarre et al., 2010). In this case report, apart from ansa-RLN anastomosis, 
cricothyroid-to-cricothyroid reinnervation and greater auricular nerve-to-superior 
laryngeal nerve anastomosis were performed for completeness. The patient showed 
good glottic closure at one year postoperatively and had minimal problems with 
swallowing, requiring enteral tube feeding for 6 days. 
Results of surgical rehabilitation by medialisation to reduce aspiration following 
unilateral vagal paralysis have shown variable outcomes. Thyroplasty and 
cricopharyngeal myotomy do not cure the problem (Miller et al., 2000). Arytenoid 
adduction is not helpful either as 66% of patients with unilateral vagal paralysis 
following skull base surgery had disappointing immediate effects of swallowing 
rehabilitation despite the excellent voice outcome. They required enteral feeding for 
more than six months. On the contrary, Flint et al. and Netterville et al. documented 
beneficial outcomes of medialisation thyroplasty in managing aspiration in this group 
of patients. Flint et al. reviewed the outcomes of thyroplasty in reducing aspiration in 
patients with dysphagia and aspiration following recurrent laryngeal nerve (RLN) 
paralysis or high vagal injury. 70% of patients with severe dysphagia had 
successfully discontinued enteral feedings (Flint et al., 1997). However duration of 
time taken for the discontinuation of the enteral feeding was not reported. The rest 
remained on enteral feeding with one of the patients undergoing a secondary 
operation of cricopharyngeal myotomy. Netterville et al. showed that thyroplasty 
expedited the consumption of initial oral intake and adequate oral intake with the 
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reduction in duration of hospital stay (Netterville et al., 1993). However, measures of 
swallowing and aspiration reduction in these studies were poorly recorded. 
Significant issues of dysphonia, dysphagia and aspiration caused by unilateral vagal 
paralysis following vagal paraganglioma excision definitely require rehabilitation. 
The surgical rehabilitation is ideally performed at the same sitting to minimise post-
operative morbidity. Injection laryngoplasty using current available substances 
mostly provides a temporary effect that requires repeated injections. Thyroplasty is 
commonly done under local anaesthesia since patients’ cooperation is deemed 
necessary by most practitioners to fine-tune the voice according to implant size and 
placement. Laryngeal reinnervation may be a good option since the operation is 
preferably done under general anaesthesia and it does not require fine-tuning of 
voice. The surgical reinnervation that aim to re-establish tone and bulk of the 
denervated muscle may be better than other surgical techniques as Woodson in 2007 
showed that spontaneous regeneration did not occur in vagus transection in cats 
possibly due to the relatively long course of the nerve to RLN to which only a small 
proportion of axons go. Furthermore, re-establishment of vocal fold mobility may be 
possible by performing selective reinnervation and this may save patients from 
irradiation therapy or tracheostomy should the tumor grow later on the opposite 
neck. A prospective study with standardised outcome measures at different time 
points is necessary to demonstrate the effect of selective reinnervation in unilateral 
vagal paralysis following the first operated side of vagal paraganglioma. 
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1.7.4 Conclusion 
A potential surgical option to improve the airway and at the same time preserving the 
voice in BVFP patients as well as for UVFP following vagal nerve tumour resection 
may be selective laryngeal reinnervation. This surgical option does not preclude the 
irreversible laser surgery should it fail to improve the airway obstruction. It involves 
reinnervation of the abductor and adductor laryngeal muscles. A suitable surgical 
technique with an appropriate donor nerve needs to be employed to ensure success. 
The surgical technique must be able to address the issue of reinnervation to the PCA 
muscle to trigger abduction during respiratory cycle, the preservation of good voice 
by strengthening the adductor muscles as well as prevention of laryngeal synkinesis. 
However the evidence of success on humans in the literature is limited to date. 
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1.8 Randomised controlled trial in UVFP intervention– the need and 
problems 
RCT is widely regarded as the best method to evaluate the efficacy of surgical 
interventions. However, not all types of surgical trials are feasible. There are three 
types of RCT in surgery; Type I - trials involving comparison between medical 
treatments in surgical patients, Type 2 – trials comparing surgical techniques and 
Type 3 – trials comparing medical treatment and surgical treatment (McCulloch, 
2002). 
Results of adequately powered RCTs are classified as level 1 (highest grade) in 
evidence-based medicine (EBM). Clinicians should integrate EBM in their clinical 
practice to ensure treatments delivered had been investigated regarding the safety 
and efficacy. A cross sectional survey of publications in otorhinolaryngology (ORL) 
journals in 1999 revealed that most therapeutic recommendations were based on 
level 4 evidence (Bentsianov et al., 2002). A retrospective review to investigate how 
many level 1 and 2 evidence were in general ORL between 2004 and 2009 showed 
that the high level of evidence was lacking compared to general medical literature 
publications. Level 1 and 2 evidence in voice literature is even rarer (4.6%) than in 
general ORL (31%) (Benninger et al., 1994). To date only three RCTs dedicated to 
the study of unilateral vocal fold paralysis (UVFP) treatments have been published 
(Hertegård et al., 2004; Lau et al., 2010; Paniello et al., 2011). There is a need for 
ORL surgeons and researchers to conduct more RCTs in this field. 
Various postulations were given to justify the slow rate of RCTs in voice literature 
although no clear evidence was given. It may be secondary to small number of 
patients in certain pathological groups, lack of reliable objective measures and sparse 
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number of drugs treating voice disorders. RCTs in surgery face methodological and 
practical challenges greater than those of drug trials due to factors including varying 
surgeon’s and patients’ equipoise, learning curve of new surgical techniques, 
difficulties to secure funding, blinding issues and variations between centres in 
multicentre trials (Ergina et al., 2009; McCulloch, 2002; Young et al., 2008).  
 
The RCT has a rigorous design to minimise biases. Components that are essential in 
a RCT to reduce the biases include blinding, standardisation of the study 
interventions and standardisation in patient selection. A standardisation of patient 
selection according to the outlined inclusion and exclusion criteria is necessary to 
minimise confounding factors. However a restriction of inclusion criteria may 
preclude the generalisability of the outcome of the study (Cook et al., 2003; McLeod, 
1999). Unlike drug trials, standardising surgical techniques is difficult as surgeons 
may vary in their experience and preference of technique particularly if it involves 
complex surgical procedure and multicentre participation (Ergina et al., 2009; 
McCulloch, 2002; McLeod, 1999). Blinding is particularly difficult in surgical trials, 
hence Solomon and McLeod found that only a third of RCTs in surgery had adequate 
blinding (Solomon and McLeod, 1995). Patients and surgeons are difficult to be 
made unaware on which type of surgery has been allocated due to issues like 
different type and site of incision, between open and closed methods, and between 
general and local anaesthesia. Inability to blind the patients in surgical trials causes 
bias especially if the primary outcome is subjective improvement in disease spesific 
symptoms or quality of life.  
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Costs to run a RCT in surgery are expensive (Cook et al., 2003; McCulloch, 2002; 
Solomon and McLeod, 1995). Funding bodies may be reluctant to award the grant to 
surgical trials due to the issues and difficulties mentioned above and poor quality of 
previous research.  
 
Another essential component of a RCT is, an adequate recruitment of patients 
according to the sample size calculation to meet the desired power and significance. 
Poor recruitment rate is a major issue in RCTs in surgery (McCulloch, 2002; Thoma 
et al., 2010). Factors that may contribute to this problem are lack of surgeons’ and 
patients’ equipoise. Equipoise is a condition whereby there is no preference between 
treatments in which both treatments are thought to be equal in outcome (Lilford et 
al., 2004).  
 
Lack of surgeons’ equipoise may be attributed to the strong preference and 
familiarity of certain surgical technique (McCulloch, 2002). This may lead to 
unwillingness to participate and recruit patients into the trial. Surgeons who agree to 
participate but had hidden preference towards a particular surgical technique may 
subconsciously contaminate the consenting process with phrases or terminologies 
that may affect patients’ willingness for randomisation (Donovan, 2002; Donovan et 
al., 2009; Lilford et al., 2004; Mills et al., 2003). Surgeons who are positive about 
randomisation also may have conflict when they face a particular patient with special 
clinical characteristics (Donovan et al., 2014; Hamilton et al., 2013; Lilford et al., 
2004). This in turn may contribute to the lack of patients’ equipoise thus affect the 
recruitment. 
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Lack of patients’ willingness to participate and be allocated to any surgical option 
arms is commonly due to strong patient treatment preference or lack of equipoise 
(Solomon and McLeod, 1995). The strong treatment preference may be attributed to 
the patient’s own research on the network or information that is received from other 
sources such as primary doctors, therapists or nurses. Other factors are like logistical 
issues, additional demand of the trial, worry of uncertainty and concern about 
information and consent (Hamilton et al., 2013; Ross et al., 1999). Unlike drugs, 
surgery is largely non-reversible and invasive. Patients tend to be reluctant to 
participate as they want to have the power to decide which surgery they will receive.  
 
The RCT is accepted as the most rigourous study design in experimenting 
effectivenes of certain surgical technique. However RCTs in surgery face many 
issues that may affect the feasibility of of the trial. Nevertheless the issues may be 
minimised by looking for strategies to overcome the methodologic difficulties and 
proper planning. Surgeons’ and patients’ equipoise issues lead to poor recruitment. It 
was recommended that perception of surgeons is explored and patients’ recruitment 
is properly planned and piloted and hence a feasibility study that includes qualitative 
methods is necessary (Lovato et al., 1997).  
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1.9 Voice outcome measures 
Voice quality assessments are optimally multidimensional due to complex nature of 
voice (Baylor et al., 2005; Carding et al., 2009a; Dejonckere et al., 2001). There is 
considerable diversity in treatment outcome measures with regards to functional 
voice assessment in UVFP used in the literature (Baylor et al., 2005). This hinders 
meta-analyses of the results of voice treatment.  A basic protocol for pre- and post 
operative treatment outcome measures has been proposed to achieve uniformity in 
the voice research methodology and to allow relevant comparisons with the literature 
when presenting or publishing the results (Dejonckere et al., 2001). The components 
of basic protocol are acoustic analysis, voice-specific patient self-reporting outcome, 
voice perceptual evaluation by professional raters, video-laryngostroboscopy 
assessment and aerodynamic analysis.  
 
Acoustic analysis is a non-invasive computer based objective assessment of voice 
quality by measuring the properties of recorded voice signals. A patient’s voice 
saying vowel /a/ is recorded in a quiet or sound treated room and then played on a 
software programme to measure the acoustic parameters. The acoustic analysis is 
potentially useful in measuring treatment outcomes following any interventions for 
vocal fold pathologies. It measures irregularity of mucosal vibration of the vocal 
folds caused by change in mass, elasticity and symmetry that may affect the F0, 
jitter, shimmer and NHR. Therefore, it provides an objective measure of the efficacy 
of voice treatments (Carding et al., 2004) and may provide valuable feedback for 
patients. The common measurement includes fundamental frequency (F0), jitter, 
shimmer and noise-to-harmonic ratio (NHR) (Amir et al., 2009). Jitter, shimmer and 
NHR, are the most common parameters reported in voice research (Brockmann-
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Bauser and Drinnan, 2011). F0 is a measurement of the mean frequency of mucosal 
vibrations of the vocal folds. Jitter and shimmer are amplitude perturbation 
measurements that measure cycle-to cycle frequency and amplitude variation 
respectively in the analysed voice sample. NHR is a measurement of degree of 
hoarseness obtained by estimating the proportion of noise in the subject’s voice. 
There are a number of validated voice-specific patient self-reporting tools in the 
literature. They are used to evaluate the impact of voice disorders to patients’ life and 
daily activity. Voice Handicap Index (VHI), Vocal Performance Questionnaire 
(VPQ) and Voice Symptom scale (VoiSS) have been used widely in voice research. 
All of these tools were shown to have excellent internal consistency (Cronbach’s 
coefficient = 0.81 to 0.95) (Carding et al., 2009). Of the three tools, VHI reached the 
highest repeatability with intraclass correlation value of 0.83. However VHI is a long 
questionnaire that consists of 30 questions. Rosen et al. had done further factor 
analysis, shortened the VHI to 10 questions (VHI-10) and validated it (Rosen et al., 
2004). It comprises three domains: functional (5 items), physical (3 items) and 
emotional (2 items). Deary et al. compared VHI-10 and VPQ as both are short and 
convenient. It was found that both are internally consistent and good overall 
indicator of the severity of voice disorders (Deary et al., 2004). The VHI-10 has been 
used in other retrospective or prospective trials involving UVFP patients and was 
able to demonstrate treatment effect before and after the operations (Carding et al., 
2004; Hogikyan and Rosen, 2002; Misono and Merati, 2012; Rosen et al., 2000).  
 
Voice perceptual evaluation is a subjective assessment of voice quality during speech 
task by professional raters using a validated scale. In voice research, patients’ 
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running speech voices are normally recorded and saved in audio files. The audio files 
are then anonymised and listened by a panel of raters who then grade the voice 
quality. The widely used scale for this purpose is GRBAS scale as proposed by 
Hirano. The G is for grade of the overall voice quality, integrating all deviant 
components. R is for roughness or harshness, B is for breathiness, A is for asthenia 
and S is for strain. The evaluation encompasses four point grading scale (0, normal 
or absence of deviance; 1, slight deviance; 2, moderate deviance; 3, severe deviance) 
(Hirano, 1981). Highest inter- and intra-rater reliability have been demonstrated for 
G, R and B (Carding et al., 2000; Webb et al., 2003).  
 
Video-laryngostroboscopy is regarded as a vital assessment tool in voice clinics. It is 
widely used as a clinical tool to examine mucosal waves of vocal folds, glottal gap 
and vocal fold mobility. It incorporates a scope with an attached camera to visualise 
the vocal folds, which is connected to a stroboscope machine that enables evaluation 
of dynamic effect of vocal fold vibration- mucosal waves. In Greek, Strobos means 
whirling, while scopein means watching or observing (Faure and Muller, 1992). 
Normal vocal folds vibrate during phonation that ranged 70 to 500 Hz in males and 
130-1,000 Hz in female (Švec and Schutte, 1996). Light from the stroboscopy that 
illuminate the vocal folds during vibration match the frequency of the voice with 
slight delay in few seconds. Thus travelling mucosal waves can be seen showing the 
vibratory pattern of the vocal folds. It gives an indication of the health of tissue 
situated between the superficial mucosa (cover) and the vocal muscle (body) (Faure 
and Muller, 1992; Hirano, 1974). Evaluation of video-laryngostroboscopy findings is 
typically qualitative: rating by voice experts assessing the visual findings of vocal 
folds- vocal fold edge, amplitude and symmetry of mucosal wave and glottal closure, 
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as first described by Hirano and Bless (Hirano and Bless, 1993). Research tools have 
been developed to improve the reliability of video-laryngostroboscopy evaluation 
(Poburka, 1999; Poburka and Bless, 1998; Rosen, 2005).  
 
The simplest aerodynamic measurement of voicing is maximum phonation time 
(MPT). It is a measurement of maximum vocal performance that is assessed 
manually using a stopwatch to time the duration. The patient is normally asked to 
sustain vowel /a/ at a comfortable loudness of voice after taking a normal breathe. 
This task is repeated three times and the longest duration is recorded. A more 
advance measurement of aerodynamic of voice is by using Aerophone (model 6600, 
Kaypentax, Lincoln Park USA). It is a tool to measure air leakage during phonation 
that indirectly measures closure of glottic gap. Parameters that normally measured 
are- maximum SPL dB and maximum flow rate (MFR) at voicing L/s that are 
indirectly calculated from intra-oral articulatory pressures. Each patient is fitted with 
a standard anaesthesia face-mask covering the nose and mouth. A small tube that 
connects the machine and the patient’s mouth is placed just slightly beyond the upper 
and lower incisors. The patient is then asked to say /pa//pa//pa/ for 3 times at 
minimum, comfortable and loudest loudness level. There should be no phonation 
break at each loudness level once data acquisition is initiated. The device is 
connected to a computer system with software that generate the data required.  
 
There has been no consensus to date on the primary outcome measures for trials 
evaluating the efficacy of treatments for UVFP (Misono and Merati, 2012). To my 
knowledge, there were three RCTs in surgery for UVFP. Each of the three RCTs 
used different primary outcome measures which was self-reported visual analogue 
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scores of voice quality (Hertegård et al., 2004), the well-validated voice handicap 
index (VHI) (Jacobson et al., 1997; Lau et al., 2010) and perceptual evaluation of 
voice by untrained listeners (Paniello et al., 2011). A meta-analysis comparing voice 
outcomes between injection laryngoplasty and thyroplasty used VHI as the primary 
outcome measures. However, crucially, surgeons’ choice of outcomes might not 
truly represent patients’ concerns (Ergina et al., 2009). Therefore it is important to 
explore what is the main concern to UVFP patients about their voice to determine the 
primary outcome measure that is most likely to be meaningful to patients in a full 
trial. 
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1.10 Acoustic analysis 
There is an increasing interest in using voice-specific patient self-reporting outcome 
to monitor treatment effect. It may be the most valuable as it reflects patients 
satisfaction and may be more meaningful (Carding et al., 2009; Hogikyan and Rosen, 
2002). Although the common questionnaires used in voice literature have been 
validated, and were found to be reliable and sensitive to change (Carding et al., 
2009), they are limited by subjectivity. Furthermore, in surgical trials, patients 
blinding is frequently impossible. Therefore, acoustic analysis is a useful outcome 
measure to support patients’ self-evaluation improvement of voice. 
The common measurement of acoustic analysis includes fundamental frequency 
(F0), jitter, shimmer and noise-to-harmonic ratio (NHR) (Amir et al., 2009). These 
parameters are measured from a recorded voice either on sustained vowel or 
continuous speech. The classic way of measuring these acoustic parameters is by 
analysing the sustained vowel /a/, /i/ or /u/. This method has been widely used 
because it is quick and simple. It is also preferred because the measurement of 
sustained vowels is relatively not affected by individual special speech 
characteristics like speaking rate, speaker’s dialect, intonation and idiosyncratic 
articulatory behaviour (Krom, 1995; Maryn et al., 2009; Parsa and Jamieson, 2001). 
The acoustic values of this method also have been used as the standard values in 
previous studies. On the other hand, acoustic analysis of continuous speech may 
represent more ‘real world’ day-to-day communication context than the sustained 
vowels (Klingholtz, 1990; Moon et al., 2012) as voice disorder symptoms frequently 
emerge in conversational voice. However the analysis of continuous speech is more 
challenging due to the dynamic properties of voice signals and necessity of 
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demarcating voiced and unvoiced segments (Maryn et al., 2009; Parsa and Jamieson, 
2001). Acoustic perturbation measures (jitter, shimmer and NHR) of voice signals of 
sustained vowels were found to be more accurate than of continuous speech (Parsa 
and Jamieson, 2001; Zhang and Jiang, 2008). 
Previous studies and reviews suggested that the results of acoustic analysis- inter- 
and intra-software, except for F0, were moderately correlated (Carding et al., 2009a) 
and authors suggested that such measures should not be used independently to 
classify vocal fold lesions (Amir et al., 2009; Brockmann-Bauser and Drinnan, 
2011). Nevertheless it may be still useful in measuring dysphonic voices in UVFP 
(Baylor et al., 2005; Inagi et al., 1997a), giving objective evidence of treatment effect 
before and after intervention. Acoustic analysis has been used widely in papers 
reporting significant voice improvement in UVFP following surgical intervention 
(Baylor et al., 2005; Chowdhury et al., 2013; Hassan et al., 2011; Ryu et al., 2012; 
Schneider-Stickler et al., 2013; Wang et al., 2011a).  
The lack of reliability of acoustic analysis may be due to several confounding effects 
such as different algorithms used by different software programmes (Bielamowicz et 
al., 1996), recording environment, type of microphone, frequency and amplitude of 
phonation during recording and distance of the microphone from the lips 
(Brockmann-Bauser and Drinnan, 2011). Therefore in an attempt to employ acoustic 
analysis as a secondary outcome in a multicentre RCT, those confounding effects 
have to be minimised. Measurement of acoustic parameters that is done at a 
particular day and time may not represent the patient’s overall voice especially if the 
voice varies through out the day. Performing acoustic analysis at different time in a 
day and in different days is difficult due to logistical reasons. A low cost software 
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application installed in a mobile Apple gadget that recently available may meet the 
specifications above (http://www.operavox.co.uk/wp/). However it has not been 
rigorously tested for its reliability and validity before. 
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1.11 Assessment of denervation and reinnervation of laryngeal muscles 
1.11.1 Laryngeal electromyography 
Laryngeal electromyography (LEMG) is a tool to assess neurological status of 
intrinsic laryngeal muscles. It requires an experienced laryngologist, 
electromyographer and a neurophysiologist to perform the procedure. LEMG is done 
while a patient lying on a couch with neck slightly extended. A laryngologist inserts 
a monopolar needle into the TA muscles through the cricothyroid membrane while 
an electromyographer operates the electromyography machine. A neurophysiologist 
then evaluates the LEMG dynamic tracings that normally done subjectively. 
 
 
 
 
 
 
Figure 1-6: Laryngeal electromyography procedure. This photo shows a needle being 
inserted at the anterior part of the neck through the cricothyroid space to reach 
targeted laryngeal muscles. 
 
LEMG provides information of normal or abnormal tracing of motor unit 
morphology, motor unit recruitment and spontaneous activity. Recruitment is defined 
as activation of motor unit during volitional activity like speech and sniffing during 
respiration. Abnormal tracing patterns are spontaneous activity (fibrillation 
potentials, positive sharp waves), polyphasic potential, nascent unit or decreased in 
motor unit recruitment. Vocal fold paralysis is confirmed when the abnormal patterns 
are seen that indicates denervation or reinnervation of laryngeal muscles. The 
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presence of polyphasic potential and/or nascent unit indicates reinnervation pattern 
whereas the presence of spontaneous activity indicates a denervation pattern. 
Following RLN injury, denervation and reinnervation patterns may be seen 
concurrently as spontaneous reinnervation is common (Bielamowicz and Stager, 
2006; Chen et al., 2011; Koufman et al., 2001; Woodson, 2007a). Laryngeal 
synkinesis should be suspected if the LEMG results could not adequately explain 
vocal fold immobility. 
LEMG has been used in clinical practice for diagnosis confirmation and prognosis 
evaluation of vocal fold paralysis, site and level of nerve injury, differentiation 
between paralysis and cricoarytenoid joint fixation and botox injection for spasmodic 
dysphonia (Anderson and Sataloff, 2004; Bielamowicz and Stager, 2006; Koufman 
et al., 2001; Mostafa et al., 2004; Munin et al., 2003; Rickert et al., 2012). Koufman 
et al. found from their retrospective LEMG data of 415 vocal fold paralysis patients 
that it altered the timing and type of surgical intervention in 40% of cases (Koufman 
et al., 2001). Ability of LEMG to provide prognosis of motion recovery varies due to 
qualitative nature of the assessment and presence of synkinesis. Rickert et al. had 
done meta-analysis of LEMG found that the positive predictive value was 90.9% 
whereas the negative predictive value was 55.6% indicating that it is excellent in 
predicting non-recovery of vocal fold motion but not in motion recovery. Absence or 
significantly decreased motor unit recruitment and presence of spontaneous activity 
usually indicate poor prognosis for motion recovery (Mostafa et al., 2004; Munin et 
al., 2003; Rickert et al., 2012). Fibrillation potential may be absent even in axonal 
loss probably due to the small number and size of the muscle fibers per motor unit of 
laryngeal muscles (Munin et al., 2003). Smith et al. did a study to improve the use of 
LEMG in predicting prognosis of vocal fold motion recovery by incorporating 
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quantitative analysis to the qualitative analysis of the LEMG in which the turns of 
amplitude per second were calculated. They found that the NPV increased to 89% 
and the PPV was 100% with sensitivity of 66.6% and specificity of 100% (Smith et 
al., 2012). Nevertheless, LEMG in clinical practice remains a qualitative tool. 
LEMG is important in ‘ruling in’ vocal fold paralysis before reinnervation 
procedures. In non-selective reinnervation, apart from voice clinical test results, 
eligibility for the procedure is based on confirmation of paralysis and poor prognosis 
for vocal fold mobility recovery. Absence of motor unit recruitment and presence of 
spontaneous activity usually indicate the poor prognosis. Maronian et al. suggested 
criteria for reinnervation procedure when there is dense denervation detection, 
defined as 1 or 2 motor unit action potentials (MUAP) which are not activated during 
speech attempts or the presence of fibrillation potentials (Maronian et al., 2003). 
Polyphasic potentials indicate on-going reinnervation however, according to 
Koufman classification (James A. Koufman et al. 2001), polyphasic potential with 
absence of spontaneous activity indicates old injury which has stopped reinnervating.  
LEMG is the only way to understand the physiologic response following 
reinnervation as histology evidence is lacking in human studies. In monitoring 
treatment effect of non-selective reinnervation, the return of laryngeal muscle tone is 
the main concern but not vocal fold mobility. The laryngeal muscle tone may be 
evaluated from the number of normal motor unit action potential (MUAP) and the 
recruitment of motor unit during voluntary laryngeal muscles contraction 
(Bielamowicz and Stager, 2006). Favourable outcomes of reinnervation may be 
indicated by the improvement of motor unit recruitment and presence of polyphasic 
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potentials as they were significantly more common in patients who had clinical 
recovery.  
However, LEMG requires considerable operator skill, is invasive and muscles are 
not directly visualized during needle positioning. LEMG results have to be evaluated 
with caution if the patient is having significant pain due to the procedure as the 
recruitment may be artificially attenuated (Smith et al., 2012). It requires an 
experienced laryngologist, electromyographer and a neurophysiologist to get a 
reliable result (Volk et al., 2012). The otolaryngologist has to be someone who 
familiar with laryngeal anatomy and has been doing botulinum injection to the larynx 
by external approach regularly. For these reasons, I hypothesised that high resolution 
MRI may be a non-invasive alternative or adjunct to provide evidence of denervation 
and reinnervation in vocal fold paralysis patients. 
1.11.2 Magnetic resonance imaging 
MRI has been useful in demonstrating denervation changes of skeletal muscles 
affecting the morphology and physiology (Kamath et al., 2007; Koltzenburg and 
Yousry, 2007) and predicting prognosis (Yamabe et al., 2008). It may objectively 
depict evidence of denervation and reinnervation by measuring the muscle atrophy, 
signal changes on T2-weighted MRI (T2-MRI) (Bendszus et al., 2002; Kikuchi et al., 
2003; Viddeleer et al., 2012; Yamabe et al., 2008), and perfusion changes on 
dynamic contrast enhanced MRI (DCE-MRI) and diffusion-weighted imaging 
(DWI).  
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In peripheral nerve neuropathies, a hyperintense signal on T2-MRI may be due to an 
increase in extracellular fluid secondary to oedema or increased in vascularity or 
fatty degeneration (Bendszus et al., 2004; Kikuchi et al., 2003; Polak et al., 1988) 
depending on the duration of nerve injury. The abnormal signal intensity changes on 
T2-MRI have been shown correlated with prognosis of nerve injury in rats (Yamabe 
et al., 2008) and with hand function in humans (Viddeleer et al., 2012). Diffusion-
weighted imaging (DWI) is a type of imaging that study water motion in tissues by 
calculating the apparent diffusion coefficient (ADC) values. The principles of DWI 
are based on random movement of water molecules in tissues. It potentially can be 
used to investigate tissues perfusion and extracellular fluid space in denervated 
muscles (Viddeleer et al., 2012). DCE-MRI is a dynamic post-gadolinium contrast 
T1-weighted imaging method used to investigate tissue microcirculation as well as 
vascular changes in tissue following treatment as well as to diagnose benign or 
malignant tumours (Knopp, Michael V et al.). It is based on fast MRI sequences in 
cinematic display of certain tissue or lesion during and after intravenous gadolinium 
injection in which the distribution of the gadolinium is repeatedly imaged. This will 
give functional information related to vascular density, structure and permeability of 
microvasculature of a lesion. Benign angiogenic processes lead to increase in 
enhancement whereas the most distinct characteristic of malignant lesions is 
leakiness of the vasculature.  
 
MRI of the larynx has been used in the investigation of tumours and aetiologies of 
vocal fold paralysis. However, its use in assessment of denervation and reinnervation 
of laryngeal muscles is absent from the literature to date. Sakai et al. investigated 
normal laryngeal structures in 62 participants using 1.5T machine and had shown 
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that MRI is efficient in demonstrating laryngeal muscles (Sakai et al., 1990). In vocal 
fold paralysis patients, MRI has been shown able to clearly depict denervation 
changes on the TA and PCA (Borges, 2010; Connor et al., 2006). A retrospective 
study was done to evaluate the ability of MRI in depicting denervation atrophy of 
laryngeal muscles (Romo and Curtin, 1999). This study involved 20 UVFP patients 
in whom four had had both CT scan and MRI. Denervation atrophy was detected 
with high frequency: 70 – 90%. They concluded that PCA muscle atrophy may be a 
useful indicator of RLN paralysis when other findings are subtle or equivocal. 
However there were no studies to correlate MRI changes with electrophysiological 
changes in denervated laryngeal muscles. 
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1.12 Assessment of visual findings of vocal folds 
Laryngeal imaging is important for diagnosis of laryngeal disorders and has a role in 
assessing treatment outcomes. To date, various techniques have been used to 
evaluate phonatory function of vocal folds qualitatively or quantitatively including 
videostroboscopy (Omori et al., 1996; Rosen, 2005), videokymography and digital 
kymography to record vocal fold vibration (Verikas et al., 2009). Videostroboscopy 
in particular is widely available and regarded as a vital assessment tool in voice 
clinics. It is widely used as a clinical tool to examine mucosal waves of vocal folds, 
glottal gap and vocal fold mobility. Normal vocal folds vibrate during phonation that 
ranged 70 to 500 Hz in males and 130-1,000 Hz in female (Švec and Schutte, 1996). 
Light from the stroboscopy that illuminate the vocal folds during vibration match the 
frequency of the voice. Thus travelling mucosal waves can be seen showing the 
vibratory pattern of the vocal folds.  
1.12.1 Visual findings of vocal folds’ vibration patterns and characters 
Evaluation of videostroboscopy findings is typically qualitative: rating by voice 
experts assessing the visual findings of vocal folds- vocal fold edge, amplitude and 
symmetry of mucosal wave and glottal closure, as first described by Hirano and 
Bless (Hirano and Bless, 1993). In UVFP, due to discrepancy in the vocal folds’ 
vertical height, tensing capability and mass, and inability to make a firm contact with 
the opposite normal vocal fold, the mucosal waves are commonly asymmetrical with 
a significant glottal gap. Videostroboscopy findings have been shown to correlate 
with acoustic and perceptual analysis of voice (Uloza et al., 2005). It has been used 
to monitor treatment effect following surgical treatments in patients with UVFP 
(Morgan et al., 2007; Rosen et al., 2007, 2009; Vinson et al., 2010).  
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However, the qualitative evaluation of videostroboscopy findings is largely 
dependent on the experience of the examiner and that in turn may affect the inter- 
and intra-rater reliability. Objective assessments of the findings have been reported 
but need sophisticated software and considerable time. Factors that may influence the 
ability to evaluate the stroboscopic findings are: 1) the evaluator’s knowledge on 
how vocal vibration relates to sound production; 2) knowledge of the anatomy and 
physiology of larynx; 3) skill with the stroboscopic technique; and 4) skill in 
interpretation of the recorded images (Hirano and Bless, 1993). A satisfactory level 
of inter- and intra-rater reliability in evaluation is important to interpret the results. 
Research tools have been developed to improve the reliability of videostroboscopy 
evaluation (Poburka, 1999; Poburka and Bless, 1998; Rosen, 2005).  
In an attempt to use videostroboscopy as an outcome measure, the inter- and intra-
rater reliability has to be determined to inform the reliability of the results of the 
study. 
1.12.2 Visual findings of vocal fold mobility  
Objective measurement of airway of glottal area is important in laryngeal research to 
measure and determine whether an intervention improves vocal fold mobility. 
Impaired vocal fold mobility leads to a reduction of the glottal airway that causes 
breathing difficulty (Dailey et al., 2005; Marina et al., 2011b; Waters et al., 1996). 
To date there is lack of non-invasive methods to objectively measure the vocal fold 
mobility.  
In BVFP, impaired vocal fold abduction during respiration reduces the size of glottal 
airway hence compromising breathing. Quantification of vocal fold mobility in terms 
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of the ability of the vocal folds to abduct is necessary to provide a measure of 
effectiveness of interventions conducted to increase glottal airway area restricted by 
mobility disorders (Dailey et al., 2005). However, validated, non-invasive 
quantitative measures are lacking. Glottal area may be assessed during respiration by 
fibre-optic endoscope commonly attached to stroboscope – videostroboscopy, can be 
used to quantify vocal fold abduction (Dailey et al., 2005; Motoyoshi et al., 2004; 
Waters et al., 1996), but accuracy is limited by distortion caused by varying distance 
from the object and the wide angle lens of the endoscope (Czaja Pawel et al., 2007; 
Dailey et al., 2005; Forkert et al., 1996). To correct for some of this, it has been 
proposed to insert a probe to measure the distance from the tip of scope to the true 
vocal folds, but this increases the size of endoscope required and is too cumbersome, 
time-consuming and uncomfortable for routine clinical application (Brancatisano et 
al., 1983). Previously an endoscopic imaging solution has been suggested (Dailey et 
al., 2005) but valid analysis only appears possible in high quality studies. 
Specifically, the camera has to be tangential to the plane of the VFs so the images are 
central position with clear visualisation of anterior commissure and vocal process.  
MRI enables high-speed imaging that enables capture of dynamic events non-
invasively with good temporal resolution. Such technology, using 0.5-3.0T 
machines, has been used to capture cardiac, bowel and oesophageal motility patterns 
(Davis et al., 1996). It has been shown able to capture vocal fold images during 
adduction and abduction (Ahmad et al., 2006, 2009; Faust et al., 2001; Schlamann et 
al., 2009). Feasibility of this technology for the detection of vocal fold mobility 
disorders has been reported (Schlamann et al., 2009). However, the ability to 
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measure glottal area change from adduction to abduction has not been explored to 
date. 
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1.13 Thesis outline 
The unifying theme of this thesis is the performance of a series of research studies 
that collectively amount to a feasibility study for clinical trials of laryngeal 
reinnervation for the treatment of vocal fold paralysis. However, the results have 
wider implications for laryngology as will be discussed.  
1.13.1 Laryngeal reinnervation in vocal fold paralysis 
Laryngeal reinnervation has two types: non-selective reinnervation and selective 
reinnervation. Non-selective reinnervation is mainly for UVFP to gain normal to near 
normal voice by re-establishing tone and bulk of the paralysed muscles. Selective 
reinnervation aims for re-establishment of vocal fold mobility in BVFP to improve 
glottal airway as well preserving a good voice. 
The question as to which treatment is better for UVFP remains outstanding: ‘non-
selective reinnervation or thyroplasty?’, a question that ideally requires an 
adequately powered and designed RCT. However, RCTs in surgery face inherent 
recruitment issues related to both surgeons’ and patients’ views and beliefs that may 
lead to failure of the trial. These issues and others were explored by carrying out the 
studies below that will be discussed in detail in chapter 2. 
I. A national survey of UK ENT consultants exploring their perception towards 
the trial as well as obtaining crude numbers of eligible UVFP patients under 
their care for such trial.  
II. A qualitative research study employing individual interview of eligible UVFP 
patients to explore issues around recruitment process as well as to investigate 
their main voice concern. 
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1.13.2 Outcome measures to monitor the treatment effect  
Treatment outcomes in voice surgery trials are recommended to be multidimensional 
and standardised. The multidimensional treatment outcomes include subjective as 
well as objective evaluation. However there are some issues around the objective and 
subjective evaluations that need investigation. 
I. Acoustic analysis is a computer based objective voice signal analysis that 
bounds to reliability issues due to several confounding effects. A potential 
software package, OperaVOX, may minimise these issues. However this 
software has not been rigorously investigated the validity and reliability. 
Therefore, its performance was compared with MDVP, a commercial 
software package that widely used in voice research. The results will be 
discussed in chapter 3. 
II. Videostroboscopy allows visual evaluation of vocal folds vibratory pattern 
and the glottal closure. The evaluation is typically subjective with variable 
inter- and intra-rater reliability. The inter- and intra-rater reliability need to be 
investigated and reported to inform the strength of the future trial results. 
Results of this study will be discussed in chapter 4. 
1.13.3 Non-invasive outcome measures for laryngeal reinnervation 
I. LEMG is important in ‘ruling in’ vocal fold paralysis before reinnervation 
procedure. In non-selective reinnervation, apart from voice clinical test 
results, eligibility for the procedure is based on confirmation of paralysis and 
poor prognosis for vocal fold mobility recovery. LEMG is also the only way 
presently to show evidence of reinnervation following the procedure as 
histology evidence is lacking in human studies. However, LEMG is invasive, 
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operator dependent and not routinely practiced by laryngologists. MRI is a 
non-invasive tool that maybe an alternative or adjunct to the LEMG. 
Therefore, a study investigating the feasibility, reliability and validity of T2-
MRI to depict TA and PCA muscle bulk and signal intensity in patients with 
UVFP was done. Results of the T2-MRI study will be discussed in chapter 5. 
The utility of DCE-MRI and DWI in showing perfusion changes of 
denervated TA and PCA that potentially resolved following reinnervation 
was explored. Results of the DCE-MRI and DWI study will be discussed in 
chapter 6. 
 
II. Re-establishment of vocal fold mobility in BVFP following selective 
reinnervation is the main aim. Quantification of vocal fold mobility in terms 
of the ability of the vocal folds to abduct is necessary to provide a measure of 
effectiveness of interventions conducted to increase glottal airway area 
restricted by mobility disorders. Glottal area assessed during respiration by 
video-laryngostroboscopy can be used to quantify vocal fold abduction, but 
accuracy is limited by distortion caused by varying distance from the object 
and the wide-angle lens of the endoscope. Validated, non-invasive 
quantitative measures are lacking. MRI has the ability to capture vocal fold 
adduction and abduction. In this thesis, a study aimed to develop and evaluate 
3.0T MRI based quantitative measures of vocal fold mobility in normal 
volunteers and vocal fold paralysis patients will be presented in chapter 7.  
 
Development of MRI sequences protocol and evaluation of its feasibility results will 
be included in Appendix 6.  
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1.13.4 Case series of laryngeal reinnervation 
In this thesis, as further preparatory work for a potential randomised controlled trial, 
I present two small case series: 
I. Case series of non-selective laryngeal reinnervation for UVFP will be 
presented to provide some preliminary results of the surgery before an RCT 
pilot study is launched. In these case series, multidimensional evaluation of 
voice outcomes will be presented including the LEMG and T2-MRI results in 
chapter 8.1. 
 
II. Case series of selective reinnervation in rehabilitating unilateral vagal 
paralysis following vagal nerve tumour resection will be discussed chapter 
8.2. Selective reinnervation may be the treatment of choice in this condition 
due to the multicentricity nature in 33% of patients especially those with 
positive family history (Fang et al., 2011; Urquhart et al., 1994). A successful 
selective reinnervation that aim at re-establishment of vocal fold mobility as 
well as improvement of voice may save those patients from irradiation or 
tracheostomy treatment options if they had a second tumour on the opposite 
side. 
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Chapter 2 A qualitative study of the views and beliefs of surgeons 
and patients on a randomised control trial of laryngeal 
reinnervation versus thyroplasty for unilateral vocal fold 
paralysis. 
(The amended part on patients' views and beliefs in this 
chapter has been accepted by the Journal of laryngology 
and Otology awaiting for publication)
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2.1 Abstract 
Objectives: A randomised control trial (RCT) of non-selective laryngeal 
reinnervation versus thyroplasty in unilateral vocal fold paralysis (UVFP) patients 
was proposed and the present study was to: 1) explore willingness of UK ENT 
surgeons to recruit patients in to the proposed RCT; and 2) explore UVFP patients’ 
perception of the proposed RCT and their voice concerns. 
Methods: A questionnaire was created using SurveyMonkey®. The survey was 
edited and approved by the ENT UK Survey Guardian prior to distribution. It was 
circulated via email invitation to the Members of ENT UK, the British Association of 
Otolaryngologists Head and Neck Surgeons between 21st October and 22nd 
November 2011. The data of the survey was managed in a spreadsheet and presented 
in absolute numbers and proportion. Seventeen eligible patients for the RCT, were 
identified from five voice clinics in London. 11 of 17 patients (18 to 65 years old, 9 
females, 2 males), were interviewed using a semi-structured topic guide after a 
minimum of two weeks to understand the proposed RCT information sheet. The 
interview was recorded, transcribed and analysed using thematic analysis.  
Results: A total of 1194 emails invitation were sent, 318 responded. 296 surgeons 
see UVFP patients in their clinical practice. 237 surgeons saw a total of 963 per year 
adult permanent UVFP patients who failed voice therapy. 40% prefer injection 
laryngoplasty and thyroplasty in managing these patients. 131 responders said they 
would be willing to participate in the proposed RCT. 100 confirmed by giving their 
names. 90% of potential trial surgeons are willing to be trained for reinnervation. 
Forty percent of the eligible patients were willing to be randomised. The interviewed 
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patients were satisfied with the clarity of the proposed RCT information sheet. Most 
of them perceived that reinnervation was more ‘attractive’ than thyroplasty. This 
may be due to certain phraseology used in the information sheet and by recruiters. 
Their main concern was reduced voice strength and the effects of this on work and 
social life. 
Conclusion: The present study of ENT UK survey and qualitative research methods 
(individual interview) of patients with UVFP, showed that an RCT of reinnervation 
versus thyroplasty in patients with UVFP is feasible in the UK. The results also 
highlight potential problem areas for recruitment of surgeon-investigators and 
patients to this trial. A potential pool of patients for the trial appears promising. The 
data of individual interview of patients presented evaluates patient-focus and 
optimisation of the trial protocol, and both recruitment and consent processes. I 
found phraseology that needed changing or avoiding during the recruitment process. 
This may in turn improve willingness of potential patients to be randomised. I also 
proposed VHI-10 to be used as the primary outcome measure in the proposed RCT. 
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2.2 Background 
Patients with unilateral vocal fold paralysis (UVFP) typically experience a hoarse, 
weak and easily tired voice. Quality of life is significantly reduced and social and 
employment opportunities are compromised (Fang et al., 2008; Smith et al., 1995). 
Therefore, maximal rehabilitation of the paralysed larynx is important for health and 
wealth alike. 
 
Various surgical treatment options have been proposed for UVFP but, to date, there 
is insufficient evidence concerning the best surgical option to improve voice quality 
in patients with UVFP. Isshiki type I thyroplasty (Isshiki et al., 1975) is widely used 
to rehabilitate the permanently paralysed larynx (Leder and Sasaki, 1994; McCulloch 
and Hoffman, 1998; McLean-Muse et al., 2000; Ryu et al., 2012). It is an operation 
in which a silastic implant is inserted through a window in the thyroid lamina 
cartilage of the larynx. This implant medialises the paralysed vocal fold to the 
midline position allowing the normal opposite vocal fold to make firm contact and 
produce a stronger voice.  
 
Another approach is non-selective laryngeal reinnervation that restores tone and bulk 
of the paralysed vocal fold (Crumley et al., 1988) thus re-enables pitch control 
resulting in normal or near normal voice (Lee et al., 2007; Lorenz et al., 2008; Wang 
et al., 2011). The innervation to the larynx is re-established by anastomosing the 
injured RLN and donor nerve. A recent systematic review of studies on reinnervation 
revealed that there is a need for a prospective trial using standardised, internationally 
accepted outcomes (Aynehchi et al., 2010). Such a trial, comparing reinnervation and 
thyroplasty in adult UVFP patients, was attempted in the US (Paniello et al., 2011), 
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but was suspended prematurely due to issues in obtaining informed consent and low 
accrual. The investigators found only 24 patients had data suitable for analysis, from 
an original target population of 298. Within this small group they found no 
significant differences in voice quality between the two treatment groups. 
Unfortunately, although providing valuable pointers, the poor governance and data 
quality of the US trial obviates its usefulness in generating the feasibility data, 
including for power analysis, that is required for a UK trial sufficiently robust to 
deliver the information required by patients. This experience highlights some of the 
commoner problems in surgical trials. The results of this study emphasises the 
importance of running a feasibility study before a full surgical trial. 
 
Which surgical option delivers superior outcomes for patients with UVFP remains 
unanswered due to lack of strong evidence in the literature. Therefore replicating the 
randomised control trial (RCT) comparing non-selective laryngeal reinnervation and 
thyroplasty is necessary. Nevertheless there remain important uncertainties to be 
resolved before a new full trial can be initiated. The perception of UK ENT surgeons 
on surgical techniques in UVFP and on randomisation of their patients specifically, 
as well as those of the patients themselves, need to be explored. So does the need for 
training both for reinnervation, an operation not widely practiced presently in the 
UK, and for thyroplasty (present standard) as the technique may vary from surgeon 
to surgeon.  
 
Issues in recruitment of eligible patients in such RCT require exploration. It is a 
problem inherent in RCT in surgery due to factors such as patients’ preferences, 
additional demand of the trial, worry of uncertainty and concern about information 
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and consent (Ross et al., 1999). It was recommended that patient recruitment is 
properly planned and piloted hence a feasibility study that includes qualitative 
methods is necessary (Lovato et al., 1997).  
 
For all these reasons, a feasibility study is a critical step prior to designing a multi-
centre, randomised clinical trial of treatment for this disabling condition. Therefore, 
the primary aims of the present study are:  
A. to explore the perception of UK surgeons on surgical techniques in UVFP 
and on randomisation of their patients in the proposed trial; and  
B. to explore the perception of symptomatic UVFP patients concerning the 
design of an RCT of non-selective laryngeal reinnervation versus thyroplasty.  
The secondary aims of the present study are as the followings: 
A. Information relating to UK ENT surgeons:- 
1. estimate the number of new cases of adults with UVFP seen by UK ENT 
surgeons annually; 
2. establish their current preferences in the treatment of adults with UVFP; 
3. investigate which specialists are most willing and able to participate in a full 
trial; 
4. investigate the level of training needed to perform the operations and how 
best to organise this training; 
5. investigate the availability of tests for outcome measures at the ENT surgeons 
centre; and 
B. Information relating to patients:- 
1. explore adult UVFP patients voice problems; 
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2. establish adult UVFP patients’ preferences for choice of treatment;  
3. what constitutes optimised patient information; and 
4. investigate their willingness to be randomised. 
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2.3 Methods 
2.3.1 For UK ENT surgeons (survey) 
Study design 
This study was carried out by running a survey through questionnaire among UK 
ENT surgeons.  
 
Questionnaire  
The questionnaire was developed through discussions with Laryngologists (MAB, 
GS, JR, KG) and a triallist (AS). It was created using SurveyMonkey®. The 
developed questionnaire was then distributed to 10 ENT surgeons for pilot test. 
Corrections and amendments were done after receiving feedbacks from the ENT 
surgeons. The final questionnaire was further edited and approved by the ENT UK 
Survey Guardian (JWF) prior to distribution through the SurveyMonkey website 
(Appendix 1). Those who were unwilling to participate were invited to give their 
reasons and comments. Analysis and themes extraction were done whereas for other 
results, descriptive analysis were made. 
 
Survey – questionnaire distribution 
It was circulated via email invitation to the Members of ENT UK, the British 
Association of Otolaryngologists Head and Neck Surgeons between 21st October and 
22nd November 2011.  
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2.3.2 For UVFP patients (individual interview) 
Study design 
This study that was approved by the local ethics committee is a prospective 
qualitative study that involved individual interview. 
  
Participation selection 
The study population included UVFP patients who were eligible for the proposed 
RCT of laryngeal reinnervation versus thyroplasty presenting to voice clinics of five 
London hospitals in the year 2011-2012. They were then given an information sheet. 
The principal investigator at the main site, Royal National Throat Nose Ear Hospital, 
evaluated the patients further within a month to confirm their eligibility. 
Subsequently consents were sought for the interview session. During the recruitment 
period, 69 UVFP patients were identified and 17 patients were eligible for the 
proposed RCT. Of the 17, ten patients  (60%) agreed to participate in the RCT and 
40% (4 of 10) of them were willing to be randomised (Table 2-1). Eleven patients 
agreed to be interviewed, 9 females and 2 males with an age range of 18 to 65 years 
old. Nine of these were English speakers of various ethnicities. Their education level 
ranged from school leaver to degree holder. The causes of the UVFP were 
thyroidectomy (five patients), thymectomy (one patient), vagal schwannoma excision 
(one patient), cervical spine procedure (one patient) and idiopathic origin (three 
patients). Duration of palsy was between 5 months to 24 months. Of the 11 patients 
who were interviewed, three patients declined surgical intervention.  
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Table 2-1: Unilateral vocal fold paralysis patients identified in the clinics 
UVFP patients identified – 69 
Not eligible - 52 Eligible – 17 
Reasons Number Participate (10) Not participate (7) 
(reasons) 
Age more than 70 12 4 UVFP patients 
were willing for 
randomisation 
• Refuse surgical 
intervention (3) 
• Only wants IL 
(2) 
• Going back to 
hometown in 
the United 
States for LR 
(1) 
• Financial issues 
and not reliable 
to follow up (1) 
• Not willing to 
do extra tests 
and travelling 
(1) 
Duration of palsy 
more than 3 years 
10 
Multiple lower 
cranial nerve 
paralysis 
7 
Tumour 4 
Severe lungs 
problem 
1 
Good vocal fold 
compensation 
6 
Prior permanent 
surgical 
intervention 
8 
Dysarthria  1 
Non-neurogenic 1 
Neuromuscular 2 
LR: laryngeal reinnervation 
IL: Injection laryngoplasty 
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Information sheet  
The information sheet explained the trial and included the study design, 
randomisation, thyroplasty procedure, reinnervation procedure, outcome measures 
and details of clinic visits.  
Interview session – individual interview 
The interview was carried out in a dedicated room using a topic guide which was a 
semi-structured questionnaire developed and based on discussions with ear nose and 
throat (ENT) consultants and UVFP patient representatives. It focused on the 
following topics:  
1. the patients’ voice problems following UVFP,  
2. problems encountered due to the voice problems,  
3. their understanding of the surgical procedures  
4. their understanding of the randomisation 
5. what makes them agree or disagree to take part in a research trial 
6. what makes them agree or disagree to accept randomisation as part of this 
trial 
The interview was done by a PhD student (myself) who is a trained ENT surgeon. It 
was recorded digitally and saved as audio files. 
 
Analysis 
Audio files of the interview were anonymised and transcribed. The transcribed data 
was analysed using thematic analysis that involved searching across the data to find 
repeated patterns of meaning (Braun and Clarke, 2006). Specifically, the transcribed 
text was first familiarised by reading it repeatedly in an active way- searching for 
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meanings, patterns and issues of potential interest. Pen and paper were used to jot 
down ideas and extract codes that identify interesting feature of the data. The coding 
process involved organising the data into meaningful groups. The codes were then 
collated and potential themes were identified and named. The coding process and 
themes identification was managed using Microsoft excel. 
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2.4 Results 
2.4.1 For ENT surgeons (survey) 
Total of 1194 email invitations were sent and 318 had responded. Of 318 responders, 
296 do see UVFP patients in their clinical practice. ENT surgeons who manage adult 
laryngology patients ‘more than 50%’ of their patients in clinics is 23.9%, followed 
by 36.8% and 39.8% for ‘10 to 50%’ and ‘less than 10%’ respectively.  237 surgeons 
saw a total of 963 per year adult permanent UVFP patients who failed voice therapy 
(Figure 2-1). 
 
 
 
 
 
 
 
 
Figure 2-1: Number of UVFP patients failed voice therapy 
 
 
 
 
 
Surgeons were grouped 
according to percentage of 
laryngology patients they see in 
a year as shown in the graph. 
On average, a surgeon sees 3 
UVFP patients who needs 
surgical intervention in a year 
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Forty percent (40%) prefer injection laryngoplasty and thyroplasty in managing these 
patients. Others choose to perform ‘injection only’ (26%), ‘thyroplasty only’ (4%), 
‘reinnervation only’ (0.4%), ‘reinnervation with or without medialisation’ (1.6%) 
and ‘to refer to other surgeons’ (28%) (Figure 2-2). General anaesthesia is the main 
choice for IL (82.6%) whereas for thyroplasty, local anaesthesia is more preferred 
(68.4%). The most popular implant used for thyroplasty is silastic block implant 
(57.9%) followed by Gore-tex® implant (35.7%), Montgomery® Implant (10%) and 
titanium implant (5%). Of 248 surgeons, 9 had performed laryngeal reinnervation in 
the last 5 years.  
 
 
Figure 2-2: Surgeons' treatment preference 
IL: Injection laryngoplasty 
IST: Isshiki thyroplasty 
LR: laryngeal reinnervation 
 
 
This figure depicts 
surgeons’ treatment 
preferences. 40% of 
surgeons who are willing to 
participate prefer IL/IST in 
managing patients with 
UVFP who need surgical 
intervention 
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A randomised controlled trial of non-selective laryngeal reinnervation versus 
thyroplasty was proposed and encouragingly 131 responders said they would be 
willing to participate in the proposed RCT. One hundred (100) confirmed by giving 
their names. Their preferred way of trial participation is summarised in (Figure 2-3). 
Those who are not willing to participate (111 responders) had given their comments. 
The comments are scrutinised in which themes are extracted and summarised in 
(Table 2-2). 
 
Regarding surveys on facilities available in centres to measure outcomes, tests that 
not widely available were laryngeal electromyography (23%) and acoustic studies 
(40%). Videolaryngostroboscopy, fiberoptic endoscopic examination of swallowing 
and videofluoroscopy are available in more than 80% of responders’ centre and the 
availability of MRI is 100%. 
 
 
Figure 2-3: Surgeons' preferred way of trial participation 
 
This figure shows surgeons’ preferred way of trial 
participation which 18% of them prefer to perform 
both reinnervation and thyroplasty in their centres, 
50% prefer to refer to the principle investigator (PI) 
for both operations and 32% wish to refer to PI for 
reinnervation and perform thyroplasty in their 
centres. 
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Table 2-2: Themes extraction of comments given by surgeons who are unwilling to participate 
 
296 responders, 40% felt unwilling or unable to participate, of which only 6 gave negative comments on reinnervation whereas others give reasons as 
in the table below. 
Themes No Examples of comments 
Negative towards 
reinnervation  
 
6 1. No evidence it could possibly work. Better off spending your time on something more feasible!  Sorry!!  
2. Very little evidence that it works, except for Mr Tucker himself. 
3. I have not seen evidence that laryngeal innervation gives useful functional outcome 
4. Thyroplasty works well and is very quick. "If it ain't broke don't fix it" 
5. Injections and thyroplasty work and results are immediate. 
6. I need to be more familiar with this procedure from my understanding before I would refer a patient 
directly for this.  I would more likely refer a patient to a trusted laryngology colleague who would most 
likely attempt conventional techniques first. Also, I am not sure if this is ethical, we have one 
management which we know works and once one is experienced complications and morbidity is low 
compared to another procedure with multiple techniques which maybe associated with higher morbidity 
depending on the type of procedure. 
 
Not managing vocal fold 
palsy primarily 
63 1. I am a trainee 
2. I am an otologist 
3. I only see paediatric cases only 
4. I would refer to our voice surgeon and the decision would be his, not mine 
5. Patients are usually referred to Tertiary referral centre at University Hospital of Wales, Cardiff 
6. Will be retiring in 15 months.  Would be happy to refer to colleague if participating 
 
Logistics reasons 
 
14 1. I see too few patients to make it worth getting involved 
2. I work exclusively in private practice and I think persuading patients to enter a trial would be difficult 
3. I wouldn't be able to provide this surgery locally and I doubt my patients would be willing to travel - we 
are in Cornwall 
4. It would depend on whether local centre was involved in trial as many patients do find it 
difficult/expensive to have to travel to different hospital for treatment and follow-up 
5. Good idea but too much other stuff on at present! 
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Themes No Examples of comments 
No skill in laryngeal 
reinnervation 
 
9 1. Never done this operation 
2. Need to know more about innervation procedure, trial and would need a local operating surgeon 
3. I do not think that I would be able to perform laryngeal reinnervation to a good enough standard to 
propose it to patients as a possible treatment option 
 
Laryngeal 
reinnervation not 
suitable for certain 
group of patients 
 
6 1. In patients with UVFP secondary to malignancy (the majority of my cases) I do not consider performing 
an Isshiki and would always prefer the very quick and less invasive Bioplastique injection. 
2. The majority of those I see are paliative patients and benefit from injection, not one of your groups. 
3. I am a skull base surgeon, the majority of my patients with unilateral cord palsy have other more 
significant pathology the management of which takes precedence. In view of this I doubt it would be 
appropriate for many of my patients to go through this trial. A unilateral cord palsy is usually the least 
of their worries, if treatment is required the simplest option is favoured. Please define the term 'isolated' 
above - do you mean no other cranial neuropathy or no other pathology?  Were I to see an idiopathic 
isolated vocal cord palsy I would consider their inclusion, but that's not the group I see.   Patients with 
bilateral vagal palsy would have a lot more to gain from reinnervation, and I would consider referring 
them for this procedure if it were available (and proven to work). 
Not keen on other 
techniques than 
injection laryngoplasty 
 
4 1. I only do laryngeal injection with Vox ( bioplastic) 
2. Don't do thyroplasty 
No reasons 9  
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2.4.2 For UVFP patients (individual interview) 
Patients’ voice problems experience following the UVFP 
Voice problems reported by the UVFP patients during the interview are listed in 
(Table 2-3). The main complaint was that they lost the strength and volume of their 
voice that affected their work and social life. They also complained of their voice 
being unpredictable, hoarse and tiring easily. Apart from voice issues, they also had 
reduced effort tolerance and mild aspiration.  
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Table 2-3: Voice problems related to unilateral vocal fold paralysis 
Voice complains 
Unpredictable Hoarse Run out of air Loss strength and volume Aspiration 
• My voice is very 
unpredictable 
• Sometimes my voice 
goes terribly high 
• My voice wavers 
• Someone was to be upset 
and be agitated, and to be 
on the verge of tears, that 
this is how I think they 
sound like 
 
• Little croaky  
• Husky  
 
• Walking and talking at the 
same time very difficult 
because I ran out of breath 
• I ran out of breath to finish 
quick long sentence 
• Weakness, the fatigue, the 
volume and strains  
• My exercise tolerance rate 
isn’t as great 
• Very difficult and tiring to 
actually speak to get the 
volume of air 
• Gasping for air constantly 
• Feel out of breath 
• If I talk without 
interruption for a longer 
period, then sometimes I 
feel dizzy as well 
• When I speak for a while 
just get short of breath 
 
• I’m in a place with loud noise I feel 
like I’m battling a lot 
• Where there is a lot of ambient 
noise, I drain out, can’t be heard 
• The communication issues that is 
the most frustrating in a normal 
environment like a café or 
restaurant, a bus terminal 
• Where it is noisy then I couldn’t 
raise 
• It’s not being able to get that 
volume level  
• No power to my voice  
• I’ve got no strength in it 
• I can’t convey my message across 
the crowd 
• More difficult to speak in a noisy 
place 
• More difficult to speak over the 
telephone 
• Talking to people on the phone, 
they can’t hear you prop 
• Lost strength and volume 
• Sounds as if I had no confidence  
• Aspiration occasionally 
liquid 
• Swallowing issues are 
just that I am more 
conscious of actively 
swallowing slowly  
• Sometimes I just choke 
and I can’t breathe and 
it’s very, very painful 
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Problems encountered due to the voice problems 
Problems encountered in the UVFP patients’ daily life are summarised in Table 2-4. 
The UVFP patients suffered decreased self-confidence at work due to the voice 
problems. They were unable to project their voice in meetings and on the phone to 
express their opinion: 
‘Even if I have an opinion, I kind of hold back’ (Participant 4) 
‘I would do other parts of my job and push another senior to do the phone calls’ 
(Participant 4) 
‘I do so much of my business over the telephone as well as being in large board 
room scenarios where people, unless they were sitting next to me, wouldn’t be able 
to hear me.  Even somebody sitting opposite me on the desk would have difficulty 
hearing me’ (Participant 9) 
 
Those who work outdoors or in a noisy environment, found it hard to carry out their 
work and one participant resorted to using a voice amplifier.  
‘Hard to do with my job especially outdoors to raise the voice above a certain level’ 
(Participant 3) 
‘The kitchen is so noisy, the machines are on and things, so to scream or to get on 
top of your voice, you really need a quiet place’ (Participant 6) 
 
An actor who has stopped performing since the voice problem stated:  
‘Haven’t been able to work for maybe two years now, quite embarrassing 
sometimes’. (Participant 1) 
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Patients isolated themselves from social gatherings, as they couldn’t converse 
effectively with other people. The more they tried, their neck tensed up and the voice 
got worse and more tiring.  
‘Socially, it bothers me if I couldn’t go out and everyone’s talking in a park when I 
just can’t get involved in their conversation so I felt kind of isolated’ (Participant 
3) 
‘I used to sing at church and I really enjoy my music. But with this problem now 
and as soon as I finished it, I go home.  I don’t stay back because there’s no point 
seeing like, seeing people singing and you can’t sing‘ (Participant 6). 
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Table 2-4: Problems encountered following the voice problems 
Problems arisen due to voice issues 
At work At social occasions 
1. Haven’t been able to work for 
maybe two years now, quite 
embarrassing sometimes 
2. Hard to do with my job especially 
outdoors to raise the voice above 
a certain level. I have got to use 
voice amplifying machines 
3. Lost a lot of confidence 
4. Not being able to speak on the 
phone if in case I broke down on 
the motorway 
5. Has forced my decision to retire 
early 
6. Hospitals, doctors, they’re 
thinking I have no confidence in 
myself 
7. I would do other parts of my job 
and push another senior to do the 
phone calls 
8. I’m embarrassed to make a phone 
call 
9. Even if I have an opinion, I kind 
of hold back 
10. Now, I don’t shout, I just clap my 
hands because my voice was 
giving me a problem 
11. The kitchen is so noisy, the 
machines are on and things, so to 
scream or to get on top of your 
voice, you really need a quiet 
place 
1. Talk to the people who are near 
as me because it’s easier 
2. Now, I’m the quiet one (less 
socialised) 
3. Socially awkward 
4. Social environment, if it’s a pub 
or a restaurant, it was difficult 
5. Socially, it bothers me if I 
couldn’t go out and everyone’s 
talking in a park when I just can’t 
get involved in their conversation 
so I felt kind of isolated 
6. When I’m angry, then my voice 
just cut 
7. I used to sing at church and I 
really enjoy my music. But with 
this problem now and as soon as I 
finished it, I go home.  I don’t 
stay back because there’s no 
point seeing like, seeing people 
singing and you can’t sing.     
 
 
 112 
 
Understanding of the surgical procedures  
After reading the information sheet and discussing the surgical procedures with ENT 
consultants prior to the interview, the patients reported that they understood that 
thyroplasty is an old type of operation that involves an artificial implant which 
pushes the paralysed vocal fold and is technically easier than laryngeal reinnervation 
(Table 2-5). They believed that it is temporary in nature and that it may need 
revision. For reinnervation, they perceived it as a permanent and ‘natural’ type of 
operation giving the paralysed vocal fold muscle a new nerve supply that makes it 
‘alive again’ (Table 2-5). However, the way the reinnervation works was not 
properly understood. Some of them had thought that it would re-establish the 
paralysed vocal fold movement.  
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Table 2-5: Unilateral vocal fold paralysis patients understanding of a) thyroplasty 
operation and b) laryngeal reinnervation operation 
 
a) Understanding on thyroplasty 
1. Artificial implant put in to augment the vocal cord  
2. Temporary thing 
3. There will be an implant to push the paralysed cord forward 
4. Put something that will help you 
5. The other option seems easier.  Just the insertion of the implant, that Seems 
something you can have under local anaesthetic 
6. When reading the sheet, it seemed to me the implant was the easier solution 
7. Well, I have read that you don’t necessarily need a general anaesthetic 
8. I feel that one of the procedures is an older-type procedure 
9. Perhaps that it might need to be redone 
 
b) Laryngeal reinnervation (LR) 
1. My brain compels messages down to my vocal cord 
2. I don’t quite understand how the nerves manage to push it over  
3. I don’t really understand how the nerve one works 
4. Giving a muscle new nerve supply 
5. Making it alive again 
6. Starts to take on its own muscle tone 
7. Take on its own muscle movement 
8. Take on its own character 
9. Relearns how do you…be used again 
10. Its new nerve, it could be like learning to talk again 
11. Allow a permanent fix as oppose to I guess when you inject with fat or the 
implant 
12. A section of the nerve taking it out from its original position and implanting it 
into the muscle 
13. Maybe I don’t understand that one properly 
14. Reinnervation, doing something with the nerves, seems like a more natural 
procedure to do because you’re using the body’s own materials rather than 
putting something in that is essentially a foreign body really 
15. Natural 
16. I was thinking like for cardiac bypass surgery, when the coronary arteries 
gets clogged, you take it off and reuse the other veins from the leg so, and 
then the heart comes back to it’s normal state even though not 100%. That’s 
the nearest to natural, so that’s where I was understanding that process 
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Understanding about randomisation 
All patients said that the information sheet was clear and easily understood. The 
understanding was further explored by asking them to describe the procedures and 
randomisation procedure. Eight of 11 UVFP patients understood the concept of 
randomisation (Table 2-6) and three of them agreed that randomisation was 
necessary. Only one patient did not really understand the meaning of randomisation 
although they were still willing for randomisation after a proper explanation had 
been given. 
‘No guarantees as to which you group you will be in’ (Participant 2) 
‘You get 50-50 chance…. I think for out of 12 people, 6 people would have the 
injection, 6 people would have the rewiring…But you don’t have the choice.  You 
would be…we would be chosen on an ad hoc basis…’ (Participant 7) 
‘Randomisation means that you are randomly selected for one or another 
treatment. So, it’s the one…somebody will decide on your behalf as to how they’re 
going to proceed with the treatment for you or how are they going to deal with it’ 
(Participant 9) 
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Table 2-6: Unilateral vocal fold paralysis patients understanding on the concept of 
randomization 
 
Understanding about randomisation 
1. Don’t know which operation they’re having 
2. Cut any prejudice  
3. Less biased  
4. No guarantees as to which you group you will be in 
5. You could end up with one or the other 
6. You get 50-50 chance 
7. I think for out of 12 people, 6 people would have the injection, 6 people 
would have the rewiring 
8. But you don’t have the choice.  You would be…we would be chosen on an ad 
hoc basis… 
9. Patients don’t know which they’ve got. 
10. Randomisation means that you are randomly selected for one or another 
treatment.  So, it’s the one…somebody will decide on your behalf as to how 
they’re going to proceed with the treatment for you or how are they going to 
deal with it 
11. So you get put into groups those people will be put into two different groups 
12. You shouldn’t be able to vote 
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Agree or disagree for participation in the trial 
Those UVFP patients who agreed to participate were motivated by the desire to help 
other patients, as they believed the outcome of the research would improve the 
service and offer other patients a better treatment (altruism). Some patients felt that 
by participating they would get quicker and better treatment as well as better 
treatment progress monitoring (self-interest) (Table 2-7).  
‘I am aware of studies needing to take place to allow progressive movement in 
research and therefore, allow other people who may have my problem in the future 
get the right and the best quality of care and treatment for their condition’ 
(Participant 2) 
Conversely, patients who declined to participate were worried about any further 
surgical interventions (anxiety). They did not want to be offered any surgical options 
as they felt surgery was invasive and might cause undesired complications. Although 
not offered by patients themselves as reason for refusing to take part, it is important 
to note that many had already had a bad experience of surgery causing their UVFP in 
the first place. Some patients said they were not ready to participate (personal) and 
that may be related to inability to comply with the extra travel for tests and clinic 
visits due to busy schedules.  
‘I understand the research, but at the moment, I don’t think I want to go through 
it…..too much going on in my life’ (Participant 5) 
‘I don’t even like going to the dentist’ (Participant 7) 
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Table 2-7: What make them agree or disagree to participate 
Agree Disagree 
Altruism Anxiety 
• I would like to answers to which there aren’t any answers to now 
• I am aware of studies needing to take place to allow progressive 
movement in research and therefore, allow other people who may 
have my problem in the future get the right and the best quality of 
care and treatment for their condition 
• It will help people 
• Just something that other people can benefit from the treatment that 
I will go through 
• Helps improve the service  
• My own experience is part of the process 
• I understand the research, but at the moment, I don’t think I want to 
go through it 
• Prefer something less invasive 
• There could be problems with surgeries 
• Sometimes it’s not 100% effective as we planned 
• Sometimes there could be complications 
• I don’t even like going to the dentist 
• I just hate any kind of medical 
• I really can’t face it 
• If I did it, I would want the easier option 
Self benefit Personal 
• I think I will get some action done on my voice soon 
• Active treatment  
• Put myself forward to have something done instead of sitting. 
• If your voice doesn’t come, then it means you are out of 
everything, to look for a job, it should be a problem, if you are in 
the job already, to communicate with people, it’s very difficult 
• And also the information I get back from doing this is a lot puts my 
mind at ease about the operation at the moment.  It just helps 
because you get more messages to know more about what’s going 
on 
• Yeah, the treatment will be good for me 
• I might in the future, but at present, I feel that I’m not ready 
• Too much going on in my life 
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Agree or disagree for randomisation 
UVFP patients who agreed for randomisation perceived that both surgical options – 
reinnervation and thyroplasty - improved voice although one of them was more 
interested in reinnervation than thyroplasty. 
‘I was more intrigued by the nerve one was because in my head, I had the feeling 
that that would give me back more control however both have the same outcome’ 
(Participant 1) 
‘As you’d explained, both of them, all they do is put your vocal cord in the middle 
and set it so that the other cord makes it easier and you lose less breathe. So they 
both have the same outcome, you know’ (Participant 1) 
‘Because you’re telling me both operations work’ (Participant 4) 
‘Both are good, isn’t it?’ (Participant 6) 
 
The other factor that encouraged them to agree on randomisation was that they still 
could have the other surgical option should the first one be unsuccessful. 
‘Whichever group I end, it’s not contraindicated to having further treatment in the 
future…. they do both work and it’s quicker than waiting…. Because you’re 
telling me both operations work…. whichever operation I have, my voice will 
improve’ (Participant 4) 
 
Those who did not agree to randomisation had strong treatment preferences. All of 
the patients who did not want to be randomised chose reinnervation instead of 
thyroplasty because they believed that reinnervation was permanent and natural 
whereas thyroplasty was temporary that involved insertion of ‘foreign body’ or 
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‘plastic’ or ‘silicone wedge’ that may dislodge during vigorous exercise or athletic 
activity.  
 
‘Nerve graft would’ve been a once, one off operation if it’s successful…. better 
long term option for my quality of life… seem to be the best option to start with 
because we could always go back to the thyroplasty if the nerve graft failed…. the 
other operation the alternative one may not have been permanent…. 
Reinnervation more of natural thing rather than having an implant… I think it’s a 
lot to do confidence as well’ (Participant 3) 
 
‘I’d prefer the nerve rewiring because I just don’t like the idea of having just 
this…an extra wedge inside I thought it’d be a bit more…natural…. I’d rather 
prefer to choose…. I don’t want to do the old-fashioned way…. personal 
preference- mainly based on talking to the speech therapist initialy.  He 
recommended it…. silicone wedge over sort of boosting the nerves. I am still quite 
athletic…. if I had a silicone wedge, I think if I had a knock or a kick to the 
head…. Because I do boxing and rugby… it might get dislodged. If it didn’t work, 
I would go with….  The wedge is plan-B to me….. From what I have read’ 
(Participant 10) 
 
I don’t like a plastic going to…I don’t like the thyroplasty idea… the side 
effects…. It’s more natural -nerve rewiring. I’ve been researching with myself as 
well’ (Participant 11) 
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The decision to have reinnervation instead of thyroplasty was influenced by 
researching, speaking to other patients who had undergone reinnervation and ENT 
surgeons or speech therapist who saw them in the clinics. 
 
‘I was not prepared to second…for second best. It was clear to me that the best 
option and the only option for me would be re-innervation but the other two 
options are far too temporary. I thoroughly researched all of the options available. 
I suppose PB (ENT consultant) had given me some fairly clear indication just by 
being frank that the fact the other tops of medialisation, the thyroplasty, the fact 
that it wasn’t something that at this stage was expected to last longer than about 10 
years, I believe MR (another ENT consultant) indicated that it was, you know, that 
both of those again were more shorter term options’ (Participant 9) 
 
Although they were aware that they still can have reinnervation if the thyroplasty did 
not work, they worried that they may not be eligible anymore due to cut off duration 
of palsy for the trial also due to age as reinnervation is thought to be less effective as 
someone become older.  
 
‘I wouldn’t be able to have the re-innervation after three years, after my initial 
injury, which would be October 13….I am 62 and my voice will probably change 
as I get older, I suppose I want to feel I have done everything I can to preserve my 
voice so that it won’t actually deteriorate too much’ (Participant 8) 
 121 
2.5 Discussion 
2.5.1 Overview  
RCT is widely proposed as the best method to evaluate the efficacy of certain 
treatments or surgical interventions. However, RCT in surgery encounters 
methodological and practical challenges greater than those of drug trials due to 
factors including varying surgeons’ and patients’ equipoise in which one surgical 
option is preferred over the other. These challenges can lead to poor recruitment 
(Abraham et al., 2006; Ergina et al., 2009; McCulloch, 2002; Ross et al., 1999). 
These authors recommend that a feasibility study employing qualitative research 
methods is carried out so that patients’ recruitment would be properly planned 
(Lewin et al., 2009; Lovato et al., 1997; Murtagh et al., 2007; Ross et al., 1999). 
Good qualitative studies deliver a major contribution in the success of RCT in 
surgery. Therefore I performed this qualitative study before embarking on the 
proposed RCT to explore surgeons’ willingness and identify problems around 
patients’ recruitment also their main voice concerns. 
2.5.2 For ENT surgeons (survey) 
Failure of any RCTs causes waste of money and time of researchers that also 
discourage them from carrying out future research. One of major barriers in an RCT 
of surgical trials is a failure to recruit adequate number of participants as may be 
only subgroup of population are eligible and some patients may have co-morbidities 
that precluded them from the surgery (McLeod, 1999). According to this survey, 
numbers of UVFP patients who are potentially to be recruited are promising. 
Average of UVFP patients eligible for surgical intervention is 3 patients per surgeon. 
137 are willing to participate and 100 had confirmed by giving out their names. So 
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potentially it is possible to get 300 patients per year. The US trial targeted 298 
patients before it was stopped prematurely at 60 patients due to irregularity in 
obtaining inform consent and low accrual (Paniello et al., 2011). This number 
potentially could be achieved by multicentre participation in the UK as the figures 
here demonstrate (McLeod, 1999). 
 
The proposed RCT in the present study is designed to investigate which surgical 
technique is more effective. Therefore it requires involvement of surgeons of 
multicentre so the conclusions drawn from the trial has general application (Lilford 
et al., 2004). However surgeons’ willingness to participate in a RCT is one of the 
barriers that would potentially affect patients’ recruitment. Strong surgical preference 
or lack of expertise in performing a new procedure may preclude a RCT (Solomon 
and McLeod, 1995). However the strong surgical preference may not reflect the 
surgeons’ willingness to recruit their patients (Litton and Delaney, 2013; Palmer et 
al., 2013). According to this survey, most of ENT surgeons in the UK prefer 
injection laryngoplasty and thyroplasty in managing their UVFP patients who failed 
voice therapy and reinnervation is the least preferred. Although ENT surgeons are 
not familiar with the reinnervation procedure, they are willing to be trained (90%) 
and 18% of them wish to perform reinnervation in their own centres. Training on 
reinnervation is then very important before embarking on an RCT to compare it with 
a more familiar surgical technique, thyroplasty. The next step after training is 
standardisation of the operative technique so the participating centres reach a set 
standard. ENT surgeons who have been trained should perform reinnervation in their 
own centres and a regular assessment should be made so the set standard is achieved. 
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Among 111 responders who were unwilling to participate, only 6 are negative 
towards reinnervation down to their belief that it will not work on patients with 
UVFP. The rests gave reasons that are not directly related to refusal to let their 
patients to be randomised. Specifically, they are concerned about their unfamiliarity 
of the reinnervation procedure, unsuitability of reinnervation for cancer patients with 
poor prognosis and patients have to make a long travel to get this done. Majority of 
them are trainees in ENT who said that they would participate if the local consultants 
decide to participate. So potentially they would be able to recruit participants and 
send them to the participating consultants.  
 
Another factor that is important before embarking a multicentre RCT is 
standardisation of outcome measures among centres. This survey asked the 
availability of facilities to measure outcomes such as acoustic studies, video-
laryngostroboscopy, laryngeal electromyography, aerodynamic studies and MRI. 
Laryngeal electromyography is important in giving evidence of reinnervation 
although it is not the primary outcome measure. Evaluation of laryngeal muscle 
characteristics before and after reinnervation is important and adds an understanding 
of mechanisms of denervation and reinnervation. Reinnervation should not be 
performed without confirming vocal fold paralysis as in some cases vocal fold 
immobility maybe due to mechanical fixation. However laryngeal electromyography 
is only available in 23% percent of centres. MRI could be an alternative as it was 
found to be available in 100% of centres. With its advanced technique, potentially 
more information of the paralysed vocal fold could be obtained such as the muscle 
bulk, fatty degeneration and perfusion of the muscle (Kamath et al., 2007; 
Koltzenburg and Yousry, 2007). 
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Measurement of voice quality is important in the proposed trial. There was major 
diversity in treatment outcome measures with regards to functional voice assessment 
used in the literature. The major diversity hinders meta-analyses of the results of 
voice treatment.  A basic protocol for pre operative and post operative functional 
voice assessment had been proposed to achieve uniformity in the voice research 
methodology and to allow relevant comparisons with the literature when presenting 
or publishing the results (Dejonckere et al., 2001). The protocol includes voice 
perceptual analysis by professionals (grade, roughness, breathiness), video-
laryngostroboscopy evaluation (closure, regularity, mucosal wave and symmetry), 
acoustic analysis (jitter, shimmer and F0), aerodynamic analysis and subjective 
rating by the patient. Unfortunately acoustic studies are only available in 40% of 
centres and they are of different type of machines.  
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2.5.3 For UVFP patients (individual interview) 
Recruitment process 
I explored the patients’ views and beliefs after they had read an information sheet 
about the proposed study. Ethical committees require information sheets to ensure 
shared treatment decision making between clinicians and patients (Charles et al., 
1998). It is recommended that sheets are clear but concise in explaining the study 
design, details of procedure, advantages and side effects (Ellis et al., 2002; Mills et 
al., 2003). The sheets can however influence patients’ perception and reasoning and 
ultimately affect the recruitment to a trial (Donovan, 2002; Donovan et al., 2009; 
Edwards et al., 1999; Mills et al., 2003). Recruiters may use terminology that 
subconsciously encourages potential patients to prefer one treatment to another 
(Donovan, 2002; Donovan et al., 2009; Mills et al., 2003). Donovan et al. have 
shown that the rate of randomisation was boosted (Donovan, 2002; Donovan et al., 
2009) after the terminologies were changed in the written informed consent.  
In the present study, patients were given a minimum of two weeks to read through 
the information sheet about the study before the interview. All patients were satisfied 
with the clarity of the content. For the description of the operations, the patients 
tended to describe reinnervation as a ‘natural’ and ‘permanent’ type of operation that 
make the vocal fold ‘alive’ again. Whereas for thyroplasty, they tended to explain it 
as a ‘temporary’, ‘old-fashioned’ type of operation using a ‘wedge’ or ‘plastic’ 
inserted into the neck to make the voice stronger, and an operation that may need 
revision at some point. Presentation of the options in the literature provided verbally 
by recruiters led to the patient perception that reinnervation might be more 
‘attractive’ than thyroplasty, a clear source of bias and lack of equipoise. The fact 
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that the reinnervation cannot presently re-establish normal vocal fold movement, but 
rather aims to improve tone and bulk of the vocal fold muscles should be conveyed 
effectively. The information sheets and recruiters also should emphasise that both 
type of operation have been shown repeatedly to be successful in strengthening 
UVFP patients’ voices, but we simply do not know which one is better at addressing 
those concerns most important to patients themselves. 
Factors that motivated patients to participate in the present study were similar to 
reasons reported by other studies such as altruism and self benefit (Daugherty et al., 
1995; Featherstone and Donovan, 2002). Conversely, patients who refused to 
participate regarded the operation as invasive, had strong treatment preferences and 
regarded participation as time consuming. Similar reasons were also mentioned in 
previous studies (Alderson, 1996; Bevan et al., 1993; Schwartz and Fox, 1995). 
Eighty per cent of UVFP patients in this study understood about randomisation and 
the importance of it but could not accept the concept of equipoise or had a strong 
treatment preference. They wanted to be in control in making decisions as to which 
surgical option they would receive. UVFP patients who accepted that ‘both treatment 
work to improve the voice’- clinical equipoise- tended to accept randomisation.  
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Voice concerns 
McCulloch et al. suggested surgical researchers run a feasibility study to identify 
suitable primary outcome measures (McCulloch, 2002). There has been no consensus 
to date on the primary outcome measures for trials evaluating the efficacy of 
treatments for UVFP. Each of the three RCTs published to date used different 
primary outcome measures such as self-reported visual analogue scores of voice 
quality (Hertegård et al., 2004), the well-validated voice handicap index (VHI) 
(Jacobson et al., 1997; Lau et al., 2010) and perceptual evaluation of voice by 
untrained listeners (Paniello et al., 2011). However, crucially, surgeons’ choice of 
outcomes might not truly represent patients’ concerns (Ergina et al., 2009). Here I 
explored UVFP patients’ concerns about their voice to determine the primary 
outcome measure that is most likely to be meaningful to patients in a full trial. It was 
found that their main concern was, reduced voice strength and volume and the effects 
of this on work and social life. Therefore, I propose a short and fully validated voice-
specific self-reported outcome tool should be used in future trials.  
 
Quality of life outcome measure has been increasingly used in clinical trials (Calvert 
et al., 2011; Temple et al., 2009). Voice-specific patient self-reported outcome is a 
disease specific quality of life measures. It has high content validity since the 
patients have been living with the voice so their satisfaction may reflect success of 
treatment (Carding et al., 2009). The tool enables assessment of level of handicap 
and impact of voice problems to the quality of life. This kind of outcome measure 
also allows assessment of the patient’s ability to use his or her voice at working or 
social environment (Hogikyan and Rosen, 2002). Furthermore objective 
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measurements of voice on one particular day and time may not represent the 
patient’s overall voice quality. The voice may vary throughout the day or worse at 
the end of working day or fluctuate from one day to another day. Therefore the 
voice-specific patient self-reported outcome may be the most appropriate tool to 
assess the overall voice quality, patients’ satisfaction and success of interventions.  
 
However the patient-self reported outcome tool is limited by its subjectivity. 
Patients’ relative concept of quality of life, degree of expectation and cultural 
differences may affect the scores of outcome. It may also introduce biases to the 
results of a RCT especially if blinding of patients is not possible. Therefore objective 
outcome measures need to be included in the trial to confirm or inform the strength 
of the results. 
 
There are a number of validated voice-specific patient self-reporting tools in the 
literature. They are used to evaluate the impact of voice disorders to patients’ life and 
daily activity. Voice Handicap Index (VHI), Vocal Performance Questionnaire 
(VPQ) and Voice Symptom scale (VoiSS) have been used widely in voice research. 
All of these tools were shown to have excellent internal consistency (Cronbach’s 
coefficient = 0.81 to 0.95) (Carding et al., 2009b). Of the three tools, VHI reached 
the highest repeatability with intraclass correlation of 0.83. However VHI is a long 
questionnaire that consists of 30 questions. Rosen et al. had done further factor 
analysis, shortened the VHI to 10 questions (VHI-10) and validated it (Rosen et al., 
2004).  
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VHI-10 is a questionnaire that incorporates 10 items measuring the ability of voice to 
compete against background noise and project. It comprises three domains: 
functional (5 items), physical (3 items) and emotional (2 items). Deary et al. 
compared VHI-10 and VPQ as both are short and convenient. It was found that both 
are internally consistent and good overall indicator of the severity of voice disorders 
(Deary et al., 2004). The VHI-10 has been used in other retrospective or prospective 
trials involving patients with UVFP and was able to demonstrate treatment effect 
before and after operation (Carding et al., 2004; Hogikyan and Rosen, 2002; Misono 
and Merati, 2012; Rosen et al., 2000).  
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2.5.4 Conclusion 
The present study of ENT UK survey and qualitative research methods (individual 
interview) of patients with UVFP, showed that an RCT of reinnervation versus 
thyroplasty in patients with UVFP is feasible in the UK. The results also highlight 
potential problem areas for recruitment of surgeon-investigators and patients to this 
trial. A potential pool of patients for the trial appears promising. The majority ENT 
surgeons in the UK who manage patients with UVFP are receptive to the proposed 
trial and willing to be trained. Trainings on laryngeal reinnervation are vital as not 
many surgeons are familiar with this surgery. The data of individual interview of 
patients presented evaluates patient-focus and optimisation of the trial protocol, and 
both recruitment and consent processes. I found phraseology that needed changing or 
avoiding during the recruitment process. This may in turn improve willingness of 
potential patients to be randomised. I also proposed VHI-10 to be used as the 
primary outcome measure in the proposed RCT.  
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Chapter 3 Reliability of OperaVOX against Multidimensional 
Voice Program (MDVP)
(The amended part of this chapter has been accepted by 
the Clinical Otolaryngology Journal awaiting for 
publication) 
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3.1 Abstract 
Objective: To evaluate the agreement between OperaVOX and MDVP. 
Methods: Fifty healthy volunteers and 50 voice disorder patients had supervised 
recordings in a quiet room using OperaVOX by the iPod’s internal microphone with 
sampling rate of 45kHz. A five seconds recording of vowel /a/ was used to measure 
fundamental frequency (F0), jitter, shimmer and noise–to–harmonic ratio (NHR). All 
healthy volunteers and 21 patients had a second recording. The recorded voices was 
also analysed using the MDVP. The inter- and intra-software reliability was analysed 
using intraclass correlation (ICC) test and Bland Altman (BA) method. Mann 
Whitney test was used to compare the acoustic parameters between healthy 
volunteers and patients. 
Results: Nine of 50 patients had severe aperiodic voice. The ICC was high with a 
confidence interval of >0.75 for the inter- and intra-software reliability except for the 
NHR. For the inter-software BA analysis, excluding the severe aperiodic voice 
datasets, the bias (95% LOA) of F0, jitter, shimmer and NHR was 0.81(11.32, -9.71); 
-0.13 (1.26, -1.52); -0.52 (1.68, -2.72); and 0.08 (0.27, -0.10). For the intra-software 
reliability, it was -1.48 (18.43, -21.39); 0.05 (1.31, -1.21); -0.01 (2.87, -2.89); and 
0.005 (0.20, -0.18), respectively. Normative data from the healthy volunteers was 
obtained. There was a significant difference in all acoustic parameters between 
volunteers and patients measured by the OperaVOX (p<0.001) except for F0 in 
females (p=0.87). 
Conclusion: OperaVOX is comparable to MDVP and has high internal consistency 
for measuring the F0, jitter and shimmer of voice except for the NHR.  
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3.2 Background 
There is an increasing requirement for robust measures of voice quality, as a means 
of assessing outcomes of treatments for voice disorders and airway surgery. These 
have value to the patient, the individual surgeon, unit audits and research, as well as 
for risk management. However, establishing such measures in a way that satisfies 
both clinical and truly patient-facing needs has proved elusive. One reason is that 
assessments of voice need to be multidimensional. They need to involve perceptual 
as well as objective evaluation such as acoustic analysis (Dejonckere et al., 2001).  
Acoustic analysis is a non-invasive computer based objective assessment of voice 
quality by measuring the properties of recorded voice signals. The common 
measurements includes fundamental frequency (F0), jitter, shimmer and noise-to-
harmonic ratio (NHR) (Amir et al., 2009). Jitter, shimmer and NHR, are the most 
common parameters reported in voice research (Brockmann-Bauser and Drinnan, 
2011). F0 is a measurement of the mean frequency of mucosal vibrations of the vocal 
folds. Jitter and shimmer are perturbation measurements that measure cycle-to cycle 
frequency and amplitude variation respectively in the analysed voice sample. NHR is 
a measurement of degree of hoarseness obtained by estimating the proportion of 
noise in the subject’s voice. 
A comprehensive, systematic and routine measurement of voice following treatment 
is only possible in hospitals with voice laboratory facilities. There are many software 
programmes available to measure acoustic parameters. Multidimensional Voice 
Program (MDVP, KayPentax, NJ, USA) is a commercial software package widely 
used in research that is available at the present study’s recruitment centre. Co-
workers at UCL, with commercial partners Oxford Research Wave Ltd., have 
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developed OperaVOX (On Person RApid VOice eXaminer), portable voice analysis 
software running on an iPod, iPhone and iPad (Apple, USA), in an attempt to meet 
the specifications above.  
In the present study, the aim was to evaluate the agreement between OperaVOX and 
MDVP by measuring the inter- and intra-software reliability. 
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3.3 Methods 
Study design 
This cross-sectional reliability study has been approved by the Local Ethics 
Committee (reference number: 11/LO/0583). 
 
Participants selection - One hundred voice samples of adult volunteers (50) and 
patients (50) with voice disorders presenting to the four laryngologists at the Royal 
National Throat Nose and Ear Hospital, London, were recruited using convenience 
sampling and their demographics are summarised in (Table 3-1). The volunteers had 
a mean age of 35.14 (s.d.10.52) years’ old, and no previous voice problems. Those 
aged more than 65 years’ old, smoking history, vocal fold pathologies, history of 
endotracheal intubation for the past six months, current or the past two weeks history 
of upper respiratory tract infection, voice handicap index-10 (VHI-10) of more than 
11 or reflux symptom index of more than 7 were excluded. The patients had a mean 
age of 48.98 (s.d. 14.35) years’ old and were diagnosed with a wide range of voice 
disorders, including: muscle tension dysphonia (MTD), laryngopharyngeal reflux 
(LPR), vocal fold paralysis, spasmodic dysphonia, sulcus vocalis, and vocal fold 
lesions. In all patients with vocal fold pathologies, diagnoses were supported and 
documented using a high-resolution digital fibreoptic nasopharyngolaryngoscope 
system (VNL-1590STi, KayPentax, USA).  
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Table 3-1: Demographic data. Where means are shown, brackets represent standard 
deviation. 
 Volunteers Patients 
Number 50 50 
Mean age 35.14 (10.52) 48.98 (14.35) 
Male 22 35 
Female 28 15 
English first language 40 39 
English second language 10 11 
Diagnosis   
Muscle tension dysphonia - 11 
Laryngopharyngeal reflux - 1 
Vocal fold paralysis - 23 
Spasmodic dysphonia - 8 
Sulcus vocalis - 2 
Vocal fold lesions  - 5 
VHI-10 1.98 (2.41) 23.54 (8.00) 
Severe aperiodic voice - 9 
Retest 50 21 
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Study software - OperaVox™, is a software application that allows voice recordings 
as well as performs on-device acoustic analysis for users either in the hospital or at 
their homes. In this study the software was installed on an iPod touch 4th generation 
(Figure 3-1). A lanyard was attached to it for the purpose of standardisation of 30cm 
lips-to-device distance (Figure 3-2). 
Instructions were provided on the page prior to the test to guide patients on how to 
perform the test and standardise the procedure. It also has a colour bar indicator to 
measure instantaneous loudness of the voice while the recording was performed (-6 
dBFS is upper end of green and -24 dBFS is lower end of green).  
 
 
 
 
 
 
 
 
 
Figure 3-1: This figure shows OperaVOX that has been installed on an iPod touch 
that shows: A) software icon; B) start analysis page; C) VHI-10 page; D) voice 
recording page; and E) results page. 
A 
E
DCB
A B C D 
E 
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Figure 3-2: This photo shows a participant holding the iPod taut during the voice 
recording 
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Multidimensional Voice Program is a widely used voice analysis software in 
published voice research.  
 
Supervised recordings were performed in a quiet room with noise threshold of  -
39dBFS, using OperaVOX by the ipod’s internal microphone with a sampling rate of 
45kHz. The start of a recording was disabled in the presence of any noise above a 
pre-determined threshold value. They were instructed to do the recording while 
sitting on a chair without any accessories worn on the wrist so as to avoid any 
background noise from being recorded onto the recorded voice. Holding the iPod 
taut with a lanyard that was worn around the neck standardised the lips-device 
distance. They were instructed to say vowel /a/ for 6 seconds at comfortable loudness 
and to keep the colour indicator within the green range while recording to ensure 
there is sufficient loudness and thereby signal to noise for accurate measurements. 
A five seconds recording of a sustained vowel /a/ was used by OperaVox to measure 
F0, jitter percent, shimmer percent and NHR. The first 500ms of the start and the end 
of the vowel was removed to avoid the start and end effect. Once satisfied with the 
recording, the participant pressed the ‘yes’ button to perform immediate analysis. A 
second recording was done within 15 minutes after the first. All voice samples were 
saved in wav.files and analysis was also performed using MDVP for comparison. 
Patients whose voices were severely aperiodic (Titze, 1995) were excluded from 
certain parts of statistical analysis. 
Statistical analysis 
Inter- and intra-software reliability was assessed by using intraclass correlation 
coefficient (ICC) (Lee et al., 1989; Shrout and Fleiss, 1979) and analysing the bias 
and 95% limit of agreement (LOA) of the Bland-Altman (BA) plot (Bland and 
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Altman, 1999), of parameters produced by OperaVOX and MDVP (inter-software), 
and between the first and second recording of each software (intra-software). The 
BA analysis was repeated after excluding severe aperiodic voice datasets. ICC values 
ranged from 0 (no correlation) to 1 (perfect correlation). The ICC has to be at least 
0.6 for the measurements to be clinically useful (Chinn, 1991). Reliability of the 
measurements was considered good for ICC of similar to 0.75 and moderate for ICC 
of between 0.5 and 0.75 (Portney and Watkins, 1993). Normative data of volunteers 
produced by each software programme was presented. Acoustic parameters were 
compared between volunteers and patients (excluding the severely aperiodic voices) 
using Mann Whitney test.  
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3.4 Results 
The data presented in (Table 3-2) was not normally distributed therefore median and 
interquartile range (IQR) was used. 
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Table 3-2: Comparison between healthy volunteers and patients with voice disorder in females and males after excluding severe aperiodic voice. 
Where medians are shown, brackets represent interquartile range (IQR).  
 Female Male 
 Volunteers 
N = 28 
Patients 
N = 28 
p value Volunteers 
N = 22 
Patients 
N = 13 
p value 
F0 M 219.43           
(197.05, 235.73) 
204.54             
(192.92, 247.70) 
0.87 116.38           
(108.57, 122.06) 
139.78               
114.60, 169.34) 
0.006 
F0 O 219.76           
(197.18, 232.96) 
203.85              
(193.45, 243.38) 
0.83 116.68           
(108.39, 122.04) 
139.83              
(114.66, 161.60) 
0.006 
Jitter (%) M 0.71                  
(0.51, 0.88) 
2.31                      
(1.24, 3.26) 
0.001 0.60                   
(0.47, 0.79) 
1.87                      
(1.19, 2.74) 
0.001 
Jitter (%) O 0.69                   
(0.48, 0.90) 
2.85                      
(1.16, 3.90) 
0.001 0.54                   
(0.44, 0.75) 
1.83                      
(1.15, 2.86) 
0.001 
Shimmer M (%) 3.16                   
(2.63, 4.01) 
6.21                      
(5.06, 8.70) 
0.001 4.46                   
(3.43, 5.36) 
6.32                      
(4.88, 8.84) 
0.003 
Shimmer O (%) 3.46                   
(2.83, 4.47) 
7.72                      
(5.27, 10.33) 
0.001 4.30                   
(3.33, 4.92) 
8.10                      
(5.03, 8.89) 
0.001 
NHR M 0.13                   
(0.12, 0.13) 
0.16                     
(0.13, 0.19) 
0.004 0.14                   
(0.14, 0.15) 
0.16                     
(0.14, 0.16) 
0.005 
NHR O 0.01                
(0.006, 0.03) 
0.06                      
(0.02, 0.24) 
0.001 0.03                   
(0.02, 0.04) 
0.05                      
(0.02, 0.07) 
0.05 
 
M = MDVP, O = OperaVOX, p = p value of Mann Whitney test  
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Inter-software reliability  
There was high inter-software agreement for F0, jitter and shimmer with ICC (95% 
CI) of 0.98 (0.97,0.99); 0.94 (0.91, 0.96); and 0.93 (0.88, 0.96) but for NHR the ICC 
was 0.52 (0.36, 0.65). The bias (95% LOA) of all the parameters before exclusion of 
the severe aperiodic voices was -0.49 (21.16, -22.14); -0.07 (1.44, -1.58); -0.91 
(3.44, -5.26); and 0.01 (0.60, -0.58) respectively. After the exclusion, the bias (95% 
LOA) was 0.81(11.32, -9.71); -0.13 (1.26, -1.52); -0.52 (1.68, -2.72); and 0.08 (0.27, 
-0.10) (Figure 3-3). 
 
 
 
 
 
 
 
 
 
 
Figure 3-3: Inter-software Bland Altman plot after excluding severe aperiodic voice. 
Dotted lines represent upper and lower 95% limit of agreement. 
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Intra-software reliability 
There was high intra-software ICC of F0, jitter and shimmer for OperaVOX: 0.93 
(0.89, 0.96); 0.92 (0.91, 0.97); and 0.96 (0.94, 0.98), and for MDVP: 0.92 (0.88, 
0.95); 0.89 (0.83, 0.93); and 0.91 (0.87, 0.94). For NHR, the ICC (95% CI) was 0.64 
(0.48, 0.76) for the MDVP, and 0.72 (0.58, 0.81) for the OperaVOX. 
 
For the MDVP, the bias (95% LOA) for F0, jitter, shimmer and NHR before 
exclusion of the severe aperiodic patients were –3.92 (38.73, -46.56); 0.12 (2.08, -
1.85); -0.33 (5.03, -4.36); and 0.02 (0.21, -0.21). After the exclusion, they were -0.88 
(18.21, -19.96), -0.05 (1.03, -1.12), 0.12 (2.84, -2.61) and 0.002 (0.07, -0.07) (Figure 
3-4).  
 
For the OperaVox, the bias (95% LOA) of F0, jitter, shimmer and NHR before 
exclusion of the severe aperiodic voices were -1.55 (37.14, -40.23); 0.11 (1.53, -
1.31); 0.08 (3.93, -3.77); and 0.03 (0.64, -0.58). After the exclusion, they were -1.48 
(18.43, -21.39); 0.05 (1.31, -1.21); -0.01 (2.87, -2.89); and 0.005 (0.20, -0.18) 
(Figure 3-5). 
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Figure 3-4: Intra-software Bland Altman plot for MDVP after excluding severe 
aperiodic voice. Dotted lines represent upper and lower 95% limit of agreement. 
 
 
 
 
 
 
 
 
 
Figure 3-5: Intra-software Bland Altman plot for OperaVOX after excluding severe 
aperiodic voice. Dotted lines represent upper and lower 95% limit of agreement. 
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Normative data 
Normal range of all the parameters of volunteers from MDVP and OperaVOX is 
summarised in Table 3-3. 
 
Table 3-3: Normative data measured by OperaVOX and MDVP. Where means are 
shown, brackets represent standard deviation. 
 Female (n = 28) Male (n =22) 
 MDVP OperaVOX MDVP OperaVOX 
F0 (SD) 217.76 (31.58) 217.85 (30.80) 116.30 (11.58) 116.29 (11.51) 
Jitter (SD)% 0.70 (0.25) 0.80 (0.44) 0.71 (0.25) 0.65 (0.23) 
Shimmer (SD) % 3.18 (0.90) 3.56 (0.94) 4.43 (1.31) 4.23 (1.26) 
NHR 0.13 (0.02) 0.03 (0.08) 0.14 (0.01) 0.03 (0.02) 
 
Comparison between healthy volunteers and patients  
There was significant difference in the F0, jitter, shimmer and NHR between 
volunteers and patients from the two software programmes (p<0.001 or p<0.05) 
except for F0 (p = 0.87) of female participants from both OperaVOX and MDVP 
(Table 3-2). The measurements were found higher in the patients group than the 
volunteers indicating abnormal voice. 
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3.5 Discussion 
Acoustic analysis is useful in treatment monitoring following any interventions for 
vocal fold pathologies. It measures irregularity of mucosal vibration of the vocal 
folds that may affect the F0, jitter, shimmer and NHR. The acoustic parameters were 
documented in papers reporting voice improvement in unilateral vocal fold paralysis 
patients following surgical intervention (Chowdhury et al., 2013; Hassan et al., 2011; 
Ryu et al., 2012; Schneider-Stickler et al., 2013; Wang et al., 2011).  
 
Previous studies suggested that inter- and intra-software acoustic parameters were 
only moderately correlated (Carding et al., 2009), therefore they are not 
recommended to be used independently (Brockmann-Bauser and Drinnan, 2011). 
The lack of reliability may be due to several confounding effect such as different 
algorithms used by different software programmes (Bielamowicz et al., 1996), 
recording environment, type of microphone, frequency and amplitude of phonation 
during recording and distance of the microphone from the lips (Brockmann-Bauser 
and Drinnan, 2011). Some of the confounding effects may have been effectively 
controlled by the OperaVOX technology as some of its features seek to ensure better 
standardisation of recording. For instance, voice recordings by the OperaVOX are 
only made possible at an acceptable level of ambient noise. The built in colour 
indicator ensures that the participants project their voice during recording so as to 
conform to accepted levels of loudness. Standardisation of lips-to-device distance 
can be achieved using a lanyard. Voices recorded by an internal mobile Apple 
device’s microphone was shown to be compatible with a direct digitisation method 
(Hornibrook et al., 2012; Lin and Hornibrook, 2011). 
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Strength of the study 
OperaVOX reliability has not previously been rigorously investigated, so in this 
study it was compared with another widely available commercial programme - 
MDVP in measuring F0, jitter, shimmer and NHR. We employed recommended 
statistical analysis - ICC and BA analysis to measure inter- and intra-software 
reliability of the new voice analysis software package.  
 
Synopsis of key findings 
Inter-software reliability showed high agreement in all parameters except the NHR. 
The BA analysis showed that OperaVOX and MDVP measured F0, jitter, shimmer 
and NHR with bias of -0.49, -0.07, -0.9 and 0.008 respectively. Intra-software 
reliability was good to excellent for all parameters. The BA analysis demonstrated 
bias of -1.55, 0.11, 0.008 and 0.003 for the respective parameters. When the severely 
aperiodic voices were removed, more precision was achieved for the inter- and intra-
software BA analysis in which the variation of bias and 95% LOA became narrower. 
This was clinically acceptable to the authors’ opinion. We also demonstrated that 
acoustic parameters measured by OperaVOX were able to differentiate normal and 
abnormal voices. These results indicate that OperaVOX is comparable to MDVP. 
However, data transfer between the two software programmes is not recommended.  
 
Previous studies have shown that normal range measured by different programmes ( 
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Table 3-4) and in different population varies (Dehqan et al., 2010; Felippe et al., 
2006; Godino-Llorente et al., 2008; Ma and Yiu, 2005; Toran and Lal, 2010). 
Normal range for all parameters measured by OperaVOX was close to the MDVP 
data except the NHR.  
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Table 3-4: Normative data from previous studies 
 Gender F0, Hz Jitter, % Shimmer, % NHR HNR 
MDVP programme Female 241.08(25.107) 0.633 (0.351) 1.997 (0.791) 0.112 (0.009)  
(from the manual) Male 141.74(21.136) 0.589 (0.535) 2.523 (0.997) 0.122 (0.014)  
       
2009  Toran and Lai 
(Nepalian) 
Female 246.45 (39.73) 0.14 (0.04) 
 
1.57(0.43) 
 
- 25.88(2.75) 
 
Male 170.05 (32.78) 0.14 (0.02) 
 
1.66(0.47) 
 
- 25.81(2.62) 
 
       
2010 Dehqan et al. 
(Iranian) 
Female 214.64 (1.16 ) 0.22 (0.01) 
 
1.21 (0.03) 
 
- 18.81 (0.96) 
 
Male 112.82 (0.94) 0.23 (0.02) 
 
1.22 (0.02) 
 
- 18.42 (0.57) 
 
2006 Fellippe et al. 
(Brazilian) 
Female 206 
 
0.62 
 
- - 10.98 
 
Male 120 
 
0.498 
 
- - 9.56 
 
2005 Ma and Yiu 
(Hong Kong) 
Female 226.06 (21.46) 
 
- 6.07 (1.17) 
 
0.24 (0.04) 
 
 
Male 139.85 (12.19) - 8.89 (0.11) 
 
0.31 (0.01) 
 
 
2008 Godino-
Ilorente  
MDVP 
Female 199.98  (31.4) 0.99 (0.70) 3.06 (1.41) - 11.6 
Male 120.56 (24.8) 0.96 (0.78) 3.53 (1.78) - 12.2 
       
2008 Godino-
Ilorente  
WPCVox 
Female 200.35 (30.9) 1.24 (0.94) 3.27 (1.40) - 18.3 
      
Male 119.70 (24.6) 0.96 (0.78) 3.86 (1.87) - 17.5 
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Comparison with other studies 
Previous authors have compared acoustic analysis obtained by different programmes 
(Table 3-5) and showed that mean F0 was the measurement least affected by the 
different algorithms (Amir et al., 2009; Bielamowicz et al., 1996; Karnell et al., 
1995). Jitter, shimmer and harmonic-to-noise ratio (HNR) was found to be poorly to 
moderately reliable when measured between or within programmes (Bough Jr. et al., 
1996; Carding et al., 2009; Rabinov et al., 1995). This observed variability is likely 
to increase in pathological voices (Amir et al., 2009; Bielamowicz et al., 1996; 
Karnell et al., 1995; Smits et al., 2005). In studies comparing MDVP to other 
software programmes (Amir et al., 2009; Godino-Llorente et al., 2008), the jitter, 
shimmer and NHR were highly correlated (r>7) but there was a significant difference 
when pathological voices were measured by different programmes (p<0.001) (Amir 
et al., 2009). However the comparison used Pearson and Spearman correlation tests 
which are not strictly valid tests to measure realibility of a new instrument (Lee et 
al., 1989).  
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Table 3-5: Previous studies inter-software or programme comparison 
Study Test  F0 Jitter % Shimmer % NHR or HNR 
1995 Karnell et al  
5500 vs SEG 
Pearson 
 
0.98  
0.47 
 
- 
 
- 
      
1995 Karnell et al  
CSpeech vs SEG 
Pearson 
 
1.00 - 0.32 - 
1995 Karnell et al  
CSpeech vs SEG 
Pearson 
 
0.98 0.64 - - 
      
1996 Bielamowicz et al.  
CSpeech, handmarking 
CSL and SoundScope 
Spearman 
 
0.97 – 0.996 0.33 - 0.61 0.82 – 0.87 HNR 
0.23 – 0.86 
      
2005 
Smits et al. 
DrSpeech vs CSL 
Pearson 
 
Pearson 
>0.90 
 
0.69 
 
0.26 
HNR 
0.74 
      
2008 Godino-Ilorente et 
al. MDVP vs WPCVox 
Pearson 
 
0.98 0.85 0.93 NHR 
0.31 
     
      
2009      Amir et al. 
MDVP vs Praat 
Pearson 
 
>0.90 0.82 
 
 
>0.70 >0.70 
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Limitations of the present study 
The only acoustic parameter included in the study that had a poor inter-software 
reliability was NHR. The NHR normative value of the two software programmes 
was also widely different. This may be due to the different algorithms used. 
Although MDVP is widely used, there is no consensus among voice experts 
regarding the ‘gold standard’ programme for acoustic analysis and hence which 
algorithm is the ‘best’. The intra-software correlation for NHR was good (0.72) but 
the lower bound 95% CI (0.58), did not reach the accepted level for good reliability. 
Therefore, clinical application of the NHR measurement derived from OperaVOX 
must be performed with caution.  
 
Intra-software reliability investigation in this study was performed by recording the 
voice twice within 15 minutes. The interval was short compared to other studies 
(Bough Jr. et al., 1996; Carding et al., 2004) possibly contributing to the observed 
intra-software high ICC.  
 
OperaVOX offers a portable, patient-friendly, cheap and simple means of acoustic 
analysis, but presently, it does not permit the same depth and breadth of more 
analysis possible with the static MDVP system. This study shows that neither is 
‘better’ or ‘worse’ than the other for most measurements in common use, and hence 
the choice of instrument must depend on the clinical or research application required.  
 
In this paper I removed the most disordered voices from my analysis and attained 
greater congruity of my results. It may prove that severely disordered voices will 
ultimately be better evaluated with tools that are adapted for non-linear behavior. 
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Such tools have begun to be used in conditions such as Cheyne-Stokes respiration 
and cerebral electrophysiology (Baken, 1996) and are in the very early stages of 
being applied to pathological voice production (Chunying et al., 2013). That said, at 
the time of writing of this article, acoustic analysis with more traditional tools is still 
by and large the technology in use for most laboratory voice analysis.  
 
3.6 Conclusion 
Here I showed OperaVOX is statistically comparable to the ‘gold standard’ (MDVP) 
for most principal phonatory outcome measures. However, given its portability, low 
cost and applicability to home or clinic, OperaVOX has greater utility and therefore 
may be preferred for voice outcome data collection in both settings. Similarly, it may 
be preferred by patients and clinicians for routine clinical data collection.  
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Chapter 4 Reliability of video-laryngostroboscopy evaluation in 
patients with unilateral vocal fold paralysis 
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4.1 Abstract 
Objective: To investigate the inter- and intra-rater reliability of video-
laryngostroboscopy evaluation in patients with unilateral vocal fold paralysis 
(UVFP). 
Methods: Videos of video-laryngostroboscopy of 22 patients with UVFP (40 videos) 
were evaluated by 3 raters (speech and language therapists, SLT) simultaneously but 
independently. All the videos were duplicated (40 x 2 = 80 videos), anonymised and 
randomised. Visual perceptual evaluation of the vocal folds’ vibratory pattern and 
structural characteristics (vocal fold position, arytenoid position and vocal fold 
bowing) was performed. The stroboscopy research instrument (SRI) was used as an 
evaluation tool to assess the vibratory pattern. The inter- and intra rater reliability 
was assessed using the kappa-weighted coefficient method.  
Results: Three parameters were found to consistently show high kappa (κ) values of 
substantial to almost perfect inter- and intra-rater reliability: mucosal asymmetry 
(0.62 to 0.90), right vocal fold periodicity (0.60 to 0.77) and closure duration (0.65 to 
0.85). For vocal fold bowing, the reliability was moderate to almost perfect (0.51 to 
0.84). Poor to fair reliability (κ <0.4) was documented for left amplitude, left vocal 
fold periodicity, right and left non-vibratory activity, vocal fold position and 
arytenoid position. 
Conclusion: Here, the reliability of video-laryngostroboscopy evaluation in 
unilateral vocal fold paralysis is reported. Mucosal asymmetry, closure duration and 
vocal fold bowing appear to be reliable parameters for clinical and research use. 
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4.2 Introduction 
Video laryngostroboscopy is important for the diagnosis of laryngeal disorders and 
has a role in assessing treatment outcomes (Cutler and Cleveland, 2002; Faure and 
Muller, 1992). It is widely available and regarded as a vital assessment tool in voice 
clinics. A survey was done on the use of video-laryngostroboscopy among 
otolaryngologists of Academy of Otolaryngology-Head and Neck Surgery in which 
27.8% of 982 randomly selected members responded (Cohen et al., 2012). The 
survey found that video-laryngostroboscopy is a common instrument used by 
otolaryngologists to evaluate the structural abnormality as well as vibration of the 
vocal folds. However one third of the responders were confused between the 
purposes of video-laryngostroboscopy and laryngoscopy (Cohen et al., 2012). 
Laryngoscopy, using rigid or flexible endoscopes is mainly to visualise gross 
structural characters of the vocal folds such as position, mobility, arytenoid position 
and the presence or absence of atrophy. video-laryngostroboscopy is an instrument 
that comprises a laryngoscope (either rigid or flexible) that is connected to a 
stroboscope and camera to record the examination. Although video-
laryngostroboscopy also allows the gross structural evaluation, it has been used to 
assess precisely the vibratory characteristics of the vocal folds. 
  
Human vocal folds vibrate during phonation that ranged 70 to 500 Hz in males and 
130-1,000 Hz in female that is too fast to be seen by naked eyes (Švec and Schutte, 
1996). Stroboscopy allows evaluation of dynamic effect of vocal fold vibration- 
mucosal waves. In Greek, Strobos means whirling, while scopein means watching or 
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observing (Faure and Muller, 1992). Video-laryngostroboscopy creates the illusion 
of slow motion by generating light flashes at the rate that is slightly delayed from the 
rate of fundamental frequency of the phonation being measured. Thus travelling 
mucosal waves can be seen showing the vibratory pattern of the vocal folds. It gives 
an indication of the health of tissue situated between the superficial mucosa (cover) 
and the vocal muscle (body) (Faure and Muller, 1992; Hirano, 1974). The body and 
cover are connected by the deep and intermediate layers of the lamina propria. The 
free motion of the mucosal waves will be affected by any disturbance of the body, 
cover or intermediate layers. In unilateral vocal fold paralysis (UVFP), flaccid vocal 
fold muscles reduced the stiffness of the underlying body causing diminution or loss 
of travelling mucosal waves (Faure and Muller, 1992; Sercarz, 1992). Reinnervation 
of the muscles that restore the muscle tone or any other surgical interventions that 
increased the body stiffness may restore travelling waves. 
 
Evaluation of video-laryngostroboscopy findings is typically qualitative: rating by 
voice experts assessing the visual findings of vocal folds- vocal fold edge, amplitude 
and symmetry of mucosal wave and glottal closure, as first described by Hirano and 
Bless (Hirano and Bless, 1993). It is largely dependent on the experience of the rater 
and that in turn may affect the inter- and intra-rater reliability (Hirano and Bless, 
1993). A satisfactory level of inter- and intra-rater reliability in evaluation is 
important as it reflects the reliability of the tool and for interpretation of the results. 
Research tools like stroboscopy research instrument (SRI) and Stroboscopy 
Evaluation Rating Form (SERF) have been developed by Rosen and Poburka 
respectively to improve the reliability of video-laryngostroboscopy evaluation 
(Poburka, 1999; Poburka and Bless, 1998; Rosen, 2005).  
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The SRI is a clinically relevant evaluation tool that was developed by Rosen (Rosen, 
2005). Eighteen raters with a mixture of durations of experience demonstrated an 
intra-rater reliability (Kendall’s Tau β) of 0.43 to 0.99 and an inter-rater reliability 
(intraclass correlation) of 0.11 to 0.65. The reliability was generally higher in the 
more experienced raters. Since then, a number of trials involving patients with UVFP 
have used this evaluation tool for video-laryngostroboscopy findings (Morgan et al., 
2007; Rosen et al., 2007, 2009; Vinson et al., 2010). However, in most studies that 
evaluate surgical intervention effect on UVFP, either using SRI or other methods of 
grading system, the consensus score of two or more raters was sought and the 
reliability was not explicitly described (Lee et al., 2007; Lorenz et al., 2008; 
Rihkanen et al., 2004; Wang et al., 2012, 2011).  
 
This study was designed to investigate the inter- and intra-rater reliability of three 
raters in evaluating video-laryngostroboscopy findings of patients with UVFP, using 
the SRI and additional measures of structure: vocal fold position, arytenoid position 
and atrophy (vocal fold bowing).   
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4.3 Methods 
Video selection 
Video-laryngostroboscopy was done using flexible nasopharyngolaryngoscope of 
(VNL-1590STi, KayPentax, USA) attached to a stroboscopy system (RLS 9100B, 
KayPentax, USA). Forty video-laryngostroboscopy video samples of 22 patients 
with UVFP (20, left; and 2, right side palsy) presenting to the Royal National Throat 
Nose Ear Hospital were collected in two ways. First, 15 videos of 15 patients who 
had been examined from 2008 to 2011 were retrieved from the archives of videos. 
Second, video samples of 7 patients (25 videos) undergoing laryngeal reinnervation 
were prospectively collected at different time points, at baseline and follow-ups. 
Four patients were examined at four time points, and the other three patients at three 
time points. All of the video samples (15 + 25 = 40) were duplicated twice (40 x 2 = 
80) for intra-rater reliability testing. Of 40 videos of the 22 patients, 28 had left, and 
12 had right vocal fold paralysis. 
 
The video samples were edited using Windows Movie Maker (Microsoft, USA) for 
the videos from the archives and iMovie (version 9.0.9, Apple, USA). Videos were 
edited to a range of 30-120 seconds to avoid raters’ fatigue and audio tracks were 
edited to prevent bias. Hearing the background voice of surgeons on the audio tracks 
who were doing the video-laryngostroboscopy may provide clues of the identity of 
patients and time point of examinations whether before or after reinnervation. The 
video clips were then randomised using Excel (Version 2011, Microsoft, USA) and 
anonymised. The raters were also unaware whether the videos were recorded before 
or after laryngeal reinnervation.  
 
 161 
Procedures  
Evaluation of vocal fold vibration patterns on the video clips was done using the SRI 
(Rosen, 2005) (Appendix 5). For evaluation of the ‘duration of closure’, raters were 
asked to observe the opening and closure of the glottal gap during phonation. It was 
broken into the categories of predominately closed, half closed/ half opened, 
predominately opened, or always open. In normal vocal folds, the gap is 
predominately closed and the opening is brief. Of nine parameters of the SRI, eight 
items were used in which the ‘type of glottal closure’ was excluded as to my opinion, 
it is less of relevance pertaining to UVFP.  
The SRI is an assessment tool that mainly used to evaluate dynamic vibration of the 
vocal folds but not the gross structural characteristics. Therefore, evaluation of the 
paralysed vocal folds’ gross structural characteristics were also included as below: 
1. vocal fold position (0, median; 1, paramedian; 2, lateral); 
2. arytenoid position at rest (0, normal; 1, partial anteromedial; 2, total 
anteromedial); 
3. arytenoid position during phonation (0, normal; 1, partial anteromedial; 2, 
total anteromedial); and  
4. vocal fold bowing (0, normal; 1, mild bowing; 2, moderate bowing; 3, severe 
bowing).  
These structural characteristics were chosen based on informal discussions with ENT 
consultants, and the previous studies that document common features of UVFP 
(Crumley, 1994; Harries and Morrison, 1996; Inagi et al., 1997b; Rosow and Sulica, 
2010; Woodson, 1993). These findings frequently contribute to the management of 
symptomatic patients with UVFP particularly in deciding surgical options. 
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Three specialist speech and language therapist raters (rater-1, rater-2 and rater-3) 
evaluated the video clips. They had limited or no prior experience of SRI, but had 
used video-laryngostroboscopy in voice clinics for over 10 years. A meeting was 
first arranged to familiarise raters with a few video clips which were then evaluated 
using the SRI. After the meeting, the 80 pre-prepared edited video clips were 
evaluated by the raters simultaneously but independently.  
 
Statistical analysis 
Inter- and intra-rater reliability for each of the SRI parameter (except type of glottal 
closure) and gross structural characteristic items were assessed using weighted kappa 
coefficient. For inter-rater reliability, a pair of raters was assessed at a time. The 
reliability is considered substantial for kappa values of 0.61 to 0.8 and moderate for 
kappa values of 0.4 to 0.6 (Landis and Koch, 1977). 
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4.4 Results 
Kappa values for the inter- and intra-rater reliability are summarised in (Table 4-1) 
and (Table 4-2). Substantial to almost perfect inter-rater reliability for each pair of 
raters κ = 0.60 to 0.9 was consistently documented for mucosal wave asymmetry 
(0.83 to 0.9), right vocal fold aperiodicity (0.61 to 0.77), left vocal fold aperiodicity 
(0.70 to 0.73), right vocal fold non-vibratory activity (0.69 to 0.85) and duration of 
closure (0.75 to 0.90). For the rest of the items, at least one of the pair of raters 
showed moderate inter-rater reliability of κ < 0.6 except for the left vocal fold non-
vibratory activity.  
 
For intra-rater reliability, substantial reliability was demonstrated for mucosal 
asymmetry (0.62 to 0.66), right vocal fold periodicity (0.60 to 0.65), duration of 
closure (0.65 to 0.85) and vocal fold bowing (0.64 for rater-2, 0.78 for rater-3). 
However for rater-1, the inter-rater reliability was moderate (0.51). For the rest of the 
parameters, κ was < 0.6.  
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Table 4-1: Summary of kappa values for inter-rater reliability 
 Items  R1 vs R2 R1 vs R3 R2 vs R3 
SRI 
 
 
 
 
 
 
mucosal wave asymmetry 0.90** 0.87** 0.83** 
R Amplitude 0.71* 0.66* 0.59 
L Amplitude 0.60* 0.77* 0.70* 
R periodicity 0.71* 0.77* 0.61* 
L periodicity 0.71* 0.73* 0.70* 
R non-vibratory activity 0.85** 0.69* 0.82** 
L non-vibratory activity 0.00 0.58 0.00 
Closure duration 0.85** 0.90** 0.75* 
Structural Vocal fold position 0.52 0.67* 0.68* 
Vocal fold bowing 0.56 0.68* 0.84** 
Arytenoid position during 
phonation 
0.70* 0.83** 0.53 
 
Table 4-2: Summary of kappa values for intra-rater reliability 
 Items  R1 R2 R3 
SRI mucosal wave asymmetry 0.66* 0.62* 0.64* 
R Amplitude 0.59 0.49 0.46 
L Amplitude 0.30 0.37 0.30 
R periodicity 0.61* 0.65* 0.60* 
L periodicity 0.34 0.46 0.28 
R non-vibratory activity 0.30 0.49 0.65* 
L non-vibratory activity 0.13 0.00 0.05 
Closure duration 0.83** 0.65* 0.82** 
Structural 
 
Vocal fold position 0.39 0.16 0.55 
Vocal fold bowing 0.51 0.78* 0.64* 
Arytenoid position during 
phonation 
0.35 0.28 0.47 
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4.5 Discussion 
Overview  
Video-laryngostroboscopy is useful in clinical practice as well as in research as it 
may alter choice of therapeutic intervention for voice disorders, as well monitor 
treatment effects (Cutler and Cleveland, 2002). It enables visualisation of vibration 
patterns of the vocal folds mucosa that cannot be seen by naked eyes on 
laryngoscopy. However, video-laryngostroboscopy also allows examination of the 
structural characteristic of vocal folds that is pertinent in diagnosis of vocal fold 
paralysis and in assessing the vocal fold position, arytenoid prolapse, vocal fold 
atrophy (bowing of the vocal fold’s edge) and glottal gap. All of these may influence 
treatment decision (Rosow and Sulica, 2010).  
 
In UVFP, due to discrepancy in the vocal folds’ vertical height, tensing capability 
and muscle tone, and inability to make a firm contact with the opposite normal vocal 
fold, the mucosal waves are commonly asymmetrical with a significant glottal gap 
(Faure and Muller, 1992; Sercarz, 1992). The excursion (amplitude) and velocity of 
mucosal waves on the paralysed side may appear reduced (Sercarz, 1992). Video-
laryngostroboscopy findings have been shown to correlate with acoustic and 
perceptual analysis of voice in which the G factor (overall dysphonia) for the 
GRBAS scale had the strongest correlation (r = 0.68 to 0.88) (Uloza et al., 2005). 
Video-laryngostroboscopy has been used in monitoring the effect of surgical 
treatments in patients with UVFP (Lee et al., 2007; Lorenz et al., 2008; Morgan et 
al., 2007; Paniello et al., 2011; Rihkanen et al., 2004; Rosen et al., 2007, 2009; Wang 
et al., 2012, 2011). However, the reliability of the evaluation is frequently not 
reported explicitly in these reports. Hence, the present study was carried out to 
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investigate the extent of inter- and intra-rater reliability in evaluating the video-
laryngostroboscopy findings in patients with UVFP.    
 
Strength of the study 
This is the first study that rigorously investigates the inter- and intra-rater reliability 
in evaluating the vibratory pattern and vocal fold structural characteristics of UVFP. 
The results may reflect the reliability of parameters and suggests which parameters 
might be most reliable in clinical trials. SRI was chosen instead of SERF because the 
SRI is more clinically relevant and less complicated. This is important to avoid raters 
fatigue that may affect the result of the present study. The SRI also has been used in 
the previous studies of surgical effectiveness in UVFP. 
 
Summary of key findings 
The present study looked at the inter- and intra-rater reliability in evaluating video-
laryngostroboscopy findings using the SRI found that two parameters had 
consistently substantial to almost perfect reliability: mucosal asymmetry and 
duration of closure. For the vocal fold paralysis structural evaluation, only vocal fold 
bowing had consistent substantial inter- and intra-rater reliability although for one of 
the raters the intra-rater reliability was only moderate.  
 
Comparison with previous work 
A number of reliability studies have been carried out to investigate the reliability of 
UVFP evaluation tools. In these, inter-rater reliability ranged from low to good and 
some of the items measured vary between sides. There was no consistency in the 
types of vocal fold disorder examined and recorded using video-laryngostroboscopy.  
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Rosen found that, of nine parameters of the video-laryngostroboscopy evaluation 
tool (SRI), four depicted an intraclass correlation coefficient (ICC) of acceptable to 
substantial reliability: left vocal fold amplitude (0.61), left non-vibratory portion 
(0.68), closure pattern (0.59), and closure duration (0.58) (Rosen, 2005). Although 
the left vocal fold amplitude and left non-vibratory pattern was acceptable but the 
right side of each was 0.25 and 0.11 respectively. Nawka and Konerding investigated 
the reliability of another video-laryngostroboscopy evaluation tool developed by 
Poburka and reported that the ICC ranged from 0.32 to 0.71. Parameters that 
depicted an ICC of acceptable to subtantial reliability were left mucosal wave (0.59), 
right non-vibrating portion (0.57), and left and right vocal fold straightness (0.71 and 
0.64) (Nawka and Konerding, 2012). The contralateral parameters of the mucosal 
wave and non-vibrating portion did not reach the acceptable reliability. 
Subsequently, Yiu et al. re-examined the reliability of amplitude, supraglottic 
activity and glottal closure and added another parameter, lesion size rating. The study 
reported that the inter- and intra-rater reliability for lesion size was good (ICC, 0.75 
to 0.81), antero-posterior supraglottic activity was substantial (ICC, 0.64) and glottal 
closure was substantial (κ, 0.64) (Yiu et al., 2013). Uloza et al. evaluated inter- and 
intra- rater reliability of video-laryngostroboscopy parameters that were measured 
using a 100-mm long visual analogue score and documented that the reliability of 
glottal closure, regularity, and symmetry of vibration was substantial to almost 
perfect (Uloza et al., 2013).  
 
Rosow et al. evaluated the inter- and intra-rater reliability of 12 parameters of 
laryngoscopy appearance of structural characteristics of 22 patients with vocal fold 
 168 
paralysis. The study reported that glottic insufficiency, vocal fold bowing and 
salivary pooling depicted the highest inter-rater reliability κ: 0.55, 0.49 and 0.45 
respectively although they are of moderate reliability (Rosow and Sulica, 2010). 
 
The present study was the first to rigorously evaluate the reliability of video-
laryngostroboscopy parameters (SRI) and structural characteristics of vocal folds in 
patients with UVFP. These parameters were chosen because they are pertinent in 
vocal fold paralysis assessment and frequently measured in published studies 
investigating the efficacy of surgical interventions. Results of the present study are 
similar to Rosen’s for closure duration, to Uloza’s for symmetry of vibration and to 
Rosow’s for vocal fold bowing.  
 
Limitations of the present study 
There are several factors that may confound visual perceptual evaluation: 
laryngoscopy procedures, parameters for evaluation, evaluation tool used, experience 
of the raters and amount of training applied(Hirano and Bless, 1993; Yiu et al., 
2013). 
 
The raters involved in the present study, although very experienced in assessing 
video-laryngostroboscopy, had limited experience in using SRI. There was no formal 
training given prior to the familiarisation meeting and this may skew results. 
Therefore, it is necessary to provide formal training to raters as well as to encourage 
them to use the tool in their daily clinical practice.  
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Evaluation of dynamic vibration of vocal folds is relatively difficult. The evaluation 
may be inaccurate if the tip of the laryngoscope is angled hence amplitude may seem 
larger on one side than the other. This angulation also may affect the laryngoscopy 
appearance of vocal fold position and arytenoid position. A careful manoeuvring of 
the laryngoscope to avoid this situation may improve the reliability of video-
laryngostroboscopy evaluation.  
 
Kappa weighted coefficient is a standard test of inter- and intra-rater reliability or 
ordinal data (Cohen, 1968; Kottner et al., 2011; Viera and Garrett, 2005; Yiu et al., 
2013). However the results may be dependent on the prevalence of pathology or 
abnormality under consideration. For small prevalence findings, a low kappa value 
may not necessarily reflect the overall agreement of the raters (Viera and Garrett, 
2005). In the present study, 20 videos belonged to 7 patients that had been taken at 
different time points post-laryngeal reinnervation. Therefore, normal or mildly 
abnormal vibration patterns or vocal fold structural findings as direct results of the 
intervention may introduce bias and affect kappa values. Future studies should 
include patients with a wider variety of UVFP severity.   
 
Clinical impact 
The present study supports the use of video-laryngostroboscopy in evaluating the 
mucosal wave asymmetry, duration of closure and vocal fold bowing in patients with 
UVFP. These parameters are important in indicating return of voice function by 
closing the glottal gap as well as the preservation of pliability of the vocal fold 
mucosa, for example that following laryngeal reinnervation.  
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4.6 Conclusion  
Here, I demonstrated the reliability of video-laryngostroboscopy as a tool for 
evaluating UVFP. A substantial inter- and intra-rater reliability was shown for the 
mucosal wave asymmetry, duration of closure and vocal fold bowing of the video-
laryngostroboscopy parameters that appear to be reliable parameters for clinical and 
research use. 
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Chapter 5 Denervation changes on T2-MRI of vocal fold paralysis: 
a repeatability study 
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5.1 Abstract 
Objective: This study investigated the repeatability and reproducibility of T2-
weighted MRI (T2-MRI) to depict laryngeal muscles’ – thyroarytenoid (TA) and 
posterior cricoarytenoid (PCA), muscle bulk and signal changes in patients with 
UVFP. 
 
Methods: T2-MRI was performed on five healthy volunteers and nine UVFP 
patients. Images were acquired in axial and coronal planes to depict TA and PCA 
(resolution, 300x297; slice thickness, 2.5mm). Five participants from each group had 
a second scan. All patients underwent laryngeal electromyography (LEMG) in which 
recruitment of motor units were graded by a neurophysiologist, unaware of MRI 
findings. Region of interest (ROI) was placed independently by two readers on:  
1) TA coronal to measure TA bulk cm2 
2) PCA axial to measure PCA bulk cm2  
3) TA axial to measure TA signal-intensity 
4) PCA axial to measure PCA signal-intensity  
Within subject repeatability and inter- and intra-reader reproducibility was assessed 
using intraclass correlation test (ICC). Comparison of metrics between groups was 
done using Mann Whitney test. 
 
Results: TA signal intensity were significantly higher, and TA bulk and PCA bulk 
were significantly smaller in paralysed muscles than normal muscles (p=0.03 to 
0.01). TA signal intensity and PCA bulk were significantly correlated with the motor 
 173 
unit recruitment on LEMG. Adequate repeatability and reproducibility (ICC=0.63 to 
0.83) was persistently demonstrated for TA bulk and signal-intensity. 
 
Conclusion: I demonstrated the repeatability and reproducibility of T2-MRI in 
depicting denervation changes in UVFP. Signal changes on TA muscles correlate 
with electrophysiological results on LEMG and may be useful in monitoring 
treatment outcome of laryngeal reinnervation in UVFP patients. 
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5.2 Introduction  
The larynx is the main route for human social interaction and critical for breathing, 
swallowing and airway protection. Loss of laryngeal function therefore has major 
implications. Muscles within the vocal folds of the larynx are innervated mainly by 
the recurrent laryngeal nerve (RLN), a branch of the vagus nerve. When the nerve 
supply to one vocal fold is interrupted, unilateral vocal fold paralysis (UVFP) ensues. 
Patients with UVFP typically experience hoarse, weak and an easily tired voice. 
Quality of life is significantly reduced and social and employment opportunities are 
compromised (Fang et al., 2008; Smith et al., 1995). Aspiration of saliva and food, 
and airway obstruction are sometimes problems also. 
 
The aim of treatment for UVFP is to achieve optimum vocal fold closure for voice 
production. One of surgical interventions that have been proposed is laryngeal 
reinnervation. It restores innervation to the larynx by ‘borrowing’ the activity of 
other motor nerves, commonly the ansa cervicalis. As such it re-establishes the tone 
and bulk of the vocal folds for speech and re-enables pitch control resulting in 
normal or near normal voice (Wang et al., 2011). 
 
Evaluation of laryngeal muscle characteristics before and after reinnervation is 
important to confirm eligibility as well as monitor treatment effect. Reinnervation 
surgery should not be performed without confirming the status of muscle paralysis. 
Sometimes mechanical fixation of the cricoarytenoid joint may be mistakenly 
diagnosed as vocal fold paralysis and this need to be ruled out (Connor et al., 2006; 
Romo and Curtin, 1999). The present investigation for this purpose is laryngeal 
electromyography (LEMG). 
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LEMG is commonly used to assess the neurological status of paralysed laryngeal 
muscles. In denervated laryngeal muscles, the electromyography shows absence or 
reduction of normal motor unit action potentials (MUAP) and recruitment during 
voluntary contraction with presence or absence of spontaneous activity. It is useful in 
showing diagnosis and prognosis of vocal fold paralysis although it is based on class 
IV evidence. It has been assumed as the gold standard as it is the only tool used to 
provide physiological evidence to reinnervation or denervation of laryngeal muscles 
(Blitzer et al., 2009). However, it requires considerable operator skill, is invasive and 
muscles are not directly visualized during needle positioning. It requires an 
experienced otolaryngologist, electromyographer and a neurophysiologist to get a 
reliable result (Volk et al., 2012). The otolaryngologist has to be someone who 
familiar with laryngeal anatomy and has been doing botulinum injection to the larynx 
by external approach regularly. Availability of LEMG is also limited; in a survey 
done among ENT consultants in the UK, only 20% has the access to LEMG whereas 
100% had access to MRI (unpublished data).  
 
MRI has been shown useful in depicting denervation changes – increased signal 
intensity and reduced bulk, in muscles. Signal changes were shown on the T2-
weighted MRI (T2-MRI) during acute, sub-acute and chronic phase of denervation 
(Kamath et al., 2007). Therefore, it may provide a non-invasive alternative or an 
adjunct to LEMG to directly assess laryngeal muscle bulk and signal intensity 
changes associated with paralysis (Connor et al., 2006; Romo and Curtin, 1999). 
Early anatomical 1.5T MRI has been used to assess laryngeal muscle bulk and fatty 
change in patients with vocal fold paralysis; but no quantitative metrics were 
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evaluated and no correlation with a corroborating standard of reference was 
performed (Romo and Curtin, 1999).  
 
This study investigated the reliability and validity of T2-MRI to depict laryngeal 
muscles’ – thyroarytenoid (TA) and posterior cricoarytenoid (PCA), muscle bulk and 
signal intensity in patients with UVFP. 
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5.3 Methods 
Local Ethics Committee approval was obtained (reference number: 11/LO/0583) for 
the study. 
Study overview 
This study investigates the reliability and validity of the T2-MRI for quantitatively 
evaluating muscle bulk and signal changes of TA and PCA in UVFP alongside 
healthy controls. Four outcomes were of interest in this study: 
1. Within subject repeatability of T2-MRI metrics measurement between first 
and second scan at two separate occasions (inter-scan). 
2. Inter- and intra-reader reproducibility of T2-MRI metrics measurements.  
3. Comparison of T2-MRI metrics between healthy volunteers and UVFP 
patients.  
4. Correlation of T2-MRI metrics with LEMG scores. 
 
Participant selection 
Healthy controls: Adult volunteers without any current or previous history of voice 
problems (excluding previous upper respiratory tract infection). Five healthy 
volunteers (2 female, 3 male) with age ranged from 28 to 41 old were included in 
this study. 
Unilateral vocal fold paralysis patients: 9 UVFP patients (7 female, 2 male) with 
age ranged from 19 to 62 years old were recruited. UVFP was identified by fibre-
optic nasopharyngolaryngoscope of (VNL-1590STi, KayPentax, USA) and 
confirmed by LEMG which was done after the scan. The causes were secondary to 
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iatrogenic or idiopathic causes. All patients had left vocal fold paralysis for more 
than 6 months and had never undergone any medialisation procedure.  
Five participants from each of the volunteer and patient groups had second visit scan 
within four weeks to assess the inter-scan repeatability. 
 
MRI protocol 
Imaging was performed on a 3T Philips Achieva TX MRI scanner (Philips 
Healthcare, The Netherlands). Sense Flex S coils of 11cm diameter were placed at 
the side of the neck covering the anterior part of the larynx below the angle of the 
mandible, while the participant lied supine on the scanner bed with the head resting 
on a headrest. The coils were held in place by putting a neck strap and sandbags at 
the side of the head and neck to minimize movement. The participants were asked 
not to move their neck or jaw, clear their throat or swallow during the image 
acquisition period. The T2-MRI protocol is shown in Table 5-1.  
 
Table 5-1: This table shows T2-MRI protocol for axial and coronal view 
T2-MRI protocol  Coronal Axial 
Sequence Name SE-TSE SE-TSE 
Repetition time (ms) 6789 3903 
Echo time (ms) 120 100 
Image resolution 0.5x.5x 0.5x0.5 
Slice thickness 2.5 2.5 
Number of slices 14 18 
Flip angle 90 90 
Field of view (FOV) mm 140x140 140x140 
Total acquisition time  5 min 32 secs 7 min 32 secs 
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LEMG protocol 
UVFP patients had LEMG performed within 4 weeks after the MRI. While patients 
lying on the couch with neck slightly extended, a laryngologist (MAB) inserted a 
monopolar needle into the TA muscles through the cricothyroid membrane while an 
electromyographer operated the electromyography machine. The PCA muscles were 
not studied due to technical challenges in accessing the muscle caused by deep 
location of the muscle. The LEMG findings were captured and saved. The LEMG 
tracing recording was then converted to an executable file (exe.file) that later rated 
by a consultant neurophysiologist who was unaware of the T2-MRI findings. The 
LEMG findings were evaluated according to Koufman classification whereby the 
item of interest in the present study is the recruitment of motor units (Koufman et al., 
2001). The motor unit recruitment was graded from 0 (no recruitment) to 4 (normal 
recruitment). LEMG results of the TA were inferred for PCA as both are innervated 
by the RLN 
 
Image analysis 
Images were downloaded to OsiriX (open-source software, Geneva, Switzerland) 
(Rosset et al., 2004) workstation for analysis. They were then quantitatively 
analysed. 
 
Two readers independently made the T2-MRI metrics measurements to assess inter-
reader reproducibility. The first reader, an Otolaryngology surgeon who has been 
trained in laryngology for 4 years and the second reader, a consultant radiologist 
experienced in body MRI (10 years). The first reader made a second measurement 
after a month from the first measurement to assess intra-reader reproducibility. The 
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muscle bulk of left and right, TA and PCA were evaluated by measuring the muscle 
area (cm2) on the slice that depicts the biggest muscle bulk by drawing a region of 
interest (ROI) on the largest cross-section of the muscle body. The TA bulk was 
measured on the coronal plane images (Figure 5-1) whereas for the PCA muscle 
measurements were made on axial images (Figure 5-2). Mean signal intensity of the 
muscles was obtained from the ROI drawn on the axial plane for both muscles 
(Figure 5-3). The signal intensity was then normalised against individual patient 
skeletal neck muscle by calculating the ratio of the laryngeal muscles to the left 
sternocleidomastoid muscle signal intensity.   
 
 
 
 
 
 
 
 
 
Figure 5-1: This figure shows T2-MRI of larynx images in coronal view showing the 
main cross-sectional bulk of thyroarytenoid muscles of a: A) healthy volunteer; and 
B) unilateral vocal fold paralysis patient. The arrow shows left side paralysis in 
which the bulk is smaller than the normal side. 
A B 
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Figure 5-2: This figure shows T2-MRI of larynx images in axial view showing 
posterior cricoarytenoid muscles of a: A) healthy volunteer; and B) unilateral vocal 
fold paralysis patient. The arrow shows left side paralysis in which the bulk is 
smaller and the signal intensity is higher than the normal side. The region of interests 
are drawn in redlines. 
 
 
 
 
 
 
 
 
 
Figure 5-3: This figure shows T2-MRI of larynx images in axial view showing 
thyroarytenoid muscles of a: A) healthy volunteer; and B) unilateral vocal fold 
paralysis patient. The arrow shows left side paralysis in which the signal intensity is 
higher than the normal side. The region of interests are drawn in redlines.  
 
A B 
A B 
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Statistical analysis 
Data of this study is presented in median and interquartile (IQR) range. 
1. Within subject repeatability of T2-MRI metrics measurement (inter-scan) was 
assessed using intraclass correlation coefficient test (ICC)- two-way mixed, 
consistency. 
2. Inter- and intra-reader reproducibility of T2-MRI metrics measurements was 
also assessed using the ICC- two-way mixed, absolute agreement.  
3. T2-MRI metrics were compared: 
a. within volunteers, left and right TA and PCA; 
b. within patients, paralysed and normal TA and PCA; 
c. between volunteers and patients, normal TA and PCA; and  
d. between volunteers normal and patients, paralysed TA and PCA. 
4. Correlation of T2-MRI metrics with LEMG scores was assessed using 
Spearman rank correlation. 
Comparison between muscles within subjects was performed using the Wilcoxon 
signed rank test. The Mann Whitney test was used for comparison across volunteer 
and patient groups. ICC values ranged from 0 (not repeatable or reproducible) to 1 
(perfect repeatability or reproducibility). The ICC has to be at least 0.6 for the 
measurements to be clinically useful (Chinn, 1991). Repeatability and reproducibility 
of the measurements was considered good for ICC of similar to 0.75 and moderate 
for ICC of between 0.5 and 0.75 (Portney and Watkins, 1993).
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5.4 Results 
The median and interquartile ranges (IQR) for the left and right TA bulk, PCA bulk, 
TA- and PCA signal intensity of healthy volunteers and patients are presented in 
Table 5-2. 
Table 5-2: This table shows the summary of anatomical parameters between healthy 
volunteers and UVFP patients. Where medians are shown, brackets represent 
interquartile ranges. 
 Volunteer  Patient  
TA bulk   
Left  0.30 (0.22, 0.32) 0.14 (0.12, 0.26) 
Right  0.29 (0.22, 0.37) 0.32 (0.23, 0.38) 
PCA bulk   
Left 0.33 (0.28, 0.42) 0.18 (0.16, 0.26) 
Right 0.33 (0.25, 0.42) 0.36 (0.31, 0.46) 
TA signal intensity   
Left 1.98 (1.71, 2.31) 2.84 (2.17, 3.61) 
Right 1.99 (1.84, 2.39) 2.06 (1.58, 2.44) 
PCA signal intensity   
Left 1.49 (1.22, 1.80) 1.69 (1.60, 2.41) 
Right 1.62 (1.32, 2.03) 1.51 (1.39, 1.93) 
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Within subject repeatability 
PCA bulk and TA signal intensity T2-MRI metrics demonstrated good within subject 
repeatability with ICC values of 0.79 and 0.83 respectively. TA bulk and PCA signal 
intensity had moderate repeatability (0.52 and 0.63, respectively). However the PCA 
signal intensity was still clinically useful. 
 
Inter- and intra-reader reproducibility 
TA bulk, TA signal intensity and PCA signal intensity T2-MRI metrics showed 
moderate inter-reader reproducibility with ICC values of 0.65, 0.71 and 0.73 
respectively, adequate to be clinically useful. PCA bulk had moderate reproducibility 
but not clinically useful (0.57).  
 
For intra-reader reproducibility, the TA signal intensity had good repeatability (ICC, 
0.76) and the TA bulk and PCA signal intensity had moderate repeatability with ICC 
values of 0.71and 0.74 respectively, adequate to be clinically useful (Table 5-3). The 
PCA bulk had moderate intra-reader reproducibility but not clinically useful (0.46). 
Table 5-3: This table shows within subject repeatability, and inter- and intra-reader 
repeatability results.  
T2-MRI metrics Within subject Inter-reader Intra-reader 
TA bulk 0.63 (0.27, 0.83) 0.65 (0.20, 0.84) 0.71 (0.01, 0.90) 
PCA bulk 0.79 (0.54, 0.91) 0.57 (0.11, 0.79) 0.46 (-0.10, 0.77) 
TA signal intensity 0.83 (0.62, 0.93) 0.71 (0.45, 0.85) 0.76 (0.60, 0.86) 
PCA signal 
intensity 
0.40 (-0.04, 0.71) 0. 73 (0.56, 0.84) 0.74 (0.57, 0.85) 
ICC values are presented in the table 
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Comparison between healthy volunteers and UVFP patients  
Within volunteers, there was no significant difference for TA bulk, PCA bulk and 
TA signal intensity T2-MRI metrics between left and right muscles (p values ranged 
from 0.27 to 0.50) except for PCA signal intensity (p = 0.04).  
 
Within patients, the TA bulk and PCA bulk were significantly smaller (p=0.01 and 
p=0.01) and the TA signal intensity was significantly higher on the paralysed side 
than the normal side. For PCA signal intensity, there was no significant difference 
between the paralysed and the normal side (p = 0.21) (Figure 5-3)  
 
For between volunteers and patients’ normal muscles, there was no significant 
difference for all the T2-MRI metrics (p=0.46 to 0.96).  
 
For between volunteers’ normal and patients’ paralysed muscles, the TA bulk and 
PCA bulk were significantly smaller (p=0.03 and p=0.01) and the TA signal intensity 
was significantly higher, on the paralysed side than the normal side. For PCA signal 
intensity, there was no significant difference between the paralysed and the normal 
side (p=0.32). 
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Table 5-4: This table shows results of comparison between healthy volunteers and 
UVFP patients. 
 Within patient Within 
volunteer 
Volunteers vs 
patients, 
(normal) 
Volunteers 
(normal) vs 
patients 
(paralysed) 
TA bulk 0.01 0.28 0.46 0.03 
PCA bulk 0.01 0.27 0.46 0.01 
TA signal 
intensity 
0.02 0.50 0.96 0.012 
PCA signal 
intensity 
0.21 0.04 0.57 0.32 
p value of the Wilcoxon sign rank test is presented in the table 
 
Correlation between T2-MRI metrics and LEMG recruitment grade 
There was strong negative correlation between LEMG recruitment motor unit and 
TA signal intensity (r = -0.70, p = 0.003) that indicates a reduction in motor unit 
recruitment is related to an increase in TA signal intensity. TA bulk had moderate 
positive correlation (r = 0.40, p = 0.12) with motor unit recruitment. 
 
Strong positive correlation was demonstrated between LEMG recruitment grade and 
PCA bulk (r = 0.66, p = 0.006) that shows a reduction in motor unit recruitment is 
related to a reduction in PCA bulk. PCA signal intensity had moderate negative 
correlation (r = -0.42, p=0.11) with motor unit recruitment. 
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Figure 5-4: This figure shows graphs of correlation between T2-MRI metrics and 
laryngeal electromyography recruitment. r: correlation value, p: p value 
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r = 0.40, p = 0.12 r = -0.70, p = 0.003 
r = -0.42, p=0.11 r = 0.66, p = 0.006 
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5.5 Discussion 
Overview 
LEMG is the present available gold standard for evaluation of denervated laryngeal 
muscles and monitoring of reinnervation. Evaluation of laryngeal muscles 
neurological status is important to decide timing and type of surgical intervention 
(Koufman et al., 2001). It is particularly important before a laryngeal reinnervation 
procedure to confirm the muscles’ neurological status and after the operation to 
measure treatment effect supporting the voice outcome measures. However, LEMG 
is invasive, operator dependent and not routinely practiced by laryngologists (Volk et 
al., 2012). The LEMG evaluation is widely qualitative that is subject to expertise and 
familiarity although there were studies been done to investigate the utility of 
objective evaluation (Smith et al., 2012; Statham et al., 2010). MRI may be a useful 
non-invasive method in objective assessment of neurological status providing 
evidence of denervation and reinnervation of laryngeal muscles. It has been shown 
that changes on MRI mirrored electrophysiological changes on electromyography 
(Küllmer et al., 1998). 
 
MRI has been useful in demonstrating denervation changes of skeletal muscles 
affecting the morphology and physiology (Kamath et al., 2007; Koltzenburg and 
Yousry, 2007) and predicting prognosis (Yamabe et al., 2008). It can objectively 
depicts evidence of denervation and reinnervation by measuring the muscle volume 
and signal changes on T2-MRI (Bendszus et al., 2002; Kikuchi et al., 2003; 
Viddeleer et al., 2012; Yamabe et al., 2008). In peripheral nerve neuropathies, the 
hyperintense signal on T2-MRI is due to an increase in extracellular fluid secondary 
to oedema or increased in vascularity and fatty degeneration (Kikuchi et al., 2003; 
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Polak et al., 1988; Wessig et al., 2004) depending on the duration of nerve injury. 
The abnormal signal changes on T2-MRI correlated with prognosis in rats (Yamabe 
et al., 2008) and with hand function in human (Viddeleer et al., 2012). 
 
Synopsis of key findings 
The findings in the present study demonstrated that the TA signal intensity was 
significantly higher, and the TA bulk and PCA bulk were significantly smaller in the 
paralysed than the normal muscles. The TA signal intensity and TA bulk also had 
strong significant correlation and moderate correlation respectively with the motor 
unit recruitment. For PCA bulk and PCA signal intensity, strong significant 
correlation and moderate correlation respectively with the motor unit recruitment 
were shown. These results indicate that the signal intensity increased as recruitment 
of motor units reduced and a reduction of muscle bulk on T2-MRI was related to 
reduction of motor unit recruitment. I expect these results are likely to demonstrate 
further statistical significance with higher number of patients included in the study.  
 
The present study also demonstrates adequate within subject repeatability and inter- 
and intra-reader reproducibility of the T2-MRI metrics measurement except for the 
PCA bulk. Among the T2-MRI metrics, TA bulk and TA signal intensity consistently 
depicts adequate repeatability and reproducibility by which the TA signal intensity 
had good within subject repeatability and intra-reader reproducibility. 
 
Comparison with previous work 
MRI in laryngeal paralysis is widely used to investigate its etiologies (Vachha et al., 
2013). Sakai et al. investigated normal laryngeal structures in 62 participants using 
 190 
1.5T machine and had shown that MRI is efficient in demonstrating laryngeal 
muscles (Sakai et al., 1990). MRI able to clearly depict denervation changes on the 
TA and PCA muscles (Borges, 2010; Connor et al., 2006). A retrospective study was 
done to evaluate the ability of MRI in depicting denervation atrophy of laryngeal of 
laryngeal muscles (Romo and Curtin, 1999). This study involved 20 UVFP patients 
in whom four of them had both CT scan and MRI. Denervation atrophy was detected 
in high frequency 70 – 90%. They concluded that PCA muscle atrophy may be a 
useful indicator of RLN paralysis when other findings are subtle or equivocal. 
 
However studies to correlate MRI changes with electrophysiological changes in 
denervated laryngeal muscles is lacking in the literature. To my knowledge the 
present study is the first to quantify the MRI changes on T2-MRI objectively and 
rigorously test the repeatability and validity against the electrophysiological changes 
on LEMG. 
 
Limitation of the present study 
T2-MRI images are susceptible to motion. Participants were not allowed to clear 
their throat or swallow during acquisition period to ensure good quality of images. 
Some UVFP patients may find it difficult especially when they have pooling of 
saliva due to swallowing issues. One dataset was excluded due to the motion artifact. 
This issue may be able to overcome by improving the time acquisition in the 
protocol. 
 
The TA muscles are commonly injected with substances for medialisation procedure 
that may alter the signal intensity. Therefore the use of T2-MRI in signal intensity 
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measurement of the TA may be limited in those patients who had received such 
procedure by which the high signal intensity can be attributed to the injection instead 
of fatty change or oedema. In this situation, PCA muscles may be used as an 
indicator (Romo and Curtin, 1999). However, PCA bulk had the lowest reliability 
and PCA signal intensity was not significantly different between the paralysed and 
normal muscles.  
 
PCA muscles were not studied for the LEMG due to technical difficulties in locating 
the muscle. The TA muscles’ LEMG results were used instead as both muscles were 
supplied by the same nerve. In a study that investigate spontaneous reinnervation in 
cats, reinnervation was documented to be more robust in TA muscles – adductor, 
than the PCA muscle – abductor (Woodson, 2007). Therefore correlation between 
PCA muscles metrics and the LEMG results need to be interpreted with caution.  
 
T2-MRI may not be suitable in in certain group of vocal fold paralysis patients such 
as those who had any screws or implants in the cervical spine or had stainless steel 
heart valve replacement or pacemaker that are not MRI compatible. If they are 
compatible, foreign bodies in the cervical spine will cause artifact that will affect 
quality of images. 
 
This study included small number of patients with limited range of neurological 
status on LEMG results. Therefore it cannot conclude whether T2-MRI anatomical 
metrics able to demonstrate the severity of paralysed muscles’ neurological status. 
Future studies should recruit more number of patients with wider temporal range, 
from acute phase to chronic phase of denervation. 
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Clinical impact 
T2-MRI is useful to depict denervation and monitor effect of reinnervation procedure 
in UVFP. A successful reinnervation was shown to reverse the high signal changes 
as shown in other skeletal muscles in animal models (Yamabe et al., 2008). The 
present study demonstrated TA signal intensity as the most useful parameter that had 
strong correlation with the motor units recruitment, good within subject repeatability 
and intra-reader reproducibility, and clinical useful intra-reader reproducibility. 
Other metrics may be useful as well and a better reliability results may be 
demonstrated if a bigger number of participants is included. A larger scale study that 
include more numbers of volunteers and patients is necessary to decide on a normal 
cut off range.  
 
The ability of the T2-MRI to differentiate between normal and paralysed muscles 
will help surgeons to decide on patients’ eligibility of reinnervation. It confirms 
paralysis by demonstrating smaller bulk (atrophy) and higher signal intensity on the 
paralysed side than the opposite normal. It also may exclude total denervation that is 
an exclusion criterion for reinnervation procedure. The T2-MRI also, potentially able 
to show increased muscle bulk following reinnervation, which contributes to voice 
improvement.  
 
5.6 Conclusion 
I demonstrated the repeatability and reproducibility of T2-MRI in depicting 
denervation changes in vocal fold paralysis muscles. Signal changes on TA muscles 
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had shown to be correlated with electrophysiological results on LEMG that is useful 
in monitoring treatment outcome of laryngeal reinnervation in UVFP patients. 
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Chapter 6 Muscle perfusion in laryngeal muscles paralysis: 
Findings on dynamic contrast enhanced MRI and diffusion 
weighted MRI 
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6.1 Abstract 
Objective: To investigate the perfusion of thyroarytenoid (TA) and posterior 
cricoarytenoid (PCA) muscle in healthy volunteers and unilateral vocal fold paralysis 
(UVFP) patients using dynamic contrast enhanced-MRI (DCE-MRI) and diffusion 
weighted-MRI (DWI). 
Methods: DWI and DCE-MRI were performed on five healthy volunteers and nine 
UVFP patients. Axial images were acquired to depict TA and PCA. Regions of 
interest were placed within left and right of TA and PCA of acquired images. For 
DCE-MRI, time intensity curve (TIC) were generated by plotting signal intensities 
during and following intravenous contrast administration. TIC slope of initial 
enhancement (SoE), maximum enhancement (ME) and area under the curve (AUC) 
at 1 minute (AUC-1) was derived. For DWI, apparent diffusion coefficient values 
(ADC) were calculated from low b-values 0, 50, 100. Left and right TA, and PCA 
MRI metrics within subjects were compared using the Wilcoxon sign rank test. The 
Mann Whitney test was used for comparison between volunteers and patients. 
Results: There was no significant difference of SoE, ME, AUC-1 and ADC, between 
the left and right of- TA and PCA in volunteers, and between volunteers and patients. 
However PCA DCE_MRI metrics were significantly higher in patients normal than 
volunteers. For patients, the paralysed TA and PCA ADC were significantly lower 
than normal muscle within subjects (p=0.01, p=0.01) and between patients and 
volunteer groups (p = 0.08, p = 0.03). For DCE-MRI, the SoE, ME and AUC-1 
(p=0.01) was lower in the paralysed PCA within patients (p=0.01) and between 
patient and volunteer groups (p=0.01 to 0.03).  
Conclusion: This study demonstrates the feasibility of assessing tissue perfusion in 
laryngeal muscles using DCE-MRI and DWI. The findings confirm that paralysed 
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TA and PCA muscles have reduced perfusion and that apparently normal 
contralateral musculature in patients with UVFP has elevated perfusion.  
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6.2 Introduction 
 
Normal skeletal muscles contain a capillary network that allows replacement of 
glucose, fatty acid and oxygen consumed in muscular activity as well as removal of 
lactic acid and carbon dioxide. Peripheral neuropathy causes these capillaries to 
involute, possibly due to an adaptive mechanism to reduce load in a functionless 
region or in response to an adverse local niche (Carpenter and Karpati, 1982). There 
have been reports that this process is followed by a relative increase in perfusion as 
muscles atrophy (Carpenter and Karpati, 1982; Murakami et al., 1998; Russo et al., 
1997) although others suggest a reduced microcirculation demonstrated by 
progressive reduction of the capillary-to-fibre ratio and capillary density per cross 
sectional area following denervation (Borisov et al., 2000)(Lu et al., 1997). 
 
Such studies have so far depended on animal models (Kato et al., 2002; Miyamaru et 
al., 2008; Shindo et al., 1992; Zealear et al., 1994). Evaluation of denervation 
changes in human thyroarytenoid (TA) and posterior cricoarytenoid (PCA) muscles 
by histology can only realistically be achieved post-mortem and so changes in 
perfusion have only been inferred or extrapolated. However, progressive innovation 
in MRI technology, and in particular diffusion weighted imaging (DWI) and 
dynamic contrast enhanced magnetic resonance imaging (DCE-MRI), may now 
present an alternative for evaluating the pathologic properties and physiologic 
changes within denervated muscles.  
DCE-MRI is based on acquisition of serial T1-weighted images prior to, during and 
following administration of intravenous gadolinium contrast (Lavini et al., 2013; 
Verstraete et al., 1996; Weber et al., 2007). Changes in the signal intensity of tissues 
 198 
with time can provide functional information related to capillary density (perfusion), 
structure and permeability of microvasculature (Lavini et al., 2013; Verstraete et al., 
1996). DCE-MRI has been used to investigate tissue microcirculation differences 
between malignant and benign tumours, post-radiation changes and evaluate the 
effects of therapeutic interventions (Knopp et al., 2001; Punwani, 2011).  
Another MRI method for measuring tissue perfusion is DWI. This relies on the 
sensitivity of MRI to water mobility. Within cellular and interstitial spaces DWI 
provides a measure of ‘Brownian motion’ of tissue water (Le Bihan et al., 1991); but 
it can also be made sensitive to intra-vascular ‘bulk motion’ of water (Padhani et al., 
2009). By acquiring diffusion images using low b-values the diffusion signal is 
sensitised to changes in tissue perfusion (Yanagisawa et al., 2009a, 2009b). ‘b-value’ 
is a diffusion gradient strength applied to T2-weighted spin-echo sequences that 
causes dephasing and rephasing of water molecules. Signal loss during rephasing is 
achieved due to water protons move out of plane. Diffusion gradient strength of 0 to 
100s/mm2 is considered low b-values and of more than 100s/mm2 is considered high 
b-values. However, studies of denervated skeletal muscle perfusion using the low b-
values DWI are lacking.  
To my knowledge, there have been no published studies on perfusion measurement 
within denervated laryngeal muscles using DWI and DCE-MRI. I aimed to 
investigate the perfusion of TA and PCA in healthy volunteers and unilateral vocal 
fold paralysis patients using DWI and DCE-MRI. 
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6.3 Methods 
Ethics statement. 
The local ethics committee approved this study and informed consent was obtained 
from all participants. 
 
Participant selection 
Healthy controls: Five healthy volunteers (2 female, 3 male) without any current or 
previous history of voice problems (excluding previous upper respiratory tract 
infection) aged between 28 and 41 years’ old were recruited. 
 
Unilateral vocal-fold paralysis patients: Nine UVFP patients (7 female, 2 male) 
aged between 19 and 62 years were recruited. UVFP was diagnosed by fibre-optic 
nasopharyngolaryngoscopy (VNL-1590STi, KayPentax, USA) and confirmed by 
laryngeal electromyography. All patients had left vocal fold paralysis for more than 6 
months and had never undergone any medialisation procedure. UVFP was iatrogenic 
in 8 patients and idiopathic in 1 patient.  
 
MRI Protocol 
Imaging was performed on a 3T Philips Achieva TX MRI scanner (Philips 
Healthcare, The Netherlands). Sense Flex S coils of 11cm diameter were placed at 
the side of the neck covering the anterior part of the larynx below the angle of the 
mandible, while the participant lied supine on the scanner bed with the head resting 
on a headrest. The coils were held in place by putting a neck strap and sandbags at 
the side of the head and neck to minimize movement. The participants were asked 
keep the neck and jaw still and avoid throat clearing or swallowing during image 
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acquisition periods. The imaging protocol for DWI and DCE-MRI is shown in Table 
6-1. DWI was always performed prior to DCE-MRI. For DCE-MRI, 0.2mmol/kg 
gadolinium, 3mls/second was injected at the beginning of the fourth acquisition of 
serial scan images.  
Table 6-1: MRI protocol of DCE-MRI and Diffusion weighted imaging (DWI) 
 DWI DCE 
Sequence Name SE-EPI  3D T1-FFE  
Repetition time (ms) 3749 4.5 
Echo time (ms) 37 2.2 
Image resolution 1.3x1.3 0.8x0.8 
Slice thickness (mm) 5 3 
Number of slices 14 24 
Flip angle 90 10 
Field of view (FOV) 100x53 150x150 
Temporal resolution 
(seconds 
NA 11.3 
No of averages 6 1 
Total acquisition time 
(minutes) 
5 min 22 secs 6 min 36 secs 
Dynamic scans - 35 
b-values 0, 50, 100 - 
 
Image analysis 
Images were downloaded to OsiriX (open-source software, Geneva, Switzerland) 
workstation for analysis (Md et al., 2004). Subsequently, an experienced 
otolaryngologist placed the region of interests (ROI). 
 
The DCE-MRI 35 serial acquisitions were registered using Robust Data 
Decomposition Registration to minimise inter acquisition respiratory and pulsatile 
motion effects (Hamy et al., 2014). TA and PCA muscles were identified on DCE-
MRI by an experienced radiologist unaware of the EMG results. Separate regions of 
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interests (ROI) were placed within the left and right TA and PCA muscles (Figure 
6-1). Images affected by motion artefacts such as swallowing or throat clearing were 
excluded. A time intensity curves (TIC) were generated for the TA and PCA by 
plotting signal intensity against the time point for the 35 acquisitions (Figure 6-2). 
Signal intensity was normalised using the formula below (Langer et al., 2009): 
𝐶 = 𝑆! − 𝑆!"#$ 𝑟! × 𝑆!"#$   
by which S = signal intensity; t = time; C = concentration; and 𝑟1 = relaxation 
constant. The native T1 (tissue properties after injection) of the tissue before the 
injection of the contrast agent (T10) was assumed to be equal to 1second. Slope of 
initial enhancement (SoE), maximum enhancement (ME) and area under the curve 
(AUC) at 1 minute (AUC-1) were derived using the formulae in Table 6-2 (Horsthuis 
et al., 2009).  
 
 
 
 
 
 
 
Figure 6-1: Post-contrast T1 weighted image from DCE MRI. The image 
demonstrates enhancement within the: A) Thyroarytenoid (TA) and B) Posterior 
cricoarytenoid (PCA) muscles. Regions of interest outlined in green lines within the 
TA and PCA are used to derive time versus signal intensity curve (below) from 
which quantitative metrics (SoE, ME, AUC-1) can be derived. 
A B 
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Figure 6-2: Time intensity curve (TIC) 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-3: These are b0 images of diffusion weighted imaging of: A) TA; and B) 
PCA. The region of interests are drawn in green lines. ‘b0 images’ indicates images 
acquired at b-value 0 s/mm2 in which the diffusion sensitising gradient is absent so 
free water in tissues appears bright due to the intrinsic T2-weighting.
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Table 6-2: Formula for DCE-MRI metrics derived from the time intensity curve 
analysis 
Metrics Formula 
Slope of enhancement 𝑆!!!! − 𝑆!!  
Maximum enhancement 𝑆!"#$ − 𝑆!"#$ 𝑆!"#$ 
Area under the curve up to time t 
(integral of TIC over the interval [0, t]) 
𝑇𝐼𝐶 𝑡 𝑑𝑡!!  
 
S = signal intensity 
t = time 
C = concentration 𝑟1 = relaxation constant 
 
 
For DWI, separate ROIs were located on the b0 image within left and right TA and 
PCA muscles (Figure 6-3) and automatically propagated b50 and b100 images. ADC 
was calculated by performing a least square fit to the mean signal intensity of each 
muscle versus b-value using Mac Excel (2011) with solver (Punwani et al., 2013).  
 
Statistical analysis 
MRI derived metrics were compared: 
• within volunteers, between left and right TA and PCA  
• within patients, between paralysed and normal TA and PCA  
• between volunteers and patients normal TA and PCA  
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• between volunteers normal and patients paralysed TA and PCA 
Comparison between muscles within subjects was performed using the Wilcoxon 
signed rank test. The Mann Whitney test was used for comparison across volunteer 
and patient groups.
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6.4 Results 
A single patient’s DCE-MRI dataset was excluded from the analysis due to severe 
residual motion artefact following RDDR registration. For DWI another patient was 
excluded from the analysis of PCA metrics due to severe image susceptibility related 
distortion precluding identification of the muscle.  
 
Within volunteers 
There was no significant difference for DCE and ADC metrics between left and right 
TA or PCA muscles (Table 6-3). 
Table 6-3: This table shows within volunteers’ median and interquartile ranges for 
DCE-MRI parameters and ADC of DWI of thyroarytenoid and posterior 
cricoarytenoid muscles. 
Thyroarytenoid muscles 
Metrics Left TA (n = 5) Right TA (n = 5) Within volunteers 
(N vs N) 
SoE 0.08 (0.05, 0.14) 0.06 (0.04, 0.12) 0.23 
ME 0.56 (0.47, 1.00) 0.55 (0.48, 0.91) 0.34 
AUC 1 minute 0.35 (0.33, 0.65) 0.34 (0.33, 0.65) 0.08 
ADC (x103) 2.70 (1.90, 4.31) 2.87 (2.58, 4.05) 0.841 
 
Posterior cricoarytenoid muscles 
Metrics Left PCA (n = 5) Right PCA (n = 5) Within volunteers 
(N vs N) 
SoE 0.07 (0.05, 0.09) 0.06 (0.04, 0.12) 0.50 
ME 0.59 (0.56, 0.62) 0.58 (0.54, 0.79) 0.50 
AUC 1 minute 0.40 (0.38, 0.41) 0.42 (0.38, 0.45) 0.34 
ADC (x103) 2.12 (1.72, 2.62) 2.42 (0.57) 0.034 
The last column showed p value of Wilcoxon sign rank test.
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Within patients 
For TA, AUC1 and ADC were significantly lower on the paralysed side compared 
with the normal side (p=0.017, p=0.04); no significant difference was demonstrated 
for the remainder of the DCE metrics (p=0.16, p=0.09). For PCA, all DCE and ADC 
metrics were significantly lower on the paralysed side than the opposite normal 
(p=0.01) (Table 6-4). 
 
Table 6-4: This table shows within patients’ median and interquartile ranges for 
DCE-MRI parameters and ADC of DWI of thyroarytenoid and posterior 
cricoarytenoid muscles. 
Thyroarytenoid muscles 
Metrics Paralysed (n = 8) Normal (n = 8) Within patients 
(paralysed vs N) 
SoE 0.06 (0.04, 0.08) 0.07 (0.06, 0.09) 0.16 
ME 0.50 (0.36, 0.64) 0.61 (0.48, 0.67) 0.09 
AUC 1 minute 0.26 (0.25, 0.39) 0.36 (0.26, 0.46) 0.017* 
ADC (x103) 1.68 (1.06, 2.28) 2.88 (2.32, 4.43) 0.04* 
 
Posterior cricoarytenoid muscles 
Metrics Paralysed Normal Within patients 
(paralysed vs N) 
SoE 0.06 (0.045, 0.07) 0.12 (0.11, 0.16) 0.01* 
ME 0.43 (0.36, 0.52) 0.75 (0.69, 0.87) 0.01* 
AUC 1 minute 0.30 (0.23, 0.37) 0.56 (0.48, 0.60) 0.01* 
ADC (x103) 1.7 (1.49, 1.83) 2.63 (2.31, 3.51) 0.01* 
The last column showed p value of Wilcoxon sign rank test. 
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Between volunteers and patients normal TA and PCA  
For TA, there was no significant difference for SoE, ME, AUC-1 and ADC between 
volunteers and patients normal (p=0.5 to 1.0). For PCA, there was also no was 
significant difference for ADC (p=0.12) between volunteers and patients normal, but 
the SoE, ME and AUC-1 were significantly higher in the patients normal than 
volunteers normal (Table 6-5). 
Table 6-5: This table shows results of comparison between volunteers and patients 
normal thyroarytenoid  and posterior cricoarytenoid muscles. 
Metrics Patients versus volunteers 
normal TA 
Patients versus volunteers 
normal PCA 
SoE 1.00 0.001* 
ME 0.96 0.03* 
AUC 1 minute 0.52 0.01* 
ADC (x103) 1.00 0.12 
Data presented is p-values of Mann Whitney test. 
Between volunteers and patients paralysed TA and PCA 
For TA, ADC was significantly lower in the paralysed than the normal but DCE was 
not significantly different. For PCA, however, both DCE and ADC were 
significantly lower in the paralysed PCA and left and right PCA of volunteers, except 
for the SoE (Table 6-6). 
Table 6-6: This table shows results of comparison between volunteers normal and 
patients paralysed thyroarytenoid posterior cricoarytenoid 
Metrics Paralysed vs L&R TA 
volunteers 
Paralysed vs R&L PCA 
volunteers 
SoE 0.32 0.08 
ME 0.15 0.01* 
AUC 1 minute 0.101 0.02* 
ADC (x103) 0.008* 0.03* 
Data presented is p-values of Mann Whitney test.
 208 
 
6.5 Discussion 
Overview 
Advances in MRI now allow the assessment of microstructure properties to 
differentiate normal and pathological tissues. Therefore, I explored the use of DCE-
MRI and DWI to evaluate perfusion of TA and PCA in order to further understand 
the pathologic changes in human denervated laryngeal muscles. 
 
Dynamic contrast enhanced MRI- DCE-MRI is a method of physiologic imaging 
that assesses tissue microcirculation, capillary permeability and composition of the 
interstitial space based on temporal signal intensity changes on T1-weighted imaging 
following extravasation of intravenous water-soluble contrast bolus injection to the 
interstitial space (Punwani, 2011). The initial SoE of the TIC relates to first pass 
tissue perfusion. It also relates to the capillary network, as a steep slope can indicate 
increased capillary density and permeability (Verstraete et al., 1996). Tissues with 
lower perfusion, capillary density and permeability have slower and sustained 
enhancement (Lavini et al., 2013). In contrary, increased capillary density or 
permeability due to neo-angiogenesis will result in rapid enhancement and rapid 
washout of contrast from tissue (Punwani, 2011). AUC a summation measure of 
contrast delivery and retention during the measurement period, is therefore reflective 
of changes in the capillary network (Punwani, 2011). 
 
Diffusion weighted imaging- Application of motion probing magnetic field 
gradients to T2-weighted MRI enables measurement of molecular water motion 
including microcirculation of blood (Khoo et al., 2011). Signal loss is proportional to 
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the displacement of water molecules and the applied diffusion gradient (reflected by 
the b-value (Khoo et al., 2011). By acquiring a series of images with incremented b-
values the displacement of water molecules can be quantified. At low diffusion 
weightings (b-values 0 to 100s/mm2) most of the signal loss within an image occurs 
due to perfusion (Khoo et al., 2011; Takahara and Kwee, 2012; Yanagisawa et al., 
2009a). 
 
Synopsis of key findings 
My main finding confirms paralysed laryngeal muscles have reduced tissue 
perfusion. We found ADC was significantly lower in paralysed TA and PCA 
compared with normal muscle. Additionally, perfusion parameters derived from 
DCE-MRI were also significantly lower in paralysed muscle. My second main 
observation was that the ‘normal’ PCA muscle within a patient with UVFP 
demonstrates higher tissue perfusion than normal PCA in healthy volunteers.  
 
Comparison with previous work 
Application of DWI in studies evaluating muscle perfusion using low b-values is 
limited. Yanagisawa et al. studied lower limb muscles perfusion following exercise. 
This study demonstrated that DWI is useful in evaluating perfusion and diffusion of 
intramuscular water molecules. It was found that muscle perfusion was increased 
after exercise and decreased with cooling. ADC at low b-values reflecting perfusion 
was confirmed when the reduction of ADC was demonstrated following temporal 
arterial occlusion (Yanagisawa et al., 2009a, 2009b). DWI in rabbits’ denervated 
limb muscles was employed using high b-values to assess the diffusion of 
extracellular space. It demonstrated increased ADC values following acute skeletal 
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muscles denervation that may be due to an increase in local blood flow although 
histological examination depicted muscle atrophy without capillary enlargement 
(Goyault et al., 2012; Holl et al., 2008). 
 
Reports on the use of DCE-MRI in studying the perfusion of skeletal muscle are 
scarce. Jiang et al and Taoka et al have evaluated perfusion within extra-ocular 
muscles in patients with Graves’ disease using DCE-MRI (Jiang et al., 2012; Taoka 
et al., 2005). Both papers demonstrated a reduction in perfusion parameters that 
correlated with disease severity in patients with Graves disease. Histological changes 
of the extraocular muscles in patient with Graves disease include perivasculitis, 
oedema, fibrosis and abnormal vasculature (Zhao et al., 2011).  
 
To my knowledge, the use of DCE-MRI and low b-values DWI in denervated 
muscles particularly laryngeal muscles has not been reported. 
 
Studies on totally denervated limb skeletal muscles showed reduced capillary density 
and fibrosis (Borisov et al., 2000; Lu et al., 1997). In laryngeal paralysis, atrophy and 
fibrosis were demonstrated within 3 months of the onset of nerve transection but 
histological examination did not include measurement of capillary density (Shindo et 
al., 1992; Zealear et al., 1994). Microvascular density is known to be reduced in 
paralysed limb skeletal muscles 2 months after denervation (Borisov et al., 2000). To 
the best of my knowledge no publications have histologically evaluated 
microvascular change in denervated laryngeal muscles; however mitochondrial 
derangement has been observed in laryngeal muscles that could reflect abnormal 
perfusion (Leão et al., 2010). My results support histological evidence at different 
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skeletal muscle sites (Borisov et al., 2000; Lu et al., 1997) to confirm reduced 
perfusion in paralysed laryngeal muscles. 
 
I also found that the normal PCA of patient group had increased perfusion as per 
DCE-MRI metrics. This may be due to overloading of the contralateral normal PCA 
to maintain the glottal airway. Eggington et al. demonstrated increased in capillary 
growth in rats skeletal muscles due to compensatory overload (Egginton et al., 1998). 
However, Lloyd et al. observed no further increase in capillary density after 12 days 
in overloaded rats muscles and no difference was found with the control group 
(Lloyd et al., 2003).  Therefore further studies in this are is necessary for laryngeal 
muscles.    
 
Limitation of the present study 
Our study has several limitations. DWI is susceptible to artefacts particularly at 
tissue interfaces such as air to soft tissue for TA or bone to soft tissue for PCA 
causing geometric image distortion (Khoo et al., 2011) and this may have influenced 
my results. However I did not observe a systematic bias in the presence or absence of 
between paralysed and non-paralysed sides. 
 
DCE-MRI also faces inherent motion artefacts susceptibility especially for TA due to 
respiration motion. One set of images of DWI and DCE-MRI was removed from 
analysis due to these issues. Respiratory motion artefacts may be the reason for the 
inability to demonstrate significant difference for DCE-MRI metrics between the 
paralysed and normal TA. 
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As commensurate with the nature of the patients included within this study I did not 
obtain histological correlates of MRI findings. Further pre-clinical work in this area 
remains to be performed. 
 
The present study included a small sample of participants, limiting my inferences. 
However even with a small sample size I was able to demonstrate that assessment of 
tissue perfusion by MRI is feasible and significant differences in tissue perfusion 
parameters exist between paralysed and normal laryngeal muscles.  
 
Clinical impact 
DCE-MRI and DWI have the potential to be used to evaluate perfusion of denervated 
laryngeal muscles and may become useful tools to monitor physiologic changes 
following denervation and reinnervation. DWI may be preferable to DCE-MRI as it 
does not require intravenous contrast, thus increasing speed and decreasing risk and 
cost.  
 
6.6 Conclusion 
This study demonstrates the feasibility of assessing tissue perfusion in laryngeal 
muscles using DCE-MRI and DWI. The findings confirm that paralysed TA and 
PCA muscles have reduced perfusion and that apparently normal contralateral 
musculature in patients with UVFP has elevated perfusion. This work will inform 
mechanistic studies of vascular change in paralysed laryngeal muscles and clinical 
studies evaluating utility perfusion parameters in predicting and monitoring 
responses to treatment.  
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Chapter 7 Functional assessment of vocal fold mobility using cine-
Magnetic Resonance Imaging  
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7.1 Abstract 
Objective: To evaluate the repeatability of quantifying functional vocal fold mobility 
by cine magnetic resonance imaging (cine-MRI) in unilateral vocal fold paralysis 
(UVFP) patients.  
Materials and methods: Cine-MRI of the vocal folds was performed on 5 healthy 
and 9 UVFP participants (gradient echo, temporal resolution: 0.7 seconds per three 
slices, axial plane). Imaging was performed during a 10-second period of quiet 
respiration and during phonation. Cine-MRI images were quantitatively analysed by 
measuring the area between the vocal fold and the midline during phonation (PA) 
and respiration (RA). Left to right ratio of PA (phonation ratio, PR) and RA 
(respiration ratio, RR) was calculated. Then the magnitude of asymmetry of left and 
right vocal fold during phonation (vocal fold phonation asymmetry, VFPa) and 
respiration (vocal fold respiration asymmetry, VFRa) was calculated as ‘1-PR’ and 
‘1-RR’ respectively. In addition, the total glottal area was determined during 
phonation and respiration, and percentage reduction associated with phonation 
calculated (VFaP – vocal fold abduction potential). Intra-session, inter-scan 
repeatability of study metrics (VFPa, VFRa, VFaP) was assessed using the intraclass 
correlation coefficient (ICC). Mann Whitney test was used to compare VFPa, VFRa 
and VFaP differences between groups. 
Results: ICC values of VFPa, VFRa and VFaP were 0.92, 0.95 and 0.90 respectively 
for intra-session, and 0.44, 0.94 and 0.82 respectively for inter-scan. VFPa 
(p=0.012), VFRa (p=0.001) were significantly lower and VFaP (p=0.008) were 
significantly higher for volunteers compared with patients.  
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Conclusion: Cine-MRI quantitative metrics show good repeatability (except VFPa) 
and feasibility for identification of patients with UVFP.
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7.2 Introduction  
A variety of techniques have been used to evaluate phonatory function of vocal folds 
qualitatively or quantitatively including videostroboscopy, videokymography and 
digital kymography to record vocal fold vibration (Omori et al., 1996; Rosen, 2005; 
Verikas et al., 2009). Videostroboscopy in particular is widely available and regarded 
as a vital assessment tool in voice clinics, where it may enhance the detection of 
laryngeal pathology such as vibration disorders that may be due to lesions, 
neurological problems and impaired mobility due to vocal fold paralysis. 
 
In vocal fold paralysis, impaired abduction during respiration reduces the size of the 
glottal airway compromising breathing. Quantification of vocal fold mobility in 
terms abduction potential is necessary to provide a measure of effectiveness of 
interventions conducted to increase the glottal airway (Dailey et al., 2005). However, 
validated, non-invasive quantitative measures are lacking. Glottal area assessed 
during respiration by flexible endoscope can be used to quantify vocal fold abduction 
(Dailey et al., 2005; Motoyoshi et al., 2004; Waters et al., 1996), but accuracy is 
limited by distortion caused by varying distance from the object and the wide angle 
lens of the endoscope (Czaja Pawel et al., 2007; Dailey et al., 2005; Forkert et al., 
1996; Motoyoshi et al., 2004; Waters et al., 1996). To correct for this, the insertion 
of a probe to measure the distance from the tip of scope to the true vocal fold has 
been suggested, but this increases the size of the endoscope required, is time-
consuming and uncomfortable for routine clinical application (Brancatisano et al., 
1983). Whilst endoscopic direct visualisation is possible it remains technically 
difficult as the camera must remain tangential to the plane of vocal folds with clear 
visualisation of the anterior commissure and vocal process is available (Dailey et al., 
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2005). Imaging of the vocal folds with magnetic resonance imaging (MRI has 
previously been suggested as an alternative (Schlamann et al., 2009).  
 
In this study, I aimed to develop and evaluate 3.0T MRI based quantitative measures 
of vocal fold mobility in normal volunteers and patients with feasibility for 
differentiating UVFP to determine feasibility for quantification of vocal fold 
mobility. 
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7.3 Methods 
The local ethics committee approved this study and informed consent was obtained 
from all participants. 
 
Study overview 
This study investigates the reliability and reproducibility of the cine-MRI for 
quantitatively evaluating vocal fold mobility in UVFP alongside healthy controls. 
The cine-MRI derived parametrics were evaluated for:  
1) within subject repeatability a) between repeated scans within the same session 
(intra-session) and b) between repeated scans in two separate sessions (inter-scan). 
2) inter-reader reproducibility of parametricsbetween 2 separate observers.  
3) application of quantitative parametrics for differentiation between healthy 
volunteers and UVFP patients. 
 
Participant selection 
Healthy controls: Five (2 female [age 39 and 40], 3 male [age 28, 31 and 35]) 
volunteers without any current or previous history of vocal fold conditions 
(excluding previous upper respiratory tract infection) were recruited among the local 
hospital staffs.  
 
Unilateral vocal fold paralysis patients: 9 UVFP patients (7 female, 2 male) with 
age ranged from 19 to 62 years old were recruited from the local hospital ear nose 
and throat specialists voice clinics. Prior to recruitment, UVFP was identified by 
flexible nasopharyngolaryngoscope of (VNL-1590STi, KayPentax, USA) and 
confirmed by laryngeal electromyography. The causes were secondary to iatrogenic 
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or idiopathic causes. All patients identified had left vocal fold paralysis for more than 
6 months and had never undergone any medialisation procedure. Patients who were 
claustrophobic or, had associated multiple lower cranial nerve palsies, vocal fold 
lesions, voice related neurological disorders (spasmodic dysphonia, voice tremor) or 
cricoarytenoid joint fixation were excluded from the study. Exclusion criteria also 
include presence of any implants in the neck region that may cause substantial image 
artifact.  
 
Cine-MRI protocol 
All participants were imaged on a 3T Philips Achieva TX MRI scanner (Philips 
Healthcare, The Netherlands). Sense Flex S coils of 11cm diameter were placed at 
the side of the neck covering the anterior part of the larynx below the angle of the 
mandible, while the participant lay supine on the scanner bed with the head resting 
on a headrest. The coils were held steady by placing a neck strap and sandbags at the 
side of the head and neck to minimize movement.  
 
Details of the protocol used for the MRI are summarized in Table 7-1. Sagittal 
reference images were used to angle the axial cine-MRI slices parallel to the vocal 
folds. Subsequently, a T2-weighted turbo spin echo coronal acquisition was 
performed to cover the larynx. Three cine-MRI axial slices were then positioned to 
ensure that the vocal folds remained within the imaging volume accounting for the 
normal vertical elevation that occurs during phonation (Figure 7-1).  
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Table 7-1: MRI protocol for vocal fold motion and coronal T2-weighted imaging 
 
 Vocal fold motion T2-weighted 
Sequence Name Fast field echo (FFE) SE-TSE 
Repetition time (ms) 2.1 6789 
Echo time (ms) 0.82 120 
Image resolution 1.5x1.5 0.5x0.5 
Slice thickness (mm) 10 2.5 
Number of slices 3 14 
Flip angle 20 90 
Field of view (FOV) (mm) 240x180 140x140 
Temporal resolution 
(seconds) 
0.764 - 
Total acquisition time  1 min 31 secs 5 min 32 secs 
Number of dynamic scans 120 - 
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Figure 7-1: A) A T2-weighted coronal view of a participant showing three slices placement, two bold lines at the top and bottom and one line in 
the middle through the superior surface of the true vocal folds. B) A sagittal reference scan showing the angulation of the axial motion sequence 
positioned at right angles to the larynx. C) A frame from an axial motion sequence image of vocal folds during respiration. 
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Functional tasks for vocal fold assessment 
Prior to imaging, participants were instructed in and practiced a standardised set of 
phonation tasks (Schlamann et al., 2009). During cine-MRI, participants were 
instructed to perform the standardized tasks. Specifically they were asked to phonate 
/hee/ for the first 10 seconds of scanning, then breathe quietly through the nose for 
10 seconds; phonate /hee/ for a further 10 seconds; breath quietly again for 10 
seconds and then phonate /hee/ for a final 10 seconds. Ten sequential cine-MRI 
acquisitions were performed during each /hee/ and quiet breathing period.  
 
Definition of parametrics reflecting vocal fold mobility  
Normal vocal folds open during respiration and close at the midline during phonation 
as shown in Figure 7-2. The glottal area is bounded by right and left vocal folds, 
anterior commissure and posterior commissure. For purposes of assessment, I 
assessed three metrics: vocal fold phonation asymmetry (VFPa), vocal fold 
respiration asymmetry (VFRa) and vocal fold abduction potential (VFaP). 
 
 
 
 
 
 
Figure 7-2: This endoscopic view of the normal larynx depicts the vocal folds 
position during: A) respiration; and B) phonation. AC: Anterior commissure, PC: 
Posterior commissure. 
A B 
AC 
P
C 
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To derive the asymmetry indices I measured glottal area. Area measurements were 
performed separately for the left and right glottal areas using a bisecting line 
connecting the anterior commissure and posterior commissure (Figure 7-3). 
Phonation area (PA) and respiration area (RA) measurements were derived from 
images acquired during phonation and respiration respectively. The ratio between the 
left and right PA and and left and right RA was defined as the phonation ratio (PR) 
and respiration ratio (RR) respectively. We anticipated that PR and RR would be 
near to unity under normal conditions, reflecting the symmetrical movement of the 
right and left vocal folds. VFPa and VFRa were calculated as 1-PR and 1-RR 
respectively. 
 
 
Figure 7-3: Schematic depicting an imaginary line bisecting the anterior and 
posterior commissure and dividing the: A) respiration; and B) phonation area into 
right and left. Note that the phonation area is very small. LRA: Left respiration area, 
RRA: Right respiration area. 
This schematic diagram was taken from 
http://en.wikipedia.org/wiki/File:Illu07_larynx02.jpg 
 
 
 
LRA 
RRA 
A B 
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In addition, the total glottal area during phonation and respiration was recorded and 
percentage reduction in the total glottal area associated with phonation calculated as 
VFaP. Paralysed vocal folds by definition are immobile and lie either in the lateral 
position or near to the midline during both phonation and respiration (Figure 7-4) 
(Woodson, 2007a). 
 
The summary of the three derived metrics is shown in Table 7-2. 
 
 
 
 
 
 
Figure 7-4: This endoscopic view of left vocal fold paralysis depicts the position of 
the paralysed vocal folds during respiration and phonation 
 
Paralysed Paralysed 
A B 
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Table 7-2: This table shows summary of vocal fold motion metrics and the inferences 
Metrics Definition and formula Interpretation 
PA Glottal area during phonation. The PA is divided into left and right PA by an 
imaginary vertical line bisecting the anterior and posterior commissure  
 
NA 
RA Glottal area during respiration. The RA is divided into left and right RA by an 
imaginary vertical line bisecting the anterior and posterior commissure 
 
NA 
VFPa PR is ratio left to right PA = LPA/RPA 
Vocal fold phonation asymmetry (VFPa) = 1-PR  
PR, close to one = normal symmetrical adduction. Therefore 
the 1-PR will be small 
 
PR, high deviation from one = asymmetrical adduction. 
Therefore the 1-PR will be large 
 
VFRa Ratio left to right RA = LRA/RRA 
Vocal fold respiration asymmetry (VFRa) = 1-RR 
 
Close to one = normal symmetrical adduction. Therefore the 
1-PR will be small 
 
High deviation from one = asymmetrical abduction. 
Therefore the 1-PR will be large 
 
VFaP Ability of the VFs to abduct by calculating the potential glottal area involved 
from adducted position (PA) to abducted position (RA) 
 𝑅𝐴 − 𝑃𝐴 𝑅𝐴 ×100 
Large VFaP = good potential glottal airway that may 
indicate both vocal folds mobile 
 
Small VFaP = small potential airway that may indicate one 
of the vocal folds is immobile 
PA: phonation area 
RA: respiration area 
PR: Phonation ratio 
RR: Respiration ratio 
VFaP: Vocal fold abduction potential 
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Image analysis 
Images were downloaded to OsiriX (open-source software, Geneva, Switzerland) 
(Md et al., 2004) workstation for analysis. The complete dataset for each participant 
comprised two intra-session cine-MRI studies (study 1 and study 2) and a third inter-
scan cine-MRI study (study 3). Each study comprised 10 sequential cine-MRI 
acquisitions performed during phonation and a second set of 10 sequential cine-MRI 
acquisitions performed during respiration. 
 
Two experienced readers independently performed measurements on each study. For 
each study the reader selected the axial cine-MRI slice that best represented glottal 
area for measurement (Figure 7-5). A vertical line was drawn from the anterior 
commissure bisecting the posterior commissure and the cervical vertebra deriving the 
triangular larynx to left and right glottal areas (Figure 7-5). A region of interest was 
then used to measure area between the bisecting vertical line medially and the vocal 
fold laterally and posteriorly (Figure 7-5). Area measurement was repeated for each 
sequential acquisition acquired during phonation and respiration respectively. Total 
glottal area was calculated by the sum of the left and right glottal area. An average 
phonation area and respiration area across the 10 acquisitions was derived and used 
for calculation of VFPa, VFRa and VFaP as defined earlier (Figure 7-6).   
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Figure 7-5: A, D: Selected image that represent glottal area during phonation and 
respiration respectively; B, E: A vertical line was drawn from anterior commissure 
bisecting the posterior commissure and the cervical vertebra dividing the triangular 
larynx to left and right glottal area; and C, F: Region of interests drawn to measure 
left and right phonation area and respiration area. 
 
 
 
 
 
 
B 
 
A C 
D E F 
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Figure 7-6: Selected sequential images of respiration at 10 time points of: A) a 
healthy volunteer; B) a patient with left vocal fold paralysis. The arrows shows right 
and left vocal fold
T=0.7s T=1.4 T=2.8s T=2.1s 
T=4.2s T=4.9 T=5.6
T=3.5
T=7.0T=6.3s 
T=0.7 T=1.4 T=2.8T=2.1
T=4.2s  
T=3.5s 
T=7.0s T=6.3s  T=5.6T=4.9s 
A 
B 
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Statistical analysis 
1) Within subject repeatability was tested using intraclass correlation coefficient test 
(ICC). 
2) Inter-reader reproducibility in measuring the VFPa, VFRa and VFaP was assessed 
using ICC. 
3) Application of quantitative parametrics for differentiation between healthy 
volunteers and UVFP patients was assessed  by comparing the mean values of VFPa, 
VFRa and VFaP between groups using Mann Whitney test. Significance was defined 
at p<0.05. 
 
ICC values ranged from 0 (not repeatable or reproducible) to 1 (perfect repeatability 
or reproducibility). The ICC has to be at least 0.6 for the measurements to be 
clinically useful (Chinn, 1991). Repeatability and reproducibility of the 
measurements was considered good for ICC of similar to 0.75 and moderate for ICC 
of between 0.5 and 0.75 (Portney and Watkins, 1993) 
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7.4 Results 
 
The median and interquartile ranges (IQR) of VFPa, VFRa and VFaP for healthy 
volunteers was 0.07 (0.04, 0.13), 0.07 (0.02, 0.15) and 93.84 (76.22, 95.17)% 
respectively; and for patients they were 1.01 (0.35, 1.96), 0.38 (0.31, 0.71) and 59.69 
(44.52, 71.78)% respectively (Figure 7-7). The median and IQR of all the metrics of 
the two intra-session cine-MRI studies (study 1 and study 2) and a third inter-scan 
cine-MRI study (study 3) are shown in Table 7-3. 
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Table 7-3: This table shows median and interquartile range of VFPa, VFRa and VFaP measurements of healthy volunteers and patients 
for measured for study-1, study-2 and study-3. 
Metrics Readers Study 1 (first 10 sequential 
images of within the same scan) 
Study 2 (second sequential10 
images of within the same scan) 
Study 3 (the first 10 sequential 
images of the second visit scan) 
Volunteer       
(n = 5) 
Patient            
(n =9) 
Volunteer        
(n = 5) 
Patient            
(n =9) 
Volunteer       
(n = 5) 
Patient            
(n =5) 
 
VFPa Reader1 0.07          
(0.04, 0.13) 
1.01          
(0.35, 1.96) 
0.13           
(0.04, 0.18) 
0.96          
(0.32, 2.30) 
0.14           
(0.06, 0.29) 
0.37          
(0.10, 0.78) 
 
Reader2 0.27          
(0.06, 0.37) 
1.0             
(0.26, 1.50) 
ND ND 0.14           
(0.11, 0.29) 
0.37          
(0.16, 0.48) 
 
VFRa Reader1 0.07          
(0.02, 0.15) 
0.38           
(0.31, 0.71) 
0.03           
(0.01, 0.12) 
0.43          
(0.35, 0.71) 
0.06           
(0.02, 0.19) 
0.73          
(0.67, 0.80) 
 
Reader2 0.12          
(0.08, 0.26) 
0.63          
(0.43, 0.72) 
ND ND 0.06          
(0.05, 0.12) 
0.73          
(0.72, 0.80) 
 
VFaP Reader1 93.84       
(76.22, 95.17) 
59.69       
(44.52, 71.78) 
89.28        
(67.74, 93.82) 
53.82       
(67.74, 93.82) 
93.26       
(88.05, 95.67) 
73.08       
(60.03, 85.40) 
 
Reader2 90.15       
(70.09, 93.21) 
52.92       
(32.04, 71.98) 
ND ND 93.25       
(93.01, 95.36) 
73.08       
(60.07, 83.49) 
ND = not done 
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Figure 7-7 These graphs show distribution of VFPa, VFRa and VFaP in left vocal fold paralysis patients and healthy volunteers. 
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Results for within subject repeatability and inter-reader reproducibility are 
summarised in Table 7-4. 
 
Within subject repeatability - Intra-session and Inter-scan variation 
Intra-session ICC values and the 95% confidence interval (CI) of VFPa, VFRa and 
VFaP of both volunteers and patients was 0.92 (0.76, 0.97), 0.95 (0.85, 0.98) and 
0.90 (0.69, 0.97) respectively. Inter-scan ICC values (95% CI) of VFPa, VFRa and 
VFaP was 0.44 (-0.24, 0.83), 0.94 (0.78, 0.98) and 0.82 (0.62, 0.97).   
 
Inter-reader reproducibility 
The ICC values (95% CI) of inter-reader reproducibility in measuring the VFPa, 
VFRa and VFaP are 0.84 (0.66, 0.93), 0.82 (0.60, 0.92) and 0.91 (0.77, 0.96) 
respectively. 
Table 7-4: Results of intra-session, inter-scan repeatability, and inter-reader 
reproducibility. 
Metrics Intra-session Inter-scan Inter-reader  
VFPa 0.92 (0.76, 0.97) 0.44 (-0.24, 0.83) 0.84 (0.66, 0.93) 
VFRa 0.95 (0.85, 0.98) 0.94 (0.78, 0.98) 0.82 (0.60, 0.92) 
VFaP 0.90 (0.69, 0.97) 0.82 (0.62, 0.97) 0.95 (0.88, 0.98) 
Results presented are ICC values and the 95% confidence interval in the bracket 
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Comparison between healthy volunteers and patients  
There was a significant difference in VFPa (p=0.012), VFRa (p=0.001) and VFaP 
(p=0.008) between volunteers and patients. The VFPa and VFRa were greater in 
patients than in volunteers indicating asymmetrical mobility of the vocal folds during 
phonation and breathing. The VFaP in the volunteers demonstrated a larger 
functional glottal airway during breathing than in patients, as both normal vocal folds 
in volunteers abduct symmetrically. 
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7.5 Discussion 
Overview 
Objective measurement of glottal airway is important in laryngeal research to 
measure whether an intervention improves vocal fold mobility. Impaired vocal fold 
mobility leads to glottal airway restriction that causes breathing difficulty (Dailey et 
al., 2005; Marina et al., 2011; Waters et al., 1996). To date, non-invasive objective 
measurements of vocal fold mobility are lacking. Cine MRI enables non-invasive 
acquisition of vocal fold adduction and abduction (Ahmad et al., 2006, 2009; Amin 
et al., 2012; Breyer et al., 2009; Davis et al., 1996; Faust et al., 2001; Schlamann et 
al., 2009; Tian et al., 2010). We further developed and assessed this technique for 
quantitative assessment of vocal fold mobility. 
 
Synopsis of key findings 
Theoretically, symmetrical mobility of vocal folds during phonation and respiration, 
will result in PR and RR near to ratio of one. Magnitude asymmetry of vocal folds 
area during phonation and respiration, VFPa and VFRa, was calculated to determine 
how deviated is the ratio from unity. Findings in the present study demonstrated that 
the magnitude asymmetry was small in volunteers and large in patients. VFaP in 
volunteers was larger than patients indicating that both vocal folds abduct producing 
larger glottal airway. There was significant difference demonstrated for VFPa, VFRa 
and VFaP between volunteers and patients. This shows that cine-MRI can be used to 
differentiate normal and abnormal vocal fold mobility.  
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Furthermore, the present study demonstrates high repeatability of the cine-MRI 
technique for measuring vocal fold mobility metrics VFRa and VFaP (ICC > 0.89). 
Inter-reader reproducibility was also almost perfect (ICC > 0.81).  
Comparison with previous works 
Previous work in a small number of paediatric patients with airway disorders has 
shown that cine-MRI of the larynx during phonation and respiration correlates with 
endoscopy findings (Faust et al., 2001); only one UVFP patient was included in this 
cohort. Schlamann et al studied 12 patients with hoarseness who were scanned using 
the cine-MRI technique and radiologists were able to qualitatively assess images to 
correctly diagnose vocal fold mobility disorders (Schlamann et al., 2009). To the best 
of my knowledge, only one previous study has measured quantitative mobility of the 
vocal folds (Ahmad et al., 2009). Ahmad et al. studied quantified horizontal vocal 
fold displacement during phonation in healthy volunteers (Ahmad et al., 2009) on 
cine-MRI by measuring change in the angle of the anterior commissure. Our study 
systematically assessed the utility of a range of cine-MRI derivable quantitative 
measures of vocal fold mobility, specifically derived from measurements of changes 
in the glottal area between the vocal folds during phonation and respiration. Our 
study is the first to assess the utility of the defined quantitative metrics in measuring 
vocal fold mobility during phonation as well as respiration in healthy volunteers and 
patients, and investigate the repeatability and reproducibility metrics.  
 
Of note, I do not expect that the temporal resolution of dynamic scans within this or 
previous studies is sufficient to capture the vibratory motion of the vocal fold; 
however it is an attempt to capture the abduction/adduction potential of the vocal 
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folds. The temporal resolution of my study is comparable to the study published by 
Schlamann et al. (Schlamann et al., 2009). We are unable to compare the temporal 
resolution of my dynamic acquisition with the other two studies, as this has not 
explicitly been described within the respective manuscripts (Ahmad et al., 2009; 
Faust et al., 2001). A summary of cine-MRI protocols comparing my study with 
others is presented in Table 7-5.  
Table 7-5: Comparison between studies that investigate vocal fold mobility. 
RapidMRI 
protocol 
Present study Ahmad et 
al. 2009 
Faust et al 
2001 
Schlamann et 
al. 2009 
Participants Healthy 
volunteers and 
UVFP patients 
Healthy 
volunteers 
Paediatric 
patients with 
airway 
disorder 
Patients with 
hoarseness that 
may or not had 
vocal fold 
palsy 
MRI machine  3.0T 1.5T 1.5T 1.5T 
Sequence Name Fast field echo 
(FFE) 
T1-
weighted 
spin echo 
sequence 
turboFLASH Steady-state 
free precession 
sequence 
(SSFP) 
Planes axial axial Axial and 
coronal 
coronal 
Repetition time 
(ms) 
1.98 128.0 2.5 282 
Echo time (ms) 0.78 4.0 1.2 1.3 
Image resolution 160x120 128x128 128x128 128x128 
Slice 
thickness(mm) 
10 5 8 4 
Number of slices 3 3 Not 
mentioned 
2 
Flip angle(°) 20 90 10 55 
Field of view 
(FOV) 
240mmx180mm 220mm 300cm 235x117.5mm2 
Temporal 
resolution (s) 
0.736s (3 images 
per 0.734s) 
Not 
mentioned 
Not 
mentioned 
4 images per 
second over 
14s  
Total acquisition 
time  
1 minute, 31 
seconds 
36.9 
seconds  
10 seconds 
per slice (32 
or 64 
images) 
14 seconds 
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Limitation of the present study 
My study has some limitations. Paralysed vocal folds have shorter length and at 
lower vertical level than the normal opposites side. I found the true edge of the vocal 
fold was sometimes not visible on the acquired cine-MRI. Previous studies have 
shown that during phonation, normal larynx elevates (Ahmad et al., 2009) and 
paralysed vocal folds lack of the vertical elevation (Faust et al., 2001). This maybe a 
contributing factor for the poor inter-scan repeatability for VFPa measurements. 
However, other measures in the present study, VFRa and VFaP demonstrated high 
repeatability and appear unaffected by this limitation. Furthermore to minimise 
potential errors caused by the elevation of the larynx, I acquired three axial slices to 
capture the level which best represents glottal area during phonation; where elevation 
occurred I selected the slice that best represented glottal area for quantitative 
analysis.  
 
Although limited by a small number of participants, the present study confirms the 
feasibility of quantifying vocal fold mobility using cine-MRI, and indicates 
capability of cine-MRI measures to reliably identify UVFP.  
 
Clinical impact 
I expect this technique would be of great benefit to non-invasively and objectively 
assess the graded improvement in vocal fold mobility that are likely to occur 
following surgical interventions aimed at re-establishing the dynamic movement of 
vocal fold.  
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7.6 Conclusion 
I have shown that cine-MRI can objectively quantify vocal fold mobility and detect 
UVFP by derived quantitative metrics. The technique can be utilised within clinical 
trials of surgical interventions as a non-invasive measure of therapeutic success. 
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Chapter 8 Case series of non-selective and selective laryngeal 
reinnervation 
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8.1 Non-selective laryngeal reinnervation in unilateral vocal fold paralysis 
patients 
8.1.1 Abstract 
Objective: There are few reported series of non-selective laryngeal reinnervation 
with well-validated subjective, objective and radiological outcome measures, and so 
speculation remains as to the effectiveness of this intervention for patients with 
unilateral vocal fold paralysis (UVFP). I present a small case series with a range of 
such outcome measures collected prospectively. 
Methods: Five patients with UVFP (3 females, 42 to 51 years old; 2 males, 32 and 
60 years old) with range of 5 to 24 months duration of vocal fold paralysis underwent 
non-selective laryngeal reinnervation using ansa cervicalis to recurrent laryngeal 
nerve technique with concomitant collagen injection laryngoplasty. All of them were 
subjected to multidimensional outcome measures (voice handicap index-10: VHI-10, 
voice perceptual evaluation, acoustic analysis, maximum phonation time, 
aerodynamic analysis and video-laryngostroboscopy analysis) in which VHI-10 was 
the primary outcome measure, at baseline, 3-, 6-, and 12-month post-reinnervation. 
Laryngeal electromyography (LEMG) and T2-weighted MRI of the larynx was 
performed at baseline and at12-months to measure the neuromuscular integrity of the 
thyroarytenoid muscle (TA). Three of five patients completed a 12-month review. 
Results: Voice improvement was achieved in all patients in whom the mean and 
standard deviation (SD) of VHI-10 scores were of 26.6 (4.83), 14.8 (8.53) and 7.8 
(7.46) at baseline, 3- and 6-month, respectively. The normal score was reached at 6-
months and maintained at 12-months in 2 of 3 patients (score: 6 and 7) who had 
completed the 12-month review. The motor units recruitment on LEMG was ‘very 
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much better’ when compared to the baseline. There was higher signal intensity 
changes detected on the paralysed TA compared to the opposite ‘control’ on T2-MRI 
images at baseline. Repeat T2-MRI at 12-month showed normalisation of the signal 
intensity compared to the baseline values. One of the 3 patients suffered a neck 
abscess post-operatively, with a VHI-10 score of 21 at 12-months, only slight 
subjective improvement in LEMG motor unit recruitment and sustained high signal 
T2-MRI at 12-months. 
Conclusion: A case series of 5 patients undergoing non-selective laryngeal 
reinnervation using an ansa-RLN technique with concomitant injection laryngoplasty 
is presented. Voice improvement was demonstrated by VHI-10 and other 
multidimensional outcome measures, and these were supported by LEMG and T2-
MRI outcomes. To my knowledge, this is the first multidimensional prospective 
study of laryngeal reinnervation and also the first to suggest that 3T MRI may be a 
promising outcome measure for future reinnervation trials.  
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8.1.2 Background 
Unilateral vocal fold paralysis (UVFP) occurs may be due to injury to the vagus 
nerve or, more commonly, its branch, the recurrent laryngeal nerve. The affected 
vocal fold become flaccid and immobile causing dysphonia and may be aspiration. It 
loses properties that determine the quality of voice like the mass, elasticity, 
resistance and symmetry of the vocal folds (Zheng et al., 1996). Different treatment 
options are available for the management of UVFP which include injection 
laryngoplasty, type I thyroplasty, arytenoid adduction and laryngeal reinnervation 
(Crumley, 1991; Isshiki et al., 1975, 1978; McCulloch and Hoffman, 1998) 
 
Non-selective laryngeal reinnervation, refers to restoration of innervation to the 
larynx by either anastomosis or implant technique using suitable donor nerves 
(Crumley, 1991; Paniello, 2000; Tucker and Rusnov, 1981). It is a safe surgery 
(Blumin and Merati, 2008) that aims to re-establish the tone and bulk of the vocal 
folds by achieving “favourable laryngeal synkinesis” (Crumley, 2000). The most 
common technique reported is ansa to recurrent laryngeal nerve anastomosis (ansa-
RLN) (Aynehchi et al., 2010). Non-selective laryngeal reinnervation using ansa-RLN 
anastomosis was re-introduced by Crumley and subsequently there were reports on 
the voice outcomes of this technique in UVFP (Crumley, 1991; Lee et al., 2007; 
Lorenz et al., 2008; Olson et al., 1998; Paniello et al., 2011; Smith et al., 2008; Wang 
et al., 2011; Zheng et al., 1996). These reported improvement of voice perceptual 
evaluation, video-laryngostroboscopy, laryngeal electromyography (LEMG) and 
acoustic analysis to varying degrees (Aynehchi et al., 2010). 
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Non-selective laryngeal reinnervation has the potential of restoring normal or near 
normal voice in UVFP patients. There are several advantages of laryngeal 
reinnervation over other surgical techniques. Specifically, it avoids vocal fold 
atrophy and provides a long-term solution by maintaining the vocal fold mass, bulk, 
tone and pliability for normal mucosal waves (Lorenz et al., 2008; Wang et al., 2011; 
Zheng et al., 1996). The possibility of other forms of laryngoplasty is preserved 
should voice outcomes reach desired levels. However, voice improvement takes up 
to 4 months (Lee et al., 2007; Lorenz et al., 2008; Maronian et al., 2003) . 
Concomitant injection laryngoplasty using absorbable material may strengthen the 
voice during this waiting period (Lee et al., 2007; Lorenz et al., 2008; Olson et al., 
1998). 
 
Here, the results of non-selective reinnervation with concomitant collagen injection 
laryngoplasty in five patients are presented. The primary voice outcome is voice 
handicap index-10 (VHI-10). The correlation between VHI-10 and neurological 
status as shown on LEMG and MRI is reported. Results of other multidimensional 
outcome measures are shown. 
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8.1.3 Methods 
Local ethics committee approval was obtained for the present study. 
Participant selection 
The study population included 5 UVFP patients (3 female, 42 to 51 years old ; 2 
male, 32 and 60 years old) who were diagnosed UVFP and met inclusion and 
exclusion criteria listed in chapter 2. They were recruited from the Royal National 
Throat Nose Ear Hospital and St. Thomas’ and Guy’s Hospital London in 2011-
2012. The causes of the UVFP were thyroidectomy (2 patients), thymectomy (1 
patient), vagal schwannoma excision (1 patient) and cervical spine procedure (1 
patient). Duration of palsy was ranged from 5 months to 24 months.  
 
Surgical procedure 
For description of surgical technique, please see 1.6, page 41 to 42.  
Temporary medialisation of the vocal fold was done at the same setting by injecting 
porcine collagen (Permacol™, Tissue Science Laboratories plc, “TSL” Aldershot 
UK) endoscopically
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Outcome measures 
The patients were assessed pre- and post-operatively for voice improvement using 
multidimensional measures and effect of reinnervation on the thyroarytenoid muscles 
as the following: 
a) voice handicap index-10 (VHI-10) (Rosen et al., 2004);  
b) maximum phonation time, seconds (MPT); 
c) voice perceptual evaluation (GRBAS) (Hirano, 1981); 
d) acoustic analysis (jitter %, shimmer %, NHR);  
e) aerodynamic analysis (maximum sound pressure level (SPL) dB, and mean 
airflow rate  (MFR) at voicing L/s);  
f) video-laryngostroboscopy;  
g) Laryngeal electromyography (LEMG); and 
h) T2-weighted MRI (T2-MRI) of larynx 
 
The primary outcome measure was VHI-10. Outcome measures for a) to f) above 
were performed at baseline and at 3-, 6- and 12-months after operation whereas 
LEMG and T2-MRI for neurological status assessment were done at baseline and 12-
months after operation. To date, 3 patients have reached 12 months’ assessment 
whereas the other 2 patients have reached 6 months’ assessment. 
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Description of outcome measures, randomisation and blinding 
Please see chapter 1, page 68 to 71 for the more detail description of outcome 
measures. 
1. Voice Handicap Index 10 (VHI 10)  
The patients answered the questions independently and the total score was 
obtained. 
 
2. Maximum phonation time (MPT)  
MPT is a measurement of maximum vocal performance that was assessed 
manually using a stopwatch to time the duration. The patient was asked to 
sustain /a/ at a comfortable loudness of voice after taking a normal breathe. This 
task was repeated three times and the longest duration was recorded.  
 
3. Voice perceptual evaluation  
Audio files of patients reading the ‘rainbow passage’ were rated by 3 raters who 
have established high inter-rater reliability (Webb et al., 2003). The audio files 
were anonymised and randomised. The raters were unaware whether the audio 
files were recorded pre-operatively or post-operatively. 
 
4. Acoustic analysis 
Voice recordings were performed in a quiet room using Multidimensional Voice 
Program (MDVP, KayPentax, NJ, USA). The microphone provided for the 
MDVP was placed at 45 degree from the angle of the mouth with 5 cm lips-to-
microphone distance. The recording was done while the patient sitting on a chair. 
Participants were instructed to say vowel /a/ for 6 seconds at comfortable 
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loudness. A five second recording of a sustained vowel /a/ was used to measure 
F0, jitter percent, shimmer percent and NHR. The first 500ms of the start and the 
end of the vowel was removed t o avoid the start and end effect.  
 
5. Aerodynamic analysis 
Aerodynamic analysis using Aerophone (model 6600, Kaypentax, Lincoln Park 
USA) was done to measure the air leakage during phonation that indirectly 
measures closure of glottic gap. Parameters measured were- maximum SPL dB, 
and MFR at voicing L/s that were indirectly calculated from intra-oral 
articulatory pressures. Each patient was fitted with a standard anaesthesia face-
mask covering the nose and mouth. A small tube that connects the machine and 
the patient’s mouth was placed just slightly beyond the upper and lower incisors. 
The patient was then asked to say /pa//pa//pa/ for 3 times at minimum, 
comfortable and loudest loudness level. There was no phonation break at each 
loudness level once data acquisition was initiated. The device was connected to a 
computer system with software that generate the data required.  
 
6. Videolaryngostroboscopic analysis 
Please see chapter 4 as well. 
 
7. Laryngeal electromyography (LEMG) 
With patients supine and with their necks slightly extended, an experienced 
laryngologist and electromyographer performed LEMG at rest and during 
phonation using a monopolar needle inserted percutaneously into the TA 
muscles. Tracings were converted to executable files (exe.file) in a random 
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order, and then rated by a clinical neurophysiologist (SF) blinded to time-point, 
who evaluated whether (a) one of the tracings demonstrated slightly better 
recruitment and contained more normal motor units; (b) one of the tracings 
demonstrated very much better recruitment and contained more normal motor 
units; or (c) there was no difference between the 2 tracings.  
8. T2-weighted magnetic resonance imaging (T2-MRI) 
Please see chapter 5 for the details of T2-MRI protocol and image analysis. In the 
present study, TA signal intensity was measured from the acquired images.   
 
Statistical analysis 
Data of the present study was presented descriptively using mean and standard 
deviation (SD) as well as in graphs for each measurement for individual patient. 
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8.1.4 Results 
Results of 5 patients at baseline, 3-, 6- and 12-month are presented. Three patients 
(patient-1,-2 and -3) had completed the 12-month review. Two patients experienced 
complications: 1) Patient-2 had a neck abscess 3 weeks after the laryngeal 
reinnervation requiring drainage and antibiotics; and 2) Patient-4 had temporary 
dysphagia requiring extended hospital stay (10 days). This resolved completely.  
 
Table 8-1: This table shows the patients’ demographics, and VHI-10 scores, MPT 
and laryngeal electromyography motor unit recruitment 
 Patient-1 Patient-2 Patient-3 Patient-4 Patient-5 
Age 40 62 32 42 56 
Gender F M M F F 
Palsy side Left Left Left Right Left 
Duration 
of palsy 
5 months 2 years 1 year 1 year 1 year 
Aetiology Thyr Vagal para-
ganglioma 
excision 
Thyr Cervical 
spine 
procedure 
(anterior 
approach) 
Thymoma 
excision 
VHI-10 21 32 29 29 22 
MPT 3 8 7 4 7.6 
LEMG – 
motor unit 
recruitment 
1 1 1 
 
1 
 
2 
 
Thyr: thyroidectomy; MPT: maximum phonation time 
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Voice handicap index-10, laryngeal electromyography (LEMG) and T2-MRI 
A maximum score for VHI-10 is 40, indicating a severe impact to the patient’s 
physical, functional and emotional concern. Voice improvement was observed in all 
patients in whom the scores were improved at 3-, 6- and 12-month from the baseline 
at (Table 8-2). The normal score for the VHI-10 was reached at 6-month and it was 
maintained at 12-month in 2 of 3 patients who had completed the 12-month review. 
For patient-2 who had the neck abscess and completed the 12-month review, the 
VHI-10 had improved from 32 to 21 at 12-month, but it did not surpass the score of 
11, which is the normal cut off (Arffa et al., 2012).  
 
Table 8-2: VHI-10 scores at pre- and post-operative 
Patient Baseline 3-month 6-month 12-month 
Patient-1 21 9 6 1 
Patient-2 32 17 21 21 
Patient-3 29 28 4 7 
Patient-4 29 14 5 - 
Patient-5 22 6 3 - 
 
LEMG tracings of the 3 patients who had completed the 12-month review revealed 
that the motor units recruitment is very much better for patient-1 and -3, and slightly 
better for patient-2 when compared with the baseline.  
 
There was higher signal intensity changes detected on the paralysed (left) 
thyroarytenoid muscles (TA) compared to the opposite normal on the T2-MRI 
images at baseline (Figure 8-1). Repeat T2-MRI at 12-month showed a reduction in 
the signal intensity of the paralysed TA compared to the baseline values (Table 8-3). 
For the normal TA, the signals had remained similar. However, for patient-2, the 
VHI-10 score was still abnormal at 12-month, the LEMG motor unit recruitment was 
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only slightly better and the high signal changes on the T2-MRI had remained at 12-
months. 
 
Normalisation of signal intensity in the 2 patients (patient-1 and -3) at the 12-month 
review demonstrated that the voice improvement at this stage was not due to the 
collagen injection but due to the reinnervation, since collagen is reabsorbed at 
between 4 and 6 months (Mallur and Rosen, 2010).  
Table 8-3: Thyroarytenoid muscles signal intensity changes at pre- and post-
operation and LEMG motor unit recruitment evaluation comparing pre and post-
operative tracings 
 
 LTA SI 
(baseline) 
LTA SI             
(12-month) 
RTA SI 
(baseline) 
RTA SI        
(12-month) 
Motor unit 
recruitment 
Patient-1 4.00 1.88 1.82 1.71 very much 
better 
Patient-2 3.47 3.48 2.48 2.20 slightly 
better 
Patient-3 3.03 1.85 1.51 1.72 very much 
better 
L, left; TA, thyroarytenoid; and SI, signal intensity 
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Figure 8-1: T2-weighted imaging of vocal folds images of patient-1, -2 and -3. Images on 
column (A) are taken at baseline and column (B) at 12-month. At baseline, the paralysed 
thyroarytenoid muscles (white arrow) had higher signal intensity than the opposite normal. 
The signal intensity normalised at 12-month except in patient-2
(A) Baseline (B) 12-month 
Patient-1 
Patient-2 
Patient-3 
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Maximum phonation time (MPT) and aerodynamic analysis 
The patients were able to sustain phonation longer following reinnervation: MPT at 
baseline, 3-, 6-month was 5.92 (2.26)s, 9.20 (4.09)s and 11.6 (4.10)s. At 12-month, 
the MPT of the 3 patients reaching this time-point were of 18, 17 and 17. The patient 
who experienced postoperative abscess reported the worst VHI-10 score, and had an 
MPT within normal range (17). Figure 8-2 shows MPT at different time points for 
each patient.  
 
For aerodynamic analysis, the maximum SPL dB and MFR L/s at baseline, 3-, 6-
month were 74.46 (1.60) dB, 76.74 (2.86) dB and 76.92 (2.61) dB respectively for 
maximum SPL; and 0.46 (0.16) L/s, 0.30 (0.11) L/s and 0.26 (0.10) L/s respectively 
for MFR. At 12-months, the maximum SPL and MFR of the 3 patients who had 
completed follow-up were 90.62, 85.74 and 87.41 dB respectively for maximum 
SPL; and 0.25, 0.39 and 0.29 L/s respectively for MFR. Figure 8-2 shows the 
maximum SPL and MFR for each patient at different time points. The intensity is 
louder and air leakage lower than pre-operatively.  
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Figure 8-2: These graphs show maximum phonation time, mean flow rate and maximum sound pressure level of 5 patients. 
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Voice perceptual evaluation and acoustic analysis 
Voice perceptual evaluation showed an improvement in the quality of voice for all 
patients following reinnervation. The inter- and intra-rater reliability of the voice 
perceptual evaluation, calculated using weighted kappa coefficient and intraclass 
correlation coefficient is shown in Table 8-4 and Table 8-5, and is similar to the 
reliability reported by Webb et al. (Webb et al., 2003). Table 8-6 showed the pre-
operative and post-operative grading for ‘G’, ‘R’ and ‘B’ of all patients. At 12-
months, the overall dysphonia of the 3 patients who completed follow-up was 0.0 
(normal).  
 
The objective voice quality evaluation; jitter percent; shimmer percent; and NHR of 
the patients’ 5-seconds vowel/a/ at baseline, 3-, 6-month was 2.28 (1.84)%, 1.52 
(1.92)% and 1.06 (0.86)% respectively for jitter; 4.95 (1.90)%, 4.27 (2.44)% and 
4.47 (2.26)% respectively for shimmer; and 0.16 (0.04), 0.17 (0.09) and 0.13 (0.02) 
respectively for NHR. At 12-months, the jitter percent, shimmer percent and NHR of 
these 3 patients were 1.00%, 0.94% and 0.38% for jitter; 2.44%, 5.38% and 2.77% 
for shimmer; and 0.10, 0.15 and 0.14 for NHR. The jitter and shimmer improved to 
within normal range at 12-months post-operatively except for the patient who had the 
neck abscess whose shimmer was 5.58% (just outside the normal range). Figure 8-3 
shows the acoustic analysis results.
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Table 8-4: Inter-rater reliability for voice perceptual evaluation as calculated using  
weighted kappa coefficient (kappa) and intraclass correlation (ICC) 
 Weighted kappa coefficient ICC 
Rater-1 vs 
Rater-2 
Rater-1 vs 
Rater-3 
Rater-2 vs 
Rater-3 
Rater-1, rater-
2, rater-3 
Overall 
dysphonia (G) 
0.87 0.87 1.00 0.95         
Roughness (R) 0.87 0.87 1.00 0.94         
Breathiness (B) 0.95 0.95 1.00 0.98         
 
Table 8-5: Intra-rater reliability for voice perceptual evaluation as calculated using 
weighted kappa coefficient (kappa) and intraclass correlation (ICC) 
 
 Rater-1 Rater-2 Rater-3 
Kappa ICC Kappa ICC Kappa ICC 
Overall 
dysphonia (G) 
0.46 0.65 0.50 0.67 0.58 0.66 
Roughness (R) 0.63 0.70 0.75 0.83 0.67 0.76 
Breathiness (B) 0.39 0.62 0.35 0.59 0.35 0.59 
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Table 8-6: Voice perceptual evaluation by the 3 raters 
 baseline 3-month 6-month 12-month 
Overall dysphonia (G) 
Normal 0 3 2 3 of 3 patients 
mild deviance 2 2 2  
moderate deviance 2 0 1  
Severe deviance 1 0 0  
Roughness (R) 
Normal 3 5 2 3 of 3 patients 
mild deviance 1 0 3  
moderate deviance 1 0 0  
Severe deviance 0 0 0  
Breathiness (B) 
Normal 0 3 2 3 of 3 patients 
mild deviance 2 2 3  
moderate deviance 2 0 0  
Severe deviance 1 0 0  
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Figure 8-3: These graphs show acoustic analysis results of 5 patients at different time points 
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Video-laryngostroboscopy analysis  
Analysis of video-laryngostroboscopy findings was shown in Table 8-7. At 6-
months, mucosal wave symmetry and duration of closure were normal in 4 patients 
and there was no vocal fold bowing in all patients. All 3 patients who had completed 
the 12-month review were normal. 
Table 8-7: Video-laryngostroboscopy analysis evaluation by 3 raters 
 baseline 3-month 6-month 12-month 
Mucosal wave asymmetry    
No asymmetry 2 5 4 3 of 3 patients 
Mildly asymmetry 1 0 1  
Moderately asymmetry 1 0 0  
Severely asymmetry 1 0 0  
Duration of closure    
Predominately closed 3 4 5 3 of 3 patients 
Half-opened and half-closed 0 1 0  
Predominately open 1 0 0  
Always open 1 0 0  
Vocal fold bowing    
No bowing 3 5 4 3 of 3 patients 
Mild bowing 1 0 1  
Moderate bowing 1 0 0  
Severe bowing 0 0 0  
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8.1.5 Discussion 
Overview 
Non-selective reinnervation is one of the surgical options available to treat UVFP. 
The operation aims to reinnervate the paralysed vocal fold muscles and thereby 
restore the tone and bulk required for a good voice. However, the technique results in 
a delay before optimum voice improvement that is much longer than with other 
medialisation techniques (Aynehchi et al., 2010). This drawback may be ameliorated 
by temporary injection laryngoplasty, although in studies, this introduces a 
significant confounding factor in determining the true treatment effect of 
reinnervation (Lorenz et al., 2008). 
 
Temporary injection materials for injection laryngoplasty include bovine gelatin, 
collagen-based products, hyaluronic acid and carboxymethylcellulose. The clinical 
effectiveness of these injection materials varies from 4 to 6 months (Mallur and 
Rosen, 2010). Wen et al. reported that porcine collagen and hyaluronic acid showed 
comparable results up to 6 months post-treatment during which time VHI-10 and 
MPT improved significantly in their retrospective case series (Wen et al., 2013). 
“Symptom-free duration of action” was 10.9 months for porcine collagen and 14.4 
months for hyaluronic acid (Wen et al., 2013). However, the mean VHI-10 at 6 
months of both groups was still abnormal (more than 11) and there were no well-
validated outcome measures beyond 6 months post-treatment. The interpretation of 
results of this study may be compromised by biases introduced by the nature of 
retrospective chart review and high dropout rate of more than 20%. Those patients 
who lost to follow up were assumed to still having effective control of their 
presenting symptoms.  
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Moonis et al. studied longitudinal imaging appearance on T1- and T2-weighted 
imaging of 6 patients following injection laryngoplasty using a human based 
collagen. There was hyperintensity on the T1- and T2-weighted images of the 
injected paralysed vocal fold. The hyperintensity on T2 was more likely due to 
increased in fluid, protein and vasculature caused by the injection. The study 
suggested that injected human based collagen product persists in the vocal folds up 
to 11 months. However, the signal changes (hyperintensity) was not measured 
objectively, each radiologic assessment was not matched with the subjective and 
objective voice quality evaluation, and of the 6 patients, only one patient had a serial 
scan over time. The rest of MRI scans was done on different patients at different time 
points (Moonis et al., 2005).  
 
Based on this data, I hypothesised that any voice improvements beyond 6 months 
following non-selective laryngeal reinnervation with concomitant injection 
laryngoplasty are likely to be due to the effects of reinnervation rather than of 
injection laryngoplasty. Here, I used LEMG as a semi-quantitative outcome measure, 
but also used 3T MRI as an exploratory outcome measure to assess muscles’ signal 
changes.  
 
Synopsis of key findings 
In the present prospective case series, reinnervation improved physical, functional 
and emotional concerns due to UVFP compared to baseline, and this was matched by 
LEMG and T2-MRI outcomes, including at a 12-month time-point in 2 patients. 
Improvement in MPT, voice perceptual evaluation, acoustic analysis, video-
laryngostroboscopy analysis and reduction of MFR were all also observed. However 
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patient-5 had minimal MPT improvement that may be due to limited pulmonary 
reserve caused by a pre-existing phrenic nerve paralysis.  
 
In patient-2 the voice improvement was not optimum, the motor unit recruitment on 
LEMG was only slightly better than the baseline and the signal changes on the T2-
MRI was still high at 12-month review. The patient was still unsatisfied with voice 
projection especially in places with high background noise. This unsatisfactory result 
may be due to the neck abscess post-operatively which may in turn have damaged 
the nascent nerve repair site. Despite this, however, at 12-months his MPT was 
within the normal range and voice and video-laryngostroboscopy outcomes were 
normal, although the voice amplitude perturbation (shimmer) remained outside the 
normal range.  
 
Some of the patients in this case series were noted to have normal voice perceptual 
evaluation before the reinnervation even though their self-rated VHI-10 was > 20. 
This is because they did not have problems with individual conversation in a quiet 
room, but had problems in crowded places or in groups where projection was 
required. In these patients, at 6- and 12-month review, the VHI-10 scores reduced to 
normal level and the voice perceptual evaluation remained normal. 
 
Comparison with previous works 
Offering temporary voice strength by injection laryngoplasty is necessary while 
waiting for the reinnervation to become effective at between 3 and 4 months. 
Previous retrospective studies reported results of non-selective reinnervation using 
ansa-RLN with concomitant injection laryngoplasty using various materials- 
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Gelfoam (Pzifer, Cambridge, MA), micronized AlloDerm (Cymetra; LifeCell Corp, 
Branchburg, NJ), or microfibrillar collagen (INSTAT Microfibrillar Collagen 
Hemostat; Ethicon, Johnson & Johnson, Somerville, NJ). The studies reported 
improvement in patient self-reported voice perception, voice perceptual evaluation 
by professionals, acoustic analysis and video-laryngostroboscopy findings more than 
6 months after reinnervation (Lee et al., 2007; Lorenz et al., 2008; Olson et al., 
1998). A significant improvement in: acoustic analysis (p<0.05) (Olson et al., 1998), 
voice perceptual evaluation (p<0.05) (Olson et al., 1998), p<0.001 (Lorenz et al., 
2008), and glottic closure and vocal fold bowing on video-laryngostroboscopy 
(p<0.05) (Lorenz et al., 2008) were reported. However none of these studies included 
LEMG results to directly assess the effect of reinnervation on laryngeal muscles. 
Further retrospective studies did not perform concomitant injections and observed  
voice outcome improvement in parallel with encouraging LEMG findings (Maronian 
et al., 2003; Wang et al., 2011). 
 
The present study employing an ansa-RLN technique with concomitant collagen 
injection laryngoplasty is the first study to my knowledge that includes T2-MRI and 
correlates it with LEMG findings to assess both resorption of injection material and 
the return of innervation to the TA muscle and also the prospective case series to use 
multidimensional assessment 
 
Limitation of the present study 
The main limitation of the present study is the small number of patients and the 
absence of a control group. Further data collection and follow-up will be continued 
and updated results reported in due course. 
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Clinical impact 
The present study provides further supporting data for the use of VHI-10 as the 
primary outcome measure for voice surgery trials for UVFP. T2-MRI may be a 
promising outcome measure for laryngeal reinnervation trials, as it may confirm 
denervation and reinnervation status as well as monitor resorption of injection 
materials. 
 
8.1.6 Conclusion 
In this prospective case series of 5 patients undergoing non-selective laryngeal 
reinnervation using ansa-RLN technique with concomitant injection laryngoplasty, 
voice improvement was demonstrated by VHI-10 and other multidimensional 
outcome measures, and these were correlated with positive findings on LEMG and 
T2-MRI. 
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8.2 Immediate selective laryngeal reinnervation in vagal paraganglioma 
patients 
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8.2.1 Abstract 
Objective: This prospective study is to present the outcomes of immediate selective 
laryngeal reinnervation in improving voice, alleviating aspiration and re-establishing 
vocal fold mobility in patients with unilateral vagal paralysis following vagal nerve 
tumour excision.  
Methods: Two women (40 and 52 years old) diagnosed with left cervical vagal 
paraganglioma undergoing excision operation were included in the study. Patient-1 
have already had left vocal fold paralysis whereas patient-2 had normal vocal folds at 
presentation. They underwent immediate selective laryngeal reinnervation using split 
phrenic nerve to the abductor branch and ansa cervicalis to the adductor branch of 
recurrent laryngeal nerve with concomitant collagen injection laryngoplasty 
following vagal tumour excision. All of them were subjected to multidimensional 
outcome measures (voice handicap index-10: VHI-10, EAT-10, voice perceptual 
evaluation, acoustic analysis, maximum phonation time, aerodynamic analysis and 
video-laryngostroboscopy analysis) at pre-operative, 1-, 6-, and 12-months post-
operative. Laryngeal electromyography (LEMG) and T2-weighted MRI (T2-MRI) of 
the larynx was performed at baseline and at 12-months to measure the neuromuscular 
integrity of the thyroarytenoid muscle and posterior cricoarytenoid muscle. Patient-1 
and patient-2 baseline was before and after respectively, vagal tumour excision. 
Their respiratory function was assessed using MRC breathlessness scale and lung 
function test. 
Results: Patient-1 and patient-2 had improved VHI-10 scores from of 23 and 18 
respectively at 1-month, to of 5 and 1 respectively at 12-months. Their EAT-10 score 
was improved from of 20 and 24 respectively at 1-month to of 3 and 1 respectively at 
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12-months. The motor units recruitment on LEMG was ‘very much better’ for 
patient-2 when compared to the baseline but for patient-1, the baseline was slightly 
better than at-12months. There was higher signal intensity changes detected on the 
paralysed TA compared to the opposite ‘control’ on T2-MRI images at baseline. 
Repeat T2-MRI at 12-month showed normalisation of the signal intensity. There was 
slight vocal fold abduction for patient-1 observed and no obvious abduction for 
patient-2. The MRC breathlessness scale of both patients had been the same at all 
time points. There was no significant decreased of post-operative FEV1 or FVC from 
the pre-selective reinnervation measurements.   
 
Conclusion: Selective reinnervation is a safe operation to be performed in an 
immediate first operated side vagal paraganglioma excision. Voice and swallowing 
improvement were demonstrated but no significant vocal fold abduction achieved. 
Reviewing patients at 1-month post-tumour excision may be the best time for 
baseline measurements in such studies. 
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8.2.2 Background 
 
Patients with cervical vagal tumour commonly present with a neck mass and the 
majority of them are asymptomatic as tumour growth is gradual. The definitive 
treatment for this condition is surgery in which post-operative unilateral vagal 
paralysis ensues (Lozano et al., 2008). Unilateral vagal paralysis patients suffer 
dysphonia, dysphagia and aspiration. Additional operative complications of 
glossopharyngeal and hypoglossal nerve paralysis worsen the swallowing problems 
(Gilmer-Hill and Kline, 2000; Miller et al., 2000).  
 
Multiple paraganglioma is common especially in patients with a positive family 
history (Urquhart et al., 1994). Netterville et al. reported that 37% of vagal 
paragangliomas were bilateral (Fang et al., 2011; Netterville JL et al., 1998). 
Multicentricity of vagal paragangliomas is a significant factor to consider in decision 
making of the therapeutic options (Lozano et al., 2008). Three of 19 patients with 
paraganglioma as reported by Urquhart et al. were subjected to irradiation therapy 
rather than surgery due to multicentricity. This was to avoid the incapacitating 
morbidity of bilateral vocal fold paralysis (BVFP) that might end up with a 
tracheostomy.  
 
Significant issues of dysphonia, dysphagia and aspiration caused by unilateral vagal 
paralysis following vagal paraganglioma excision definitely require rehabilitation. 
Surgical interventions to improve voice and swallowing in this condition include 
thyroplasty, arytenoid adduction, injection laryngoplasty and laryngeal reinnervation 
(Bielamowicz et al., 2000; Fang et al., 2011; Lamarre et al., 2011; Miller et al., 2000; 
Urquhart et al., 1994). These studies had shown the usefulness of the surgical 
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interventions in rehabilitating the voice and swallowing issues. However their results 
were limited by the retrospectivity of the studies, inherent biases and the lack of 
details of voice and swallowing treatment outcome monitoring effect. 
 
Surgical interventions are ideally performed at the same sitting to minimise post-
operative morbidity. Injection laryngoplasty using current available substances 
usually provides only a temporary effect, necessitating repeated injections. 
Thyroplasty is commonly done under local anaesthesia since patients’ cooperation is 
necessary to fine-tune the voice according to implant size and placement. Laryngeal 
reinnervation may be a good option since the operation is preferably done under 
general anaesthesia and it does not require fine-tuning of voice. The surgical 
reinnervation that aims to re-establish tone and bulk of the denervated muscle may be 
better than other surgical techniques as Woodson in 2007 had shown in cats that 
spontaneous regeneration did not occur in vagus transection possibly due long course 
of the nerve to RLN and only small proportion of the axons goes to RLN (Woodson, 
2007). Further more, re-establishment of vocal fold mobility may be possible by 
performing selective reinnervation that may save patients from irradiation therapy or 
tracheostomy should the tumour grow later on the opposite neck. A prospective study 
with standardised outcome measures is necessary to demonstrate the effect of 
selective reinnervation in unilateral vagal paralysis following the first operated side 
of vagal paraganglioma. 
 
This prospective study is to present the outcomes of selective laryngeal reinnervation 
in improving voice, alleviating aspiration and re-establishing vocal fold mobility in 
patients with unilateral vagal paralysis following vagal nerve tumour excision.  
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8.2.3 Methods 
Patient selection 
Two female patients diagnosed with left cervical vagal paraganglioma from ENT 
clinics of Charing Cross Hospital undergoing excision operation were included in the 
study. Patient-1 (40 years old) have already had left vocal fold paralysis at 
presentation to the clinic whereas patient-2 (52 years old) had normal vocal folds at 
presentation. Neither of them had any other medical problems.  
 
Outcome measures 
The patients were assessed pre- and post-operatively for voice improvement using 
multidimensional measures, effect of reinnervation on the thyroarytenoid muscles, 
swallowing and respiratory condition as the following: 
a) voice handicap index-10 (VHI-10);  
b) voice perceptual evaluation (GRBAS);  
c) acoustic analysis (jitter(%), shimmer(%), NHR);  
d) aerodynamic analysis (maximum SPL(dB), mean SPL(dB), mean airflow rate 
at voicing(MFR, L/s));  
e) video-laryngostroboscopy (mucosal asymmetry, duration of closure, vocal 
fold bowing; vocal fold abduction); 
f) swallowing questionnaire (EAT-10);  
g) Medical Research Council (MRC) breathlessness scale;  
h) pulmonary function test (FEV1, FVC);  
i) laryngeal electromyography (LEMG); and 
 272 
j) thyroarytenoid muscles (TA) signal intensity and posterior cricoarytenoid 
(PCA bulk) on T2 weighted MRI of larynx (T2-MRI). 
 
Outcome measures for no. 1 to 8 above were done at pre-operative and at 1, 6 and 12 
months post-operative whereas the LEMG and T2-MRI for neurological status 
assessment were done at baseline, 6 and 12 months after operation. For the LEMG 
and T2-MRI, the baseline point was different for patient-1 and patient-2. The patient-
1 had the baseline tests done before the surgery (tumour excision plus selective 
reinnervation plus injection laryngoplasty that was done at the same sitting). This is 
because patient-1 had already had UVFP before the tumour excision. Whereas, 
patient-2 who had pre-operative normal vocal folds, had the LEMG and T2-MRI 
done 5 weeks after the surgery (tumour excision plus injection laryngoplasty) that 
was 1 week before the selective reinnervation. The selective reinnervation that was 
initially planned for the same sitting as that for tumour excision for patient-2 had to 
be done later due to unavoidable circumstances. 
 
For details of description of outcome measures, please refer chapter 8.1, page 247 to 
249. 
 
Selective reinnervation – surgical technique 
Selective laryngeal reinnervation was done following a vagal nerve tumour operation 
either at the same setting or 5 weeks following the excision operation. A separate 
incision was made on the neck lower to the first incision for vagal nerve tumour 
removal. The separate incision followed the skin crease. Thyropharyngeus muscle 
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overlying the lateral border of thyroid cartilage lamina was divided for the purpose of 
intra-laryngeal RLN dissection. The main trunk of the RLN was identified behind the 
cricothyroid joint. The abductor and adductor branch of the RLN were then 
identified. Phrenic nerve was normally found deep to the transverse cervical artery 
overlying the anterior scalenus muscle. Split phrenic nerve technique was used to 
reinnervate the PCA muscle. Greater auricular nerve was used as a cable graft to 
bridge the phrenic nerve and the distal stump of the RLN before it branched into the 
abductor branch. The adductor branch of RLN was anastomosed to the ipsilateral 
ansa cervicalis nerve (Crumley and Izdebski, 1986). Injection to the left vocal fold 
using porcine collagen (Permacol™, Tissue Science Laboratories plc, “TSL” 
Aldershot UK) was done to temporarily help the voice while waiting for the 
reinnervation to come into effect. 
 
 274 
8.2.4 Results 
Results of the two patients’ vocal assessments, swallowing assessments and 
aerodynamic analysis at before operation, 1-, 6- and 12-months after operation were 
summarised in Table 8-8. For neurological and pulmonary function status 
assessments, the data was summarised in Table 8-9and Table 8-10 respectively. 
 
Patient-1 
This patient complained of hoarseness for 12 months before the diagnosis of left 
cervical vagal paraganglioma. Her VHI-10 was 16/40 and her voice was grade 2 for 
overall dysphonia and MPT was 15s. For aerodynamic analysis, MFR at voicing was 
0.11L/s and maximum SPL was 90.81dB. On video-laryngostroboscopic 
examination, the left vocal fold was immobile, in paramedian position although no 
mucosal asymmetry, normal duration of vocal fold closure and no significant bowing 
of the vocal fold edge noted (Figure 8-4). She had slight dysphagia and aspiration 
that her EAT-10 was 6/40. LEMG of TA showed small amplitude motor unit that 
firing at high rate in isolation that may represent conduction block. T2-MRI showed 
increased signal intensity on the left TA (Figure 8-7). She did not complain any 
significant difficulty in breathing (MRC breathlessness scale, grade 2) that she had 
breathlessness only when she was hurrying on the level or climbing up a slight hill. 
Her chest X-ray findings and pulmonary function test results were normal. 
 
She had selective reinnervation and collagen injection at the same sitting with the 
excision of vagal paraganglioma. There was evidence of left diaphragmatic paralysis 
post-operatively on the chest X-ray. She was on nasogastric tube feeding for about a 
week and then discharged home with oral feeding. The tumour excision was 
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complicated by left side tongue and soft palate weakness. At 1-month review, her 
voice was grade 1 for overall dysphonia and the VHI-10 was 23/40. Her EAT-10 was 
20/40 and she managed semi-solid food. Her MRC breathlessness scale did not 
change from the pre-operative state. 
 
At 6 and 12 months review, her swallowing continued to improve after the selective 
reinnervation. Her voice was mildly dysphonic (G, 1). LEMG showed polyphasic 
pattern (large) that was consistent with reinnervation. However, the motor unit 
recruitment at baseline was slightly better than the post-operative. T2-MRI TA signal 
intensity and PCA bulk of the paralysed side reduced and increased respectively to 
almost similar to the opposite normal side (Figure 8-7, Figure 8-8 and Figure 8-9). 
Her VHI-10 and EAT-10 were within normal limits (Figure 8-6). The overall grade 
for dysphonia was grade 1 and her MPT was 10s. Her pulmonary symptoms and 
function remain unchanged.  
 
Acoustic analysis results and maximum SPL had been within normal limits 
throughout all time points. The MFR was worst at 6-months (0.31 L/s) and improved 
to 0.21 L/s at 12-months. There was slight left vocal fold abduction re-established.   
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Figure 8-4: Videostroboscopy images of patient-1 during phonation (left column) 
and breathing (right column) at: (A) before; (B) 1-; (C) 6-; and (D) 12-months post 
selective reinnervation 
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Patient-2 
This patient complained of left neck mass and was diagnosed left vagal 
paraganglioma. She did not have any voice or swallowing issues by which all of her 
clinical assessment parameters were within normal limit. She was planned for 
selective reinnervation at the same sitting as that for the vagal paraganglioma 
excision. However due to unavoidable circumstances, only vocal fold injection with 
collagen was performed. She was on nasogastric tube feeding for about a week after 
the tumour excision and then discharged home with oral feeding.  
 
Selective reinnervation was done 5 weeks after the vagal paraganglioma excision. At 
4-weeks post-excision and collagen injection, before the selective reinnervation, her 
VHI-10 was 18/40, overall grade for dysphonia was grade 1, EAT-10 was 24/40, and 
MPT was 10s. LEMG of the TA revealed absent motor unit recruitment with 
fibrillation potential. T2-MRI showed increased signal intensity of the left TA 
(paralysed) but there was no significant reduction in the left PCA bulk (Figure 8-7 
and Figure 8-9). Her chest X-ray findings and pulmonary function test results were 
normal. She did not complain any significant difficulty in breathing (MRC 
breathlessness scale, grade 2) in which she had breathlessness when she was hurrying 
on the level or climbing up a slight hill. Immediate post-selective reinnervation, there 
was evidence of left diaphragmatic paralysis post-operatively on the chest X-ray.  
 
At 6- and 12-months, her voice and swallowing continue to improve (Figure 8-6). 
LEMG showed polyphasic pattern that consistent with reinnervation and the 
recruitment was very much better than the baseline. T2-MRI TA signal intensity and 
PCA bulk of the paralysed side reduced and increased respectively to almost similar 
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to the opposite normal side (Figure 8-7, Figure 8-8 and Figure 8-9). At 12-months, 
her VHI-10 and EAT-10 were within normal limit. The overall grade for dysphonia 
was grade 0 and her MPT was 10s. Her pulmonary symptoms and function remain 
unchanged.  
 
Acoustic analysis results and maximum SPL had been within normal limit 
throughout all time points. The MFR was worst at 1-month (0.37 L/s) and improved 
to 0.27L/s at 12-months. There was no significant left vocal fold movement re-
established.  
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Figure 8-5: Videostroboscopy images of patient-2 during phonation (left column) 
and breathing (right column) at: (A)1-; (B) 6-; and (C) 12-months post-selective 
reinnervation. Her normal vocal folds before operation is not shown here. 
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Figure 8-6: Graphs depict improvement of voice and swallowing in patient-1 and 
patient-2 as measured by the VHI-10 and EAT-10.  
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Table 8-8: Summary of voice assessments, acoustic analysis and aerodynamic analysis of patient-1 and patient-2. 
  Patient-1     Patient-2   
 Pre-operative 1m 6m 12m  Pre-operative 1m 6m 12m 
VHI-10 16 23 17 5  0 18 3 1 
Overall dysphonia grade (G) 2 1 2 1  0 1 0 0 
Roughness (R) 2 1 1 0  0 1 0 0 
Breathiness (B) 1 1 2 1  0 1 0 0 
Jitter  1.46 1.44 2.41 1.4  0.53 1.09 0.86 0.54 
Shimmer 2.71 1.28 1.9 1.67  1.76 3.54 2 2.36 
NHR 0.1 0.08 0.1 0.07  0.12 0.11 0.08 0.09 
MPT 15 10 9 10  15 10 9 9 
max SPL 90.81 88.83 87.83 84.73  87.4 80.56 92.78 89.12 
mean flow rate (L/s) 0.11 0.18 0.3 0.21  0.19 0.37 0.15 0.27 
Mucosal asymmetry 0 0 0 0  0 2 0 0 
Duration of closure 0 0 1 0  0 1 0 0 
Vocal fold bowing 0 0 1 0  0 1 0 0 
EAT-10 6 20 6 3  0 24 2 1 
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Table 8-9: Results of T2-MRI and laryngeal electromyography 
 Patient-1 Patient-2 
 Right side Left side (paralysed) Right side Left side (paralysed) 
 baseline 12m baseline 12m baseline 12m baseline 12m 
TA signal intensity 1.88 1.67 2.40 1.55 1.94 1.90 2.76 1.73 
PCA bulk 0.31 0.33 0.27 0.32 0.32 0.30 0.21 0.25 
Comparison motor unit recruitment at 12 months 
Between baseline and post-operative 
baseline slightly better than post-operative Post-operative very much better than baseline 
 
 
Table 8-10: Pulmonary function status at before and after selective reinnervation 
  Patient-1      Patient-2  
 before 1m 6m 12m  before 1m 6m 12m 
MRC scale 2 2 2 2  2 2 2 2 
FEV1 2.61 Not done 2.59 2.57  2.97 Not done 2.86 2.97 
FVC 3.39 Not done 3.4 3.44  4 Not done 3.91 4.00 
FEV1/FVC (%) 77 Not done 76.08 74.72  74.25 Not done 73.02 74.18 
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Figure 8-7: Patient-1 (top row) and patient-2 (bottom row), T2-MRI showing signal intensity changes on the left TA muscle at baseline 
(A,D); 6- (B,E); and 12-months (C,F) following the reinnervation. The arrow shows the left TA. 
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Figure 8-8: Patient-1 T2-MRI PCA bulk on axial plane at: baseline (A); 6- (B); and 12-months (C) post-selective reinnervation. The 
arrow shows the paralysed side. 
 
 
 
 
 
 
 
Figure 8-9: Patient-2 T2-MRI depicting PCA bulk on axial plane at baseline (A); 6- (B); and 12-months (C) post-selective reinnervation. 
The arrow shows the paralysed side. 
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8.2.5 Discussion 
Overview 
Vagal paragangliomas are rare but cause significant post-tumour excision morbidity 
as a result of unilateral vagal paralysis (Netterville JL et al., 1998). Multiple 
paragangliomas are common especially in those with a positive family history, and 
this results treatment dilemma: a later synchronous contralateral lesion will cause 
airway obstruction due to BVFP (Lozano et al., 2008). Selective reinnervation has 
been reported as a treatment option for BVFP to re-establish vocal fold abduction to 
improve the glottal airway as well preserving a good voice. The operation involves 
reinnervation of the PCA muscles with the phrenic nerve and adductor muscles with 
the ansa cervicalis nerve (ansa-RLN). Therefore selective laryngeal reinnervation is a 
potential attractive option to rehabilitate the post-operative morbidities. 
 
Synopsis of key findings 
Both patients demonstrated improvement of voice and swallowing following the 
selective reinnervation. The patients’ perception on physical, functional and 
emotional effect of voice (VHI-10) and swallowing assessment (EAT-10) returned to 
normal range at 12-months post-reinnervation. At 1-month up to 6-months after the 
tumour excision, their voice and swallowing were helped temporarily by bulking up 
the vocal fold with the collagen injection. Patient-2 had better and earlier voice and 
swallowing improvement than patient-1 because the latter had left side tongue and 
soft palate weakness as well. The soft palate weakness causes hypernasality and may 
contribute to the mild abnormality of overall dysphonia and breathiness score 
component of voice perceptual evaluation. Both of the patients were on enteral 
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feeding only for a week and none of them had aspiration pneumonia throughout 
follow-up. 
 
LEMG and T2-MRI findings showed improvement of neurological status that 
correlate with the voice and swallowing improvement. For patient-2, the TA motor 
unit recruitment was slightly better at baseline than 12-months because the baseline 
test was done prior to tumour removal. The vagus nerve was still intact but had 
conduction block causing vocal fold paralysis. Therefore the motor units morphology 
and recruitment appeared healthier than after the vagal tumour excision. The T2-MRI 
showed reduced TA signal intensity and increased PCA bulk at 12-months. The 
reversal of signal intensity may indicate reinnervation of the paralysed muscles as 
well as resorption of the collagen substance that was injected into the vocal fold 
immediately after the vagal paraganglioma excision. 
 
For glottal airway, there was slight abduction for patient-1 observed and no obvious 
vocal fold abduction for patient-2. Nevertheless using phrenic nerve for selective 
reinnervation did not cause significant morbidity to the pulmonary function in the 
present study. The MRC breathlessness scale of both patients had been the same at 
all time points. There was no obvious decreased of post-operative FEV1 or FVC 
from the pre-selective reinnervation measurements.   
 
Strength of the study 
This is a prospective study of case series that includes multidimensional analysis to 
monitor voice and swallowing outcomes of unilateral vagal paralysis patients who 
had primary or immediate selective reinnervation following vagal paraganglioma 
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excision. The success of reinnervation in improving voice and swallowing was 
correlated with evidence of reinnervation on LEMG and T2-MRI findings.  
 
Comparison with previous studies 
Laryngeal reinnervation (non-selective) has been reported to improve voice and 
swallowing in unilateral vagal paralysis following vagal paraganglioma excision.  
Lee et al. and Lorenz et al. included this group of patients in their retrospective 
studies whereby they had ansa-RLN reinnervation immediately after the tumour 
removed. They documented favourable outcome of ansa-RLN anastomosis 
characterised by improvement in patients’ voice perception, acoustic analysis, long 
lasting improvement of the glottic closure and maintenance of the vocal fold edge 
(Lee et al., 2007; Lorenz et al., 2008). However in these studies, data analysis of 
those patients was problematic due to unavailability of the preoperative data since 
the voice was normal before the tumour resection.  
Lamarre et al. reported a case of vagal paraganglioma resection with primary 
reinnervation of the larynx in the same sitting. In this case report, apart from ansa-
RLN anastomosis, cricothyroid-to-cricothyroid reinnervation and greater auricular 
nerve-to-superior laryngeal nerve anastomosis were performed. The patient showed 
good glottic closure at 12-months postoperatively and recovered swallowing function 
but the measurements was not explicitly reported. To date there are no published 
attempts at selective reinnervation to the PCA to re-establish vocal fold abduction in 
this group of patients.  
 288 
Limitation of study 
This study only included two patients and there was no control arm. The small 
number of subjects was due to the rare nature of the tumour that is about 9.1% of 
head and neck paragangliomas (Lozano et al., 2008; Netterville JL et al., 1998). 
However it provides comprehensive and prospective treatment monitoring effect.  
 
Selective reinnervation in the present study successfully improved the voice and 
swallowing but failed to re-establish significant vocal fold abduction. This may be 
due laryngeal synkinesis or inability of axons from the phrenic nerve to trigger the 
abduction movement. Nevertheless, the paralysed PCA exhibited reinnervation 
changes indicated by increased in muscle bulk on T2-MRI. However there was no 
PCA LEMG data available to verify this due to technical challenges in assessing the 
muscles. Although PCA and TA are both supplied by the RLN, the degree of 
reinnervation may be different as the PCA is supplied by the abductor axons and the 
TA is supplied by the adductor axons. The presence of laryngeal synkinesis was also 
not included in the TA LEMG evaluation.  
 
Clinical applicability 
This study demonstrates the applicability of performing immediate selective 
reinnervation or at the same sitting in vagal paraganglioma excision to reduce the 
post-operative morbidities. It re-established the tone and bulk of the TA thus 
improved the voice to normal or near normal as well as swallowing. Theoretically, a 
successful re-establishment of vocal fold abduction will save future dilemma of 
treatment decision making should the tumour grow on the opposite side. Phrenic 
nerve split arguably should be replaced with another technique introduced by Marie 
 289 
that uses root of the phrenic nerve (C4) (Marina et al., 2011; Remacle and Eckel, 
2010). 
 
8.2.6 Conclusion 
Selective reinnervation (split phrenic nerve to abductor branch and ansa cervicalis to 
adductor branch) is a safe operation to be performed in an immediate first operated 
side vagal paraganglioma excision. Voice and swallowing improvement were 
demonstrated but no significant vocal fold abduction achieved. Future studies 
probably should use the root of the phrenic nerve instead of the split phrenic nerve 
technique. Reviewing patients at 1-month post-tumour excision may be the best time 
for baseline measurements in such studies. 
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General conclusion 
The unifying theme of this thesis is a series of research studies collectively 
representing a feasibility study for clinical trials of laryngeal reinnervation for the 
treatment of vocal fold paralysis.  
 
In chapter 2, I have shown that an RCT of reinnervation versus thyroplasty in 
patients with UVFP is feasible in the UK. The results of the ENT UK survey and 
qualitative study of patients with UVFP, also highlight potential problem areas for 
recruitment of surgeon-investigators and patients to this trial. A potential pool of 
patients for the trial appears promising. The majority of ENT surgeons in the UK 
who manage patients with UVFP are receptive to the proposed trial and are willing to 
be trained. Training on laryngeal reinnervation is vital as not many surgeons are 
familiar with this surgery. The data of individual interview of patients presented 
evaluates patient-focus and optimisation of the trial protocol, and both recruitment 
and consent processes. I found phraseology that needed changing or avoiding during 
the recruitment process. This may in turn improve willingness of potential patients to 
be randomised. I also proposed VHI-10 to be used as the primary outcome measure 
in the proposed RCT.  
 
In chapter 3, I have shown that OperaVOX (a potential new software package that 
was installed in an iPod touch) is statistically comparable to the ‘gold standard’ 
(MDVP) for most principal phonatory outcome measures. However, given its 
portability, low cost and applicability to home or clinic, OperaVOX has greater 
utility and therefore may be preferred for voice outcome data collection in both 
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settings. Similarly, it may be preferred by patients and clinicians for routine clinical 
data collection.  
 
In chapter 4, I demonstrated the reliability of video-laryngostroboscopy as a tool for 
evaluating UVFP. A substantial inter- and intra-rater reliability was shown for the 
mucosal wave asymmetry, duration of closure and vocal fold bowing of the video-
laryngostroboscopy parameters that appear to be reliable parameters for clinical and 
research use. These parameters are important in indicating return of voice function 
by closing the glottal gap as well as the preservation of pliability of the vocal fold 
mucosa, for example that following laryngeal reinnervation.  
 
In chapter 5, I demonstrated the repeatability and reproducibility of T2-MRI as a 
non-invasive tool in depicting denervation changes in vocal fold paralysis muscles. 
Signal changes on TA muscles had shown to be correlated with electrophysiological 
results on LEMG that is useful in monitoring treatment outcome of laryngeal 
reinnervation in UVFP patients. Other metrics may be useful as well and better 
reliability may be demonstrated if a bigger number of participants are included. A 
larger scale study that includes more volunteers and patients is necessary to decide 
on a normal cut off range.  
 
In chapter 6, I examined the feasibility of assessing tissue perfusion in laryngeal 
muscles using DCE-MRI and DWI. The findings confirm that paralysed TA and 
PCA muscles have reduced perfusion and that apparently normal contralateral 
musculature in patients with UVFP has elevated perfusion. This work will inform 
mechanistic studies of vascular change in paralysed laryngeal muscles and clinical 
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studies evaluating utility perfusion parameters in predicting and monitoring 
responses to treatment.  
 
In chapter 7, I have shown that cine-MRI quantitative metrics are feasible to 
objectively quantify vocal fold mobility and had high repeatability (except VFPa) for 
identification of patients with UVFP. I propose that this technique would be of great 
benefit to non-invasively and objectively assess the graded improvement in vocal 
fold mobility that are likely to occur following surgical interventions aimed at re-
establishing the dynamic movement of vocal fold.  
 
In chapter 8.1, I have presented a prospective case series of 5 patients undergoing 
non-selective laryngeal reinnervation using ansa-RLN technique with concomitant 
injection laryngoplasty, voice improvement was demonstrated by VHI-10 and other 
multidimensional outcome measures, and these were correlated with positive 
findings on LEMG and T2-MRI. The present study provides further supporting data 
for the use of VHI-10 as the primary outcome measure for voice surgery trials for 
UVFP. T2-MRI may be a promising outcome measure for laryngeal reinnervation 
trials, as it may confirm denervation and reinnervation status as well as monitor 
resorption of injection materials. 
 
In chapter 8.2, I have reported that selective reinnervation (split phrenic nerve to 
abductor branch and ansa cervicalis to adductor branch) is a safe operation to be 
performed in an immediate (first operated side) vagal paraganglioma excision. Voice 
and swallowing improvement were demonstrated but no significant vocal fold 
abduction achieved. Future studies probably should use the root of the phrenic nerve 
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instead of the split phrenic nerve technique. Reviewing patients at 1-month post-
tumour excision may be the best time for baseline measurements in such studies. 
 
In summary, I have shown that a randomised trial of laryngeal reinnervation versus 
thyroplasty is feasible in the UK, and have validated patient- and observer-rated 
outcome measures. I have also shown that MRI may offer an alternative to 
electromyography in the assessment of laryngeal neuromuscular function in future 
trials and the clinic.  
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General limitations and future research 
The ENT UK survey results were promising but the surgeons’ equipoise in 
management of patients with UVFP is unknown. Another survey that employs 
surgeons’ equipoise measurement is necessary to address ENT surgeons, members of 
British Laryngological Association who have main interest in managing patients with 
UVFP.  
 
The qualitative study interviewing eligible patients for the proposed RCT gave some 
input on the percentage of willingness for randomisation. However, the results 
cannot be generalised as the recruitment centre was only in a few hospitals in 
London. A multi-centre pilot study of the RCT with integrated qualitative research is 
necessary to confirm the feasibility also the sensitivity of the proposed primary 
outcome measure (VHI-10).  
 
T2-MRI images are susceptible to motion artefacts. Participants were not allowed to 
clear their throat or swallow during acquisition period to ensure good quality of 
images. Some UVFP patients may find it difficult especially when they have pooling 
of saliva due to swallowing issues. This issue may be overcome by improving the 
time acquisition in the protocol.  
 
The T2-MRI study had included small number of patients with a limited range of 
neurological status on LEMG results. Therefore, based on this study, I could not 
make a conclusion whether T2-MRI anatomical metrics can be used to demonstrate 
the severity of paralysed muscles’ neurological status.  Future studies should recruit 
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more number of patients with wider temporal range, from acute phase to chronic 
phase of denervation.  
 
In the DCE-MRI and DWI study, as commensurate with the nature of the patients 
included within this study I did not obtain histological correlates of MRI findings. 
Further pre-clinical work in this area remains to be performed. 
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Appendix 1- ENT UK survey questionnaire 
Laryngeal reinnervation versus thyroplasty in unilateral vocal fold paralysis  
1. Do you see patients with unilateral vocal fold paralysis in your clinical practice?  
 
Yes/ No 
 
2. What proportion of your patients are adult laryngology patients? 
Less than 10%  
10 to 50%  
More than 50%  
 
3. How many cases a year do you see conforming to the following descriptions? 
An adult patient with unilateral vocal 
fold paralysis (UVFP) 
 
Adult UVFP showing no voice 
improvement following voice therapy 
 
 
4. What treatment option(s) would you consider for an adult patient with unilateral vocal 
fold paralysis, showing no voice improvement following voice therapy? 
Injection laryngoplasty  
Isshiki Type I Thyroplasty  
Laryngeal Reinnervation with or 
without medialisation 
 
Refer to other ENT Consultant/ 
Laryngologist (please specify the names 
and hospital of colleagues to whom you 
would refer in the box 
 
 
Other (please specify) 
 
 
 
5. Please indicate your preferred type of anaesthesia for the surgical options. 
 
 Preferred type of anaesthesia 
 General anaesthesia Local anaesthesia 
Injection laryngoplasty   
Isshiki type I thyroplasty   
 
6. If you do Isshiki Type I Thyroplasty, what would be your choice of implant? 
Silastic block implant  
Montgomery implant  
Gore-tex implant  
Titanium implant  
  Others(please specify)   
 
7. Have you performed any laryngeal reinnervation surgery in the last 5 years? 
 320 
Yes  
 
8. If a trial comparing the effectiveness of laryngeal reinnervation versus Isshiki type I 
thyroplasty for adult patients with UVFP due to isolated permanent recurrent laryngeal 
nerve paralysis showing no voice improvement following voice therapy was initiated, 
would you be willing to enter patients into such a trial? 
  
No. Please give reason in 
the box 
below 
 
Please provide reason if 
your answer is 'No' 
 
 
 
9. If you would like to participate in this trial, please provide your details below. 
Name   
Hospital   
Place  
 
10. If your patients are willing to enter the trial, would you 
Refer my patient to the 
principal investigator for 
both types of surgery 
 
 
Perform Isshiki type I 
thyroplasty in my own 
centre, but refer my patient 
to the principal investigator 
for laryngeal reinnervation 
 
Perform both sorts of 
surgery in my centre 
 
 
11. Would you like to receive training in 
 Yes  No 
Isshiki Type I Thyroplasty   
Laryngeal reinnervation   
 
12. What kind of hospitals are you practising in? 
District General Hospital  
University Teaching 
Hospital 
 
Private Hospital  
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13. Which of these tests are available in your centre? 
Videolaryngostroboscopy  
Acoustic studies  
Aerodynamic studies  
Laryngeal electromyography  
Fiberoptic endoscopic 
examination of swallowing 
(FEES) 
 
Videoflouroscopic swallow 
evaluation 
 
Magnetic resonance 
imaging 
 
 
14. Please feel free to make any further comments below 
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Appendix 2 – Participant information sheet 
(for patients with voice box weakness) 
   
Study title : Laryngeal Reinnervation versus Type I Thyroplasty (PhD Research 
Project) 
 
We would like to invite you to take part in our research study. Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you. One of our team will go through the information sheet with you 
and answer any questions you have. We suggest this should take about 10 minutes. 
 
Before you decide whether or not to take part, it is important to understand why the 
research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear, or if you would like more information. 
 
(Part 1 tells you the purpose of this study and what will happen to you if you take 
part.  
Part 2 gives you more detailed information about the conduct of the study). 
 
Thank you for reading this. 
 
PART 1 
 
1.1 What is the purpose of this study? 
One of the nerves to your voice box (larynx) is not working well and this is affecting 
your voice and possibly your swallowing and breathing. We want to compare two 
different operations used to treat this problem. In the first operation, we repair the 
neck nerves using parts of other, unaffected nerves instead (‘laryngeal 
reinnervation’). The alternative (traditional) method is to move around bits of tissue 
(cartilage) to give you a better voice. We do not know which of these methods is 
better and so invite you consider taking part in our research.  
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1.2 Why have I been invited?  
You have been invited because you have voice box weakness and may be 
swallowing problems due to nerve injury or of unknown cause. We need to do one of 
the above procedures to improve these problems. There will be 12 participants in 
total for this study  
1.3 Do I Have To Take Part? 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or not to take part, will not affect the 
standard of care you receive. 
 
1.4 What Will Happen To Me If I Take Part? 
Sometimes we don’t know which way of treating patients is best. To find out, we 
need to compare different treatments. We put people into groups and give each group 
a different treatment. The results are compared to see if one is better. To try to make 
sure the groups are the same to start with, each participant is put into a group by 
chance (randomly, so this is called ‘randomisation’). You have a 50-50 chance 
undergoing either treatment or operation. The two different operations are explained 
below: 
 
One operation (‘thyroplasty’) is carried out under local anaesthesia, with some 
medicine that makes you sleepy and relaxed. A small cut will be made on your neck. 
A small block made from a safe type of plastic will be placed into the side of your 
voice box, and this pushes the weak vocal cord into a position which is better for 
speech and swallowing. You would not have pain during the operation and you 
would not remember the operation. The operation lasts about 1 hour. 
 
The other operation (‘reinnervation’) is to improve the strength of the muscles in the 
voice-box and is carried out under general anaesthesia.  A small cut will be made on 
your neck. During the operation, the nerve supplying your voice box will identified 
and will be connected to the nerve which supplies one of the muscles on the front of 
your neck. Any changes in the way this neck muscle works after the operation are 
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not noticeable. At the same time a safe substance made of collagen will be injected 
into the weak vocal cord using a telescope through your mouth. The collagen 
injection is not permanent, but will give you some useful voice improvement while 
we wait for the result of the nerve rewiring to take effect. The operation lasts about 2 
hours. 
 
After either operation, you will be kept overnight at the RNTNE Hospital. Then, we 
will see you in clinic 3 month, 6 months and 12 months afterwards so that we can see 
how you are getting on. 
 
Before and after the operation we will:  
• record your voice at speech room as well using and a specially designed easy-
to-use portable voice recorder on an Apple ipod touch - OperaVOX™ 
• record your vocal cord movements using a camera connected to a telescope 
passed through the nose 
• measure your swallowing  
• measure how well the muscles are recovering using a special study described 
below (electromyography) 
• measure your breathing function by flow volume loop test 
Electromyography will be done in the clinic with you lying down.  It will be carried 
out by experienced doctors. One doctor will put tiny needles into the voice-box 
muscles being tested through the front part of neck. You will be asked to make 
sounds to test how each muscle moves. Typically, this takes about 10 minutes in 
total. You may experience brief pain or discomfort during insertion of the needles 
(similar to that when you have a blood test at the doctors), but most people find the 
tests fine. Rarely, there is temporary mild bleeding or bruising at the needle sites.  
 
We wish to also do an extra test that is not done normally for patients with your 
problem. The tests are called magnetic resonance imaging (MRI) that will be carried 
out at the University College London Hospital. For MRI, you lie down in a dark tube 
for up to 1 hour whilst the machine takes pictures of the voice box. These are like X-
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rays, but do not have the same risks as X-rays and give better pictures. However, 
some people find that lying in the tube is an uncomfortable experience. It is also 
noisy, but you will be given headphones to make it quieter and music can be played 
through these. MRI will be done before surgery and at 12 months after surgery.  
 
 
Diagram of events in this study 
 
Identification of patients at the ENT clinics in Central and East London 
 
 
Initial interview: if consent agreed and obtained, first questionnaires, voice 
recordings, throat examination and swallowing tests done. Electromyography, MRI 
and ultrasound scanning will be done according to available dates 
 
 
 
Randomisation (see above) 
 
Reinnervation plus collagen injection             Thyroplasty 
 
 
 
Operation 
 
 
Clinic visits at 3 month, 6 months and 12 months at the RNTNEH for more 
questionnaires, voice recordings and throat examination. Electromyography and MRI 
will be repeated at 12months after operation. Voice recordings using OperaVOX™ 
will be done at home monthly. 
 
 
1.5 Expenses and payments 
 326 
We will reimburse the travel expenses during visits either to RNTNEH or University 
College London Hospital for the purpose of this study. 
 
1.6 What will I have to do? 
People who have thyroplasty operations will be given an antibiotic called 
erythromycin. Please inform us if you are allergic to it for us to substitute it with 
other type of antibiotic. It is best if you stick to the dates of appointment for clinics. 
This is important for us to compare the changes after surgery between different 
people and operations. You need to let us know if there are any changes in your 
voice and swallowing problems after the surgery during the clinic visits. You will be 
asked to fill in questionnaires about these changes.  
It is important to inform the doctor if you are on any blood-thinning medications or if 
you have a bleeding disorder prior to having the electromyography performed. You 
are encouraged to wear a shirt or top that allows access to the lower neck and to 
avoid neck jewellery on the date of the exam. 
1.7 What are the alternatives for treatment? 
The alternative treatment available is injection of some sort of filling material into 
the affected vocal fold using a special instrument through mouth. However this 
treatment measure is not long lasting in most people and the injection may need to be 
repeated every few months.   
1.8 What are the side effects or disadvantages of taking part? 
Reinnervation and thyroplasty are established operations to treat a paralysed voice 
box (larynx) but there is not enough information to tell us which one is better since a 
study like this one has not been published yet.  
 
We do not predict any significant disadvantages in taking part in this study. If you 
are selected for the first operation, it will be done under general anaesthesia instead 
of local anaesthesia. An anaesthetist will do an assessment to identify any higher 
risks than normal of your having anaesthetic side effects. 
 
Both are safe operations with no significant risk or side effects reported in the 
literature. Reinnervation has a delayed effect because the rewired nerve needs at least 
three months to regain its function. However the delay in its effect should not be 
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noticeable as we will also inject some fat to temporarily improve the position of the 
vocal cord as described.  
 
Possible side effects of the operations are very similar: swelling of the neck, blood 
clot accumulation or infection of the wound, and difficulty in breathing may occur. 
These may occur with any form of surgery in the neck area, and are not uncommon. 
The chances of these happening are the same whichever operation you receive. 
 
You need to undergo two extra tests as part of this study which you would not have 
received if you were receiving treatment outside a trial. The tests are Magnetic 
Resonance Imaging (MRI) and ultrasound scanning which are described above. They 
will be performed at the University College London Hospital on the same day. We 
will repay any costs you have to pay out to attend these scans.  
 
With regards to the MRI and ultrasound scanning, there would be no risk of exposure 
to radiation. However some people might experience claustrophobia (a feeling of 
stuffiness due to being in a small space) with MRI. 
1.9 What are the possible benefits of taking part? 
The main benefit is the knowledge that you are helping to improve care for future 
patients who may have the problem and who need the operation. By taking part in 
this study we will know which procedure is more effective in improving the voice 
and swallowing. 
1.10 What happens when the research study stops? 
You will be getting regular clinic visits after the trial to monitor the long term 
changes. Additional treatment will be provided if necessary. The monitoring will be 
done by the chief investigator and his team. 
 
You will be informed about the continuation of treatment after the trial. This would 
not incur any additional costs since it is part of daily clinical practice.  The 
conclusion of the trial will be presented at an international conference and will be 
sent for publication. The conclusion of this study will indicate the feasibility of a 
bigger trial which will be carried out accordingly and in due course. The trial results 
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will provide some evidence of efficacy because randomisation will be performed but 
it will be inadequate due to the small number of subjects. 
1.11 What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this is 
given in Part 2. 
 
1.12 Will my taking part in the study be kept confidential? 
 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The details are included in Part 2. 
PART 2 
2.1 What if new information becomes available? 
Sometimes during the course of a research project, new information becomes 
available about the treatment that is being studied. If this happens, the study doctor 
will tell you about it and discuss with you whether you want to continue to take part. 
If you decide to withdraw, your operation will proceed as normal. If you decide to 
continue, you will be asked to sign an updated consent form.  
 
2.2 What will happen if I don’t want to carry on with the study?  
At any stage prior to surgery, you can decide to withdraw from the study.  You can 
withdraw from treatment but keep in contact with us to let us know your progress. 
Information collected may still be used. Your doctor will look after you normally, 
the same as if the study were not happening at all.  Withdrawing from the study will 
not affect your treatment in any way and you will not offend anybody by doing so. 
You are also free to ask the opinion of your GP, or other doctors and nurses about the 
study if you wish. 
2.3 What if there is a problem? 
Every care will be taken in the course of this study.  However, in the unlikely event 
that you are injured by taking part, compensation may be available.  
If you suspect that the injury is the result of the Sponsor’s (University College 
London) or the hospital's negligence then you may be able to claim compensation.  
After discussing with your research doctor, please make the claim in writing to the 
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Professor Martin Birchall who is the Chief Investigator for the research and is based 
at the RNTNEH. The Chief Investigator will then pass the claim to the Sponsor’s 
Insurers, via the Sponsor’s office. You may have to bear the costs of the legal action 
initially, and you should consult a lawyer about this. 
 
Regardless of this, if you wish to complain, or have any concerns about any aspect of 
the way you have been approached or treated by members of staff or about any side 
effects (adverse events) you may have experienced due to your participation in the 
research, the normal National Health Service complaints mechanisms are available to 
you. Please ask your research doctor if you would like more information on this. 
Details can also be obtained from the Department of Health website: 
http://www.dh.gov.uk.  
2.4 Will my taking part in this study be kept confidential? 
Information collected about you during the course of the research will be kept strictly 
confidential. Any data that have your identifiable personal data will be removed. 
Names would not be written in full but with the first letter of given name and 
surname with number coding. Electronic data will be kept in computers secured with 
password and non-electronic data will be kept in a locked cabinet. The data is only 
accessible by the research team members. No data will be kept in laptops. If there is 
pressing need to do so, the data will be saved in an encrypted file. The personal data 
confidentiality will follow the NHS Code of Confidentiality. 
 
In accordance with current UCL Records Management Policy, research findings will 
need to be stored by UCL as sponsor for 20 years after the research has finished. The 
UCL Records Office provides a service to UCL staff and maintains archived records 
in a safe and secure off site location. All activities are conducted in accordance with 
the Data Protection Act and UCL Data Protection Policy. Access to the data is 
strongly regulated and permissions to access the data are treated case by case.  
2.5 Involvement of the General Practitioner/Family doctor (GP)   
Your GP will be notified of your participation in this study with your permission. 
2.6 What will happen to any samples I give? 
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There wouldn’t be any blood or tissue sample taken. Your voice and voice box 
findings will be recorded to monitor and analyse the changes. The recordings will be 
kept in computers encrypted with password. 
2.7 What will happen to the results of the research study? 
We hope to recruit twelve participants into this study.  Once it has all been 
completed we will present the results at an international meeting attended by doctors 
from around the world. After this, we will publish the results in an appropriate 
scientific journal.  This could take about a year in total. If you wish, we will make 
sure you receive your own copy of the results and paper as soon as we have them. 
2.8 Who is organising and funding the research? 
The sponsor is the University College London. So far the research is funded by the 
internal funding. The internal funder will pay RNTNEH for including you in this 
study.  
2.9 Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by the Research Ethics Committee. 
 
You will be given a copy and a signed consent form to keep. 
2.10 What if I have other concerns? 
The general information about this research will be available at the Ear Institute website 
http://www.ucl.ac.uk/silva/ear/staff/marinamatbaki. To get the specific information 
about this research project, you need to contact the researcher (Professor Birchall or Marina -  
020 7915 1308). Alternatively, you may email as below. 
If you have any concerns or questions, you may contact any one of the researchers 
listed below for advice at the Royal National Throat Nose and Ear Hospital, tel: 020 
7915 1308. Leave your contact number to Anne Oliphant for the researchers to return 
your call. 
 
Professor Martin Birchall, Consultant and Professor of Head and Neck Surgery 
(m.birchall@ucl.ac.uk) 
Dr Marina Mat Baki, PhD Student in laryngology (sjjgmbm@live.ucl.ac.uk) 
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Appendix 3 – Voice Handicap Index (VHI-10) 
Instructions: These are statements that many people have used to describe their voices and 
the effects of 
their voices on their lives. Circle the response that indicates how frequently you have the 
same experience. 
0 = never 1 = almost never 2 = sometimes 3 = almost always 4 = always 
Fl. My voice makes it difficult for people to hear me. 0 1 2 3 4 
F2. People have difficulty understanding me in a noisy 
room 
0 1 2 3 4 
F8. My voice difficulties restrict personal and social life 0 1 2 3 4 
F9. I feel left out of conversations because of my voice 0 1 2 3 4 
F10. My voice problem causes me to lose income 0 1 2 3 4 
P5. I feel as though I have to strain to produce voice 0 1 2 3 4 
P6. The clarity of my voice is unpredictable 0 1 2 3 4 
E4. My voice problem upsets me 0 1 2 3 4 
E6. My voice makes me feel handicapped 0 1 2 3 4 
P3. People ask, “What’s wrong with your voice?” 0 1 2 3 4 
VHI-10 = _______ 
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Appendix 4 - Eating Assessment Tool (Eat-10) 
Tick the appropriate response 
To what extent are the following scenarios problematic for you? 
0 = no problem 
4 = severe problem 
1 My swallowing problem has caused me to lose 
weight 
0 1 2 3 4 
2  My swallowing problem interferes with my 
ability to go out for meals 
0 1 2 3 4 
3 Swallowing liquids takes extra effort 0 1 2 3 4 
4 Swallowing solids takes extra effort 0 1 2 3 4 
5 Swallowing pills takes extra effort 0 1 2 3 4 
6 Swallowing is painful 0 1 2 3 4 
7 The pleasure of eating is affected by my 
swallowing 
0 1 2 3 4 
8 When I swallow food sticks in my throat 0 1 2 3 4 
9 I cough when I eat 0 1 2 3 4 
10 Swallowing is stressful 0 1 2 3 4 
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Appendix 5- Stroboscopy Research Instrument 
Stroboscopy Research Instrument 
Normal = 0; Mild = 1; Moderate = 2; Severe = 3 
Amplitude normal mild mod severe none 
Right 
Left 
Periodicity normal mild mod severe none 
Right 
Left 
Non-
vibratory 
segment 
none Anterior 
1/3 
Middle 
1/3 
Posterior 
1/3 
The 
whole 
vocal 
Right 
Left 
Duration of 
closure 
Predominately 
closed 
½ 
closed 
½ 
opened 
Predominately 
opened 
Always 
open 
Asymmetry 
normal mild mod severe Symmetry of mucosal displacement 
Mucosal segments that  
do not participate in vibratory 
activity 
Duration of mucosal 
contact during vocal 
fold vibration 
Is the horizontal excursion away 
from midline reduced? 
How irregular is the frequency of 
vibration of each vocal fold? 
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Appendix 6 – Stage I and II MRI study  
Stage I: Protocol development 
 5 healthy volunteers who do not have any voice problems were invited to 
participate. A protocol for anatomical metrics (T2 weighted imaging, T1 weighted 
imaging) and functional metrics (diffusion weighted imaging, dynamic contrast 
enhanced imaging, cine imaging for vocal fold mobility) on 3T MRI will be 
determined. The final protocol was then used for Phase II, feasibility study to find 
out whether it is feasible on UVFP patients. The final protocol that comprises T1-
weighted imaging (non-fat suppression), post-contrast T1-weighted imaging (fat 
suppression), T2-weighted imaging, diffusion weighted imaging (DWI), dynamic 
contrast enhanced MRI (DCE-MRI) and cine-MRI (Table 1) 
Table 1: Protocol developed for MRI larynx on 3Tesla machine 
 T1 
weighted  
T2 
weighted  
DWI DCE-MRI Cine-MRI 
Sequence Name SE SE-TSE SE-EPI FFE FFE 
Repetition time (ms) 450 4000 2000 4.4 1.98 
Echo time (ms) 10 100 80 2.2 0.78 
Image resolution 348x310 300x297 116x115 188x186 160x120 
Slice thickness 2.5mm 2.5mm 5mm 3mm 10mm 
Number of slices 25 28 14 24 3 
No of averages 6 4 6 1 1 
Diffusion weighting 
(b-value) 
n/a n/a 0, 50, 100, 
300, 600, 
1000 
n/a n/a 
Temporal resolution 
(s) 
n/a n/a n/a 19.1 0.736 
Total acquisition 
time (mins) 
9min 9sec 10min 
42sec 
10min 
4sec 
11min 
10sec 
1.28 
 
Stage II: Feasibility study 
Five healthy volunteers and 5 UVFP patients identified from ENT clinics were 
invited to participate. These patients were scanned using a 3T MRI scanner using the 
final protocol in table 4 that has been developed in stage I.  
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Imaging was performed on a 3T Philips Achieva multi-transmit MRI scanner using 
the manufacturers 16 channel head and neck coil. MRI was performed to evaluate 
macrostructure (muscle bulk and fatty change – T1/T2 weighted imaging), 
microstructure (cellularity/perfusion – diffusion weighted imaging), vascularity 
(perfusion characteristics – dynamic contrast enhanced imaging) and motion 
(movement during phonation – cine MRI) as per protocol from stage I study. All of 
the patients had laryngeal electromyography performed to confirm vocal cord 
paralysis and the findings were classified according to Koufman and Walkers 
classification (Koufman et al., 2001). 
 
RESULTS 
A. Macrostructure 
I. Image quality assessment 
Two head and neck radiologist consultants review the images of 5 healthy volunteers 
and 4 UVFP patients acquired using the protocol developed. Majority of the coronal 
T2-weighted images (Figure 1, Figure 2) and cine-MRI (Figure 3) for vocal cord 
motion had been scored as good and for the axial T2-weighted images majority was 
excellent. None of the images were rated as very poor.  On the other hand, majority 
of the T1 weighted images (Figure 4, Figure 5) were rated as fair with some of them 
were of very poor quality.  
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Figure 2: Image quality evaluation 
of axial T2-weighted imaging for 
PCA muscle 
Figure 1: Image quality evaluation 
of coronal T2-weighted imaging 
for TA muscle 
Figure 3: Image quality evaluation 
of cine imaging for vocal fold 
mobility 
Figure 4: Image quality evaluation 
of T1-weighted imaging for TA 
muscle
Figure 5: Image quality evaluation of 
T1-weighted imaging for PCA 
muscle
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II. Quantitative result 
 
Five UVFP patients and 5 healthy volunteers with matched age had undergone MRI 
scan on a 3Tesla MRI machine according to the protocol developed. Only 3 patients 
had their TA muscles analysed because the other 2 patients had injection 
laryngoplasty to their vocal folds. T2-weighted imaging generally showed muscle of 
the paralysed PCA was smaller than the opposite normal and the volunteers’ PCA. 
The absolute value of difference (ABSD) between paralysed and normal muscle in 
patients was significantly larger compared to volunteers (Table 2) except in one 
patient. There were also abnormal signal changes on the paralysed muscles (Figure 
5). The signal was more hyperintense on the paralysed muscles therefore the ratio of 
mean signal intensity of normal muscles to the opposite paralysed muscle was 
significantly smaller than the volunteers’ right to left normal muscles (Table 2). 
Similar findings were also seen on TA muscles (Figure 7)(Table 3). 
 
 
 
 
 
 
 
 
Figure 6: T2 weighted axial images through the 
vocal cord muscles in a patient with left vocal 
cord paralysis (arrowhead). Note increased 
relative T2 signal of the paralysed left PCA 
muscle 
Figure 7: T2 weighted coronal images through 
the vocal cord muscles in a patient with left 
vocal cord paralysis (arrowhead). Note 
increased relative T2 signal and smaller bulk of 
the paralysed left TA muscle 
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Table 2: Muscle bulk and signal intensity of posterior cricoarytenoid muscle. 
ABSD: Absolute value of difference 
SD: Standard deviation 
IQR: interquarile range 
Variables Vocal fold paralysis (5 
subjects, 5 paralysed 
vocal folds) 
Volunteers (5 subjects, 
10 normal vocal folds) 
Age, mean (SD) 44.0 (16.53) 32.4 (5.98) 
Independent t-test P = 0.187 
Gender Female (4) Female (3) 
Muscle bulk 
Median (IQR)  0.19 (0.16, 0.34) 0.493 (0.3, 0.5) 
Mann-Whitney test P = 0.008 
Median (IQR) ABSD 0.97 (0.43, 01.67) 0.28 (0.005, 0.09) 
Mann-Whitney U 
test 
P = 0.009 
Signal intensity  
Ratio R vs L or N vs P 
Median (IQR)  0.61 (0.55, 0.82) 1.01(0.97, 1.19) 
Mann-Whitney U 
test 
P = 0.016 
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Table 3: Muscle bulk and signal intensity of thyroarytenoid muscle. 
Variables Vocal fold paralysis (5 
subjects, 5 paralysed 
vocal folds, 2 missing 
data) 
Volunteers (5 subjects, 
10 normal vocal folds) 
Muscle bulk 
Median (IQR)  0.23 (0.21, 0.27) 0.40 (0.39, 0.80) 
Mann-Whitney U test P = 0.01 
Median (IQR) ABSD 0.72 (0.63, 01.79) 0.04 (0.01, 0.08) 
Mann-Whitney U test P = 0.025 
Signal intensity  
Ratio R vs L or N vs P 
Median (IQR)  0.47 (0.46, 0.51) 1.08 (1.0, 1.15) 
Mann-Whitney U test P = 0.025 
ABSD: Absolute value of difference 
SD: Standard deviation 
IQR: interquarile range 
R : right, L : left, N : normal, P : paralysed 
B. Microstructure 
I. Diffusion weighted imaging (DWI) 
Mean apparent diffusion coefficient (ADC) value for low b values that represent 
perfusion of healthy volunteers was 2.4±0.5 x10-3mm2s-1 (Table 4). The ADC value 
of paralysed vocal fold increased in one patient whereas in the other 2 patients, it was 
decreased. This preliminary result indicates a higher perfusion in 1 patient whereas 
the other 2 patients showed lower perfusion related ADC on the paralysed side of the 
TA muscles. Reliable signal of PCA muscles could not be acquired on the DWI. 
Future work will focus on low b values of DWI and improvement of signal to noise 
ratio.  
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Table 4: ADC thyroarytenoid muscles of volunteers 
Thyroarytenoid muscle 
Volunteer 
ADC of low b values 
(0, 50, 100) 
x10-3mm2s-1
Right Left 
V01 2.15 2.13 
V02 2.35 2.52 
V03 2.19 1.60 
V04 1.88 2.80 
V05 3.12 3.17 
Mean (SD) 2.4 (0.5) 
Table 5: ADC thyroarytenoid muscles of patients 
Thyroarytenoid muscle 
Patient 
ADC 0f low b values 
(0, 50, 100) 
x10-3mm2s-1
Right Left 
P01 
4.22 6.71 
P02 injection injection 
P03 injection injection 
P04 2.28 1.47 
P05 2.86 2.04 
Injection : injection laryngoplasty done on the vocal cords 
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II. Dynamic contrast enhancement imaging (DCE)
Time intensity curve (TIC) was generated for all participants except one patient who 
had too much movement on the TA muscle during image acquisition that a 
reasonable TIC could not be generated. Differences of DCE parameters between two 
vocal fold muscles of the same subject were shown in ratio ‘right to left’ in 
volunteers and ‘normal to paralysed’ vocal cord in patients (Table 6, Table 7). A 
bigger ratio ‘more than 1’ in patients indicates a bigger value in the normal than the 
paralysed vocal folds. Mean ratio ‘close to one’ indicates that there is not much 
difference between the 2 vocal cords. Mean ratio of slope, ME and AUC in 
volunteers between right and left of PCA and TA muscles were closed to 1. Mean 
ratio of slope in patients was 1.67, far ‘larger than 1’, which indicates lower rate of 
initial enhancement of the paralysed muscles than the opposite normal muscles 
although it was not statistically significant different from the volunteers group. The 
mean of ME and AUC of patients were close to one. However if we analyse the 
parameters by case-to-case basis (Table 8), 3 patients with high vagal paralysis 
showed lower slope, ME and AUC of the PCA muscles than the normal opposite 
PCA muscles whereas the other 2 patients who had recurrent laryngeal nerve 
paralysis had almost similar values of all the metrics except the slope in patient 05. 
On the other hand, these 2 patients’ paralysed TA muscles showed smaller slope and 
AUC than the opposite normal TA muscles. Regarding patterns of TIC of both 
normal TA and PCA muscles of healthy volunteers after reaching the initial 
maximum, most of them showed type B, 3 had type A and 1 had type C. Normal 
vocal fold muscles in patients showed mostly type B except in 2 patients, 1 was type 
A and the other one was type C. The opposite paralysed vocal folds showed the 
similar type of TIC but with smaller slope, ME or AUC. All of the TIC patterns of 
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the paralysed vocal cord muscles did not show evidence of wash-out pattern except 
in the paralysed PCA of patient 04.  
Table 6: Ratio of DCE parameters of posterior cricoarytenoid (PCA) muscles 
Mean (SD) ratio of DCE parameters – PCA muscles 
 
SoE ME AUC 
Volunteers  
Mean (SD) 1.03 (0.17) 1.07 (0.08) 0.95 (0.07) 
Median (IQR) 0.99 (0.74,1.35) 1.02 (0.94,1.23) 0.94 (0.90,1.01) 
 Patients 
Mean (SD) 1.67 (0.71) 1.14 (0.23) 1.07 (0.11) 
Median (IQR) 1.51 (1.16,2.26) 1.05 (0.94,1.38) 1.11 (0.94,1.17) 
Mann Whitney 
U test p = 0.175 p = 0.754 p = 0.117 
SD: Standard deviation 
IQR: interquartile range 
Table 7: Ratio of DCE parameters of thyroarytenoid (TA) muscles 
mean (SD) ratio of DCE parameters – TA muscles 
slope ME AUC 
Volunteers 1.11 (0.33) 1.04 (0.13) 1.01 (0.25) 
Patient 04 1.92 0.73 1.14 
Patient 05 1.71 1.17 1.14 
SD: Standard deviation 
DCE: Dynamic contrast enhancement 
ME: Maximum enhancement AUC: 
Area under the curve 
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Table 8: Summary of UVFP patients results 
Patient 01 Patient 02 Patient 03 Patient 04 Patient 05 
Age 40 18 52 61 51 
Gender F M F F F 
Palsy Left Left Left Left Left 
Duratio
n 
1 year 2 years 1 month 5 months 8 months 
Etiolog
y 
Vagal 
paragangliom
a (tumour 
compression) 
Skull base 
meningioma 
(post-
excision) 
Vagal 
paragangliom
a (post-
excision) 
Thyroidectom
y (benign) 
Thyroidectom
y (papillary 
carcinoma) 
LEMG Class III Class V Class V Class III Class IV 
MUAP +1 0 0 +1 +1 
PU +1 0 0 +3 +3 
FP 0 +3 +3 0 +1 
*Surger
y 
Nil Hydroxyapetit
e IL 
Collagen IL Nil Nil 
Muscle bulk (ABSD) 
TA  Reduced 
0.153 
Injected Injected Reduced 
0.121 
Reduced 
0.266 
PCA Reduced 
0.232 
Reduced 
0.352 
Similar 
0.047 
Reduced 
0.167 
Reduced 
0.236 
Signal intensity (ratio) 
TA 0.55 Injected Injected 0.45 0.47 
     PCA 0.99 0.55 0.65 0.61 0.55 
DCE 
(ratio) 
PCA TA PCA TA PCA TA PCA TA PCA TA 
SoE 2.85 1.37 1.51 0.97 1.92 1.66 1.71 
ME 1.38 1.39 1.05 0.87 0.73 0.99 1.17 
AUC 1.17 1.16 1.11 0.93 1.13 0.95 1.14 
DWI 
Low b 
values 
N= 4.22 
P= 6.71 
N= 2.28 
P= 1.47 
N= 2.86 
P= 2.04 
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PU = Polyphasic unit 
FP = Fibrillation potential 
* : surgical intervention prior to MRI
Injected = Patients had undergone injection laryngoplasty 
ABSD = Absolute value of difference 
N = Normal muscle 
P = Paralysed muscle 
MUAP: Motor unit action potential 
C. Vocal fold mobility 
RESULTS: 3T-MRI cine scans demonstrated good quality of dynamic images 
enables measurement of vocal fold motion by measuring the glottal area (GA) 
(Figure 8, Figure 9). One of the patients, phonation area was not able to visualise 
down to distortion of the images probably due to vocal cord compensation and small 
bilateral laryngocoeles. In the normal volunteers, the ratio of glottal area during 
respiration or phonation was near to 1 with time (Figure 10, Figure 11). The mean 
PR across time was 0.97±0.12 and the mean RR across time was 0.94±0.1 (Table 9). 
This indicates that the vocal folds able to abduct and adduct equally exhibiting equal 
right and left GA. In UVFP patients, who all had left paralysis, the ratio of glottal 
area during respiration or phonation was far less or more from 1 with time (Figure 
12, Figure 13). The mean PR was 0.58±0.27 and the mean RR was 1.66±0.16 (Table 
9). The ratio calculated was right to left so a low PR indicates left paralysis since the 
left phonation area was bigger due to inability of the vocal fold to adduct and a high 
RR indicates that the right respiration area was bigger due to the ability of the right 
normal vocal fold to abduct. 
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Table 9: Phonation ratio (PR) and respiration ratio (RR) of volunteers and patients 
Subjects PR (SD) RR (SD) 
Volunteers 0.97±0.12 0.94±0.1 
Patients 0.58±0.27 1.66±0.16 
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Figure 8: Images taken from cine imaging of volunteers depict phonation area 
(left column) and respiration area (right column). The left and right respective 
area was of similar size 
Volunteer 01 
Volunteer 02 
 
Volunteer 03 
 
Volunteer 04 
Volunteer 05 
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Figure 9: Images taken from cine imaging of UVFP patients depict phonation area 
(left column) and respiration area (right column). There was discrepancy between 
left and right respective area. Patient 02 phonation area was not visualised. 
 
Patient 1 
Patient 2 
Patient 3 
Patient 4 
Patient 5 
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Figure 10: Respiration area right and left glottal area of a healthy volunteer. Note 
that the ratio across time is near to 1 
 
         
Figure 11: Phonation area right and left glottal area of a healthy volunteer. Note that 
the ratio across time is near to 1 
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Figure 12: Respiration area of a patient with left vocal fold paralysis (arrow head). 
Note that the ratio across time if far more than 1 
 
             
Figure 13: Phonation ratio of a patient with left vocal fold paralysis (arrow head). 
Note that the ratio is far less than 1 across time 
 
